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Abstract  
Inadequately treated wastewater effluent serves as a reservoir of potentially pathogenic bacteria and 
contributes to the spread of these organisms in the environment, including Staphylococcus aureus (S. 
aureus), a faecal bacterium known to cause pneumonia, septicaemia and skin infections in humans. The 
presence of S. aureus in water has become problematic as it has been shown to exhibit resistance 
towards β-lactam antibiotics commonly used to treat infections, including methicillin, leading to the 
emergence of methicillin-resistant S. aureus (MRSA). The current study aimed to determine the 
prevalence of MRSA and mecA (known to induce methicillin resistance) in the influent, treated effluent 
and receiving surface rivers of two wastewater treatment plants (WWTPs) in Durban. The study also 
evaluated the antibiogram and virulence gene profiles of MRSA isolates recovered from the treated 
effluent and receiving surface water using the Kirby-Bauer disc diffusion and PCR assays. Genetic 
fingerprinting was carried out to determine the phylogenetic relationship between isolates with selected 
antibiogram profiles. The prevalence of MRSA in WWTP1 ranged from 11.45-85.63% 
(influent), 16.28-39.36% (before chlorination), 2.16-5.07% (after chlorination), 1.06-7.24% 
(downstream) and 4.95-14.09% (upstream). In WWTP2, the prevalence of MRSA for the 
influent ranged from 48.25-86.18%, before chlorination; 23.73-93.75%, after chlorination; 
4.28-48.82%, downstream; 1.74-19.31% and upstream; 5.90-28.78%. Correlation studies of 
selected physico-chemical parameters to the prevalence of MRSA was carried out. The real-
time PCR assay showed a reduction in the concentration of mecA from the influent to the treated 
effluent in both WWTPs. The highest resistance was observed towards lincomycin (100%), followed 
by oxacillin (98.75%), cefoxitin and penicillin (97.50%) and ampicillin (96.25%). Additionally, 
72.50%, 66.25%, 52.50%, 40% and 33.75% of the isolates showed resistance against cefozolin, 
azithromycin, amoxicillin/clavulanic acid, erythromycin and vancomycin, respectively. The following 
antibiotic resistance genes were detected in resistant isolates: aac(6ꞌ)/aph(2ꞌꞌ) in 56.25%, ermC in 
62.50%, msrA in 22.50% and blaZ and tetK in 70%. The virulence genes hla and sea were detected in 
57.50% of the isolates, hld in 1.25% and the lukS P/V gene was not detected. Thirteen pulsotypes 
 v 
 
(designated A-M) was generated for selected isolates using pulse field gel electrophoresis, correlating 
them to their respective antibiograms. The study revealed a lower prevalence of MRSA and 
concentration of mecA in the treated effluent as compared to the influent of both WWTPs. It also 
revealed that these multi-drug resistant strains, isolated from the treated effluent and receiving surface 
waters, are potentially pathogenic and could contribute to the spread of disease in the environment. 
Hence, the need for more stringent monitoring and evaluation of treatment performance of the WWTPs. 
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CHAPTER ONE 
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1.0 Introduction 
Water is considered to be an important and precious resource as it supports all life (Reda, 2016). 
It is used for various domestic and industrial purposes, such as in food production, irrigation 
and electricity generation (Shukla et al., 2013). Access to safe drinking water is vital for the 
sustainable development and improvement of the quality of life in both developing and 
developed countries (Reda, 2016). It is estimated that 2.1 billion of the global population do 
not have access to reliable and safe water and 2.3 billion do not have access to proper sanitation, 
resulting in the spread of waterborne diseases (WHO and UNICEF, 2017). An increasing 
population size, high number of immunocompromised patients, poor water supply, inadequate 
sanitation and interruptions of water supply places the South African population at risk of 
developing infectious intestinal diseases (Luyt et al., 2012; Kumar et al., 2015). Additionally, 
inefficient wastewater management and practices have led to the disposal of improperly treated 
wastewater effluents into natural water bodies (Kumar et al., 2015).  
This improperly treated effluent may harbour potentially pathogenic microorganisms, 
including strains of Vibrio cholerae, Salmonella spp., Shigella spp., Escherichia coli and 
Staphylococcus aureus (S. aureus) (Almagro-Moreno and Taylor, 2013). In addition, 
wastewater treatment plants (WWTPs) could serve as a reservoir for antibiotic resistant 
bacteria (ARB) and antibiotic resistance genes (ARGs) (Thapaliya et al., 2017). Contamination 
of receiving surface waters with improperly treated effluent may lead to the spread of water-
related diseases as well as contribute to the dissemination of ARB and ARGs in the 
environment (Pandey et al., 2014). 
S. aureus has been associated with a variety of infections which include; pneumonia, 
septicaemia, skin and soft tissue infections. Challenges have emerged in treating these 
infections due to resistance to antibiotics such as methicillin. The first isolated methicillin 
resistant S. aureus (MRSA) was related to clinical settings (Börjesson et al., 2009). However, 
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infections emerged amongst people who were not exposed to this risk factor and cases of 
unrelated, clinical-associated MRSA infections have since increased (Börjesson et al., 2009). 
According to Goldstein et al. (2012), improperly treated effluent from WWTPs are possible 
reservoirs for MRSA and that its discharge into surface waters exposes many communities to 
MRSA. Goldstein et al. (2012) and Thompson et al. (2013) have detected MRSA in municipal 
and hospital wastewaters, respectively. Other studies have reported an increased survival span 
of MRSA in river and sea waters (Thapaliya et al., 2017). Few studies have been reported on 
the detection and characterization of MRSA from treated wastewater effluent and receiving 
rivers. The discharge of improperly treated wastewater effluent containing some MRSA strains 
into receiving surface waters may expose individuals and animals who come into contact and/or 
use this water to MRSA, resulting in the potential rapid spread of antibiotic resistant infections 
(Goldstein et al., 2012; Thapaliya et al., 2017). Therefore, effluent of WWTPs and receiving 
surface waters must be regularly assessed to ensure good quality treated wastewater effluent is 
discharged into water bodies to protect the health of the general public (Kumar et al., 2015).  
1.1 Scope of the study: 
According to Börjesson et al. (2010), treated wastewater effluent and its respective receiving 
surface waters have become a reservoir for MRSA. The mecA gene, which encodes for a 
penicillin binding protein that confers resistance to methicillin in S. aureus (David and Daum, 
2010; Al-Abbas, 2012; Rahimi and Shokoohizadeh, 2016), has also been detected in the 
influent and treated effluent of WWTPs (Börjesson et al., 2009). The presence of MRSA in 
treated effluent and its respective receiving surface waters could pose a health threat to those 
who rely on these water sources for domestic and agricultural purposes (Goldstein et al., 2012). 
Previous studies carried out by Goldstein et al. (2012) not only revealed the presence of MRSA 
in treated wastewater effluent of four WWTPs, but also showed that isolated strains were multi-
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drug resistant and harboured virulence genes. The discharge of MRSA into the environment 
poses a health threat to those with weakened immune systems as well as promotes the 
dissemination of antibiotic resistant and virulent bacterial strains in receiving water bodies. 
Thus far, studies in South Africa have mainly focused on characterization of MRSA in clinical 
strains (Moodley et al., 2010).  To the best of our knowledge, no studies have reported on the 
characterization of antibiotic resistance and virulence gene attributes of MRSA isolates 
obtained from the treated effluent of WWTPs and receiving rivers in Durban, South Africa.  
This project aimed to determine the prevalence of MRSA in treated wastewater effluent and 
receiving rivers of two independent WWTPs in Durban, Kwa-Zulu Natal. The study also aimed 
to quantify the mecA gene and correlate it to the microbial counts from each respective 
sampling point to determine if WWTPs contribute to the spread of resistant bacteria and 
resistance genes in the environment. Further, the study aimed to determine the antibiogram and 
virulence gene profiles of the MRSA isolates. Screening for the presence of virulence genes 
will provide information on the potential pathogenicity of MRSA and the role of these WWTPs 
in the spread of MRSA in communities and the environment through the receiving rivers. The 
antibiogram analysis will reveal the resistance/susceptibility profiles of the isolates and will 
allow for better understanding of the treatment regime required to control MRSA-associated 
infections in affected communities. It also aimed to determine possible correlation between 
antibiotic resistant phenotype and genotype of the resistant MRSA strains.  
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1.2 Hypotheses: 
It is hypothesized that there is a high prevalence of MRSA in treated wastewater effluent of the 
investigated WWTPs and their respective receiving surface waters. It is also hypothesized that 
MRSA isolates from the treated effluent are multi-drug resistant, and harbour antibiotic 
resistance and virulence determinants. It is further hypothesized that isolates with similar 
antibiograms may be genetically related.  
1.3 Aims:  
1.3.1. To determine the prevalence of MRSA in the treated wastewater effluent and receiving 
surface waters by enumerating presumptive MRSA and S. aureus in the water sample using 
the membrane filtration technique and appropriate selective media over a six-month period and 
by quantifying the mecA gene in the water sample using real-time PCR.  
1.3.2. To confirm the identity of MRSA isolates from the water sample using the catalase, 
oxidase and coagulase tests and PCR amplification of the mecA gene. 
1.3.3. To determine the antibiotic resistance/susceptibility profile using the Kirby-Bauer disc 
diffusion assay. 
1.3.4. To detect the presence of specific antibiotic resistance genes (aac(6ꞌ)/aph(2ꞌꞌ), blaZ, 
ermC, msrA and tetK) using PCR. 
1.3.5. To detect the presence of specific virulence genes (hla, hld, lukS/F PV and sea) using 
PCR. 
1.3.6. To determine the genetic fingerprint using pulsed field gel electrophoresis. 
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1.4 Objectives: 
1.4.1. To determine the prevalence of MRSA and S. aureus in the treated effluent and receiving 
surface waters of two independent wastewater treatment plants (WWTPs) in the Durban area 
via plate count method and q-PCR quantification of mecA gene. 
1.4.2. To isolate, purify and identify MRSA recovered from treated effluent of these WWTPs 
and receiving rivers using appropriate biochemical and molecular tests. 
1.4.3. To determine the antibiotic resistance profiles of the MRSA isolates. 
1.4.4. To profile the virulence gene signatures of the MRSA isolates. 
1.4.5. To determine the genetic diversity of selected MRSA isolates. 
1.5 Layout of the dissertation: 
The dissertation is divided into five chapters. Chapter one deals with a general introduction. It 
also highlights the scope of the study, hypotheses, objectives and aims which were carried out. 
Literature reviews related to this study is presented in chapter 2, whilst chapter three focuses 
on the prevalence of MRSA and quantification of the mecA gene present in wastewater influent, 
effluent and receiving surface waters. Chapter four deals with the characterization of MRSA 
recovered from treated effluent and receiving rivers, focusing on their antibiogram, virulence 
gene signatures and genetic fingerprints. Chapter five conclude and summarizes the findings 
of this study and highlights future aspects of the study.  
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Literature Review 
2.1 Introduction  
Water is vital for the existence of life; hence, must be easily accessed to all (Cabral, 2010). 
Water is used for sanitation, in agriculture and most importantly for drinking (Cabral, 2010). 
However, water shortages and an insufficient supply of good quality water have led to major 
concerns in environmental, industrial and municipal sectors (Kumar et al., 2015). In many 
countries of African continent, little or no access to proper sanitation or functional wastewater 
treatment systems have led to contamination of water bodies which include rivers and lakes, 
bearing major consequences for public health and the environment (Bateganyaa et al., 2015; 
Jhansi and Mishra 2013). Faecal contamination of water resources has led to the spread of 
waterborne diseases (Kumar et al., 2015). According to the World Health Organization (WHO) 
and UNICEF, it is estimated that 159 million people drink water from untreated water sources 
and 2.3 billion people lack proper sanitation.  The death toll for children under 5 years reached 
361 000 due to diarrhoeal diseases transmitted through water (WHO and UNICEF, 2017). A 
sustainable development goal of WHO is to provide people with free to access water, from a 
safe and reliable water source, without faecal or chemical contamination (Hunter et al., 2010). 
Therefore, it is important that strict regulations be implemented globally to allow people their 
basic right, to access safe water. 
2.2 Overview of water in South Africa 
South Africa is a semi-arid country making water a precious natural resource (Pitman, 2011). 
Hedden and Cilliers (2014) reported that South Africa receives an annual average rainfall of 
495 mm, far below the global average of 1033 mm, making it the 30th driest country in the 
world. This is alarming considering that the water used per capita (253 litres per day) is above 
the global average of 173 litres per day (Hedden and Cilliers, 2014). 
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The increase demand on water resources and service delivery of domestic water is highly 
influenced by the relocation of people into industrialized provinces (such as Gauteng) (Luyt et 
al., 2012). Reasons for poor water quality in South Africa include but are not limited to poor 
service delivery, the lack of proper infrastructure, acid mine drainage, interruptions of water 
supply due to burst pipes, low maintenance of communal taps and poor waste and wastewater 
management practices. With an increasing population size and number of 
immunocompromised patients, poor water quality places the population at risk for developing 
waterborne intestinal diseases Little or no access to safe drinking water and improper sanitation 
also influences the spread for waterborne diseases (Luyt et al., 2012). However, in order to 
assess the microbial quality of water in South Africa, The National Microbial Monitoring 
Programme for Surface Water (NMMP) was developed and implemented by the Department 
of Water Affairs (DWA). They aim to regularly collect and analyse water samples from specific 
sampling sites. These sample sites are based on the following criteria: 1) if the land-use, either 
directly or indirectly, contributes to faecal contamination (including land used to house 
informal settlements and for agricultural activities), 2) the size of the population that may use 
the water resource and 3) the purpose of the water-use in that area (Luyt et al., 2012).    
2.3 Wastewater 
The decline of the quality of water in the environment is influenced by the discharge of 
improperly treated wastewater into waterbodies including rivers (Popa et al., 2012). 
Wastewater can be defined as industrial, domestic, commercial and storm water runoff, whilst 
urban wastewater is considered to be a mixture of domestic and industrial wastewater, sewage 
and rainwater, whilst agricultural wastewater is water originating from farms, agricultural 
activities and contaminated groundwater (Naidoo and Olaniran, 2013). 
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Wastewater serves as a source of faecal microorganisms which has led to numerous outbreaks 
of waterborne diseases affecting numerous people in both developed and developing countries 
(Cabral, 2010). Potentially pathogenic microorganisms include strains of Vibrio cholera, 
Salmonella spp., Shigella, Escherichia coli and Staphylococcus aureus. Vibrio cholera is 
responsible for cholera and symptoms of infection include diarrhoea and gastrointestinal tract 
infections (Almagro-Moreno and Taylor, 2013). Salmonella belongs to the family 
Enterobacteriaceae and has been associated with Salmonellosis which results in typhoid or 
gastroenteritis, while infections mediated by Shigella strains causes abdominal cramps and 
bloody stools (Feasey et al., 2012; Mardaneh et al., 2013). Pathogenic strains of Escherichia 
coli including Enterotoxigenic E. coli, Enterohemorrhagic E. coli and Enteroinvasive E. coli 
strains have been associated with gastroenteritis, diarrhoea, vomiting, abdominal cramps, chills 
and bloody stools (Cabral, 2010).  
Therefore, it is imperative that regular water microbiological tests are carried out to assess the 
presence of pathogenic bacteria in wastewater effluent and receiving rivers (Cabral, 2010). 
Detection of indicator organisms, which are members of the microflora of the human and 
animal intestinal tracts, are used to assess the microbial load of water (Luyt et al., 2012). 
According to Cabral (2010) an ideal faecal bacterial indicator should meet the following 
requirements:   
1) Should exist in a high concentration in the human intestine and faeces; 
2) Should be detected in the receiving waters easily, rapidly and economically; 
3) Should not be pathogenic; 
4) Should be present in a higher concentration than potential pathogenic bacteria; 
5) Multiplication must only occur in the enteric environment; 
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6) It must not be present in the gut of farm and domestic animals and 
7) It should have similar growth patterns to pathogenic bacteria. 
Physico--chemical analysis of the water should also be explored as Lokhande et al. (2011) 
demonstrated that physico-chemical characteristics influence the survival of microorganisms. 
This includes analysis of:  pH, temperature, salinity, total dissolved solids (TDS), turbidity, 
electrical conductivity, resistivity, biological oxygen demand (BOD) and Chemical oxygen 
demand (COD).  
2.4 Wastewater treatment plants  
Wastewater is transported to a centralized wastewater treatment plant (WWTP) via 
underground pipes to receive proper wastewater treatment (Popa et al., 2012). According to 
Hendricks and Pool (2012), the wastewater treatment process consists of three essential steps 
namely; primary treatment: this involves the pre-treatment of raw wastewater and facilitates 
the removal of coarse and fine grit by use of sedimentation tanks to allow heavier organic 
particles to settle to the bottom. Secondary treatment: uses aerated biological digestion by 
bacteria which allows for the removal of the remaining suspended and dissolved materials. 
Nitrification and de-nitrification can also be used. Thereafter, the wastewater is separated into 
the solid and liquid phase in the sedimentation tanks. Wastewater then enters the maturation 
pond for additional pathogen removal, and; tertiary treatment: which makes use of ultraviolet 
light or chlorine for disinfection before the release of the treated effluent into receiving surface 
waters.  
Of concern, is the discharge of improperly treated effluent from WWTPs into receiving surface 
waters which may bear negative consequences for end-users (Bateganyaa et al., 2015). 
Contributing factors include poor operation of the wastewater treatment plants due to unskilled 
staff or mechanical malfunctions with the WWTP itself (Popa et al., 2012). Additionally, the 
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quantity of wastewater received exceeds the treatment capacity of the WWTP which may result 
in either inefficient treatment or periodic leaks (Popa et al., 2012). The effects of the discharge 
of improperly treated wastewater on the surrounding environment has been documented by 
Naidoo and Olaniran (2013). Receiving surface waters are used by humans and livestock for 
drinking as well as domestic and recreational purposes. Therefore, use of this water may result 
in illness due to the high bacterial loads found in wastewater. Additionally, the discharge of 
improperly treated effluent may result in the deposition of organic matter and nutrients which 
negatively impacts the environment, micro- and macro-fauna (Naidoo and Olaniran, 2013). It 
may also result in eutrophication and temporary oxygen deficiencies which may disturb the 
communities of that environment (Naidoo and Olaniran, 2013).  Failure to treat waste properly 
may also lead to turbid effluent discharge which causes a deposition of sand and grit into the 
water systems, disturbing the sediment characteristics and water flow (Naidoo and Olaniran, 
2013).  
Considering these factors, it is imperative that the proper measures to be put in place to ensure 
that wastewater is treated to acceptable standards prior to discharge into the environment 
(Kumar et al., 2015). The Department of Water Affairs and Sanitation make use of The South 
African Water Quality Guidelines to determine the quality of water, regardless of its source, 
and establish if it is acceptable to be used for domestic purposes. They have also developed the 
Green Drop status to regulate quality of water in wastewater management.  
There are 121 WWTPs that are owned and operated by the Department of Public Works 
Services (DPW) across the nine provinces of South Africa. These WWTPs were assessed and 
the report showed that none of the WWTPs achieved green drop status. The DPW Green Drop 
status was reported to be 14.5% indicating the WWTPs performance to be unsatisfactory.  
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In a report assessing the Green Drop status of WWTPs in South Africa, carried out by The 
Department of Water Affair in 2013, it was reported that the provincial Green Drop status for 
all provinces (except for Western Cape) achieved green drop scores below 30%.  This means 
that most WWTPs in each province did not meet the regulatory requirements and the 
wastewater treatment management were deemed of poor practice. The eThekwini Metro 
municipality was ranked fourth in the country achieving a green drop score of 90.45%. The 
green drop report from 2011 showed that out of the 27 WWTPs within the eThekwini Metro 
municipality, nine had a green drop score >90%, fifteen had a green drop score of >80% and 
three had a score of >70%. Compared to previous reports carried out by the Department of 
Water Affairs in 2009, 19/27 WWTPs showed to improve their respective green drop scores 
whilst 7/27 showed a decline.  
2.5 Staphylococcus aureus 
Staphylococcus aureus (S. aureus) are Gram-positive, cocci shaped cells which are arranged 
in clusters (Gould, 2011). They are identified by the presence of yellow colonies on Mannitol 
Salt Agar due to their ability to ferment mannitol (Ayeni et al., 2015). They are commonly 
found in the nose, mouth, upper respiratory tracts of humans and mucous membranes (Alfatemi 
et al., 2014) and are causative agents for pneumonia, septicemia, skin infections and urinary 
tract infections (Goldstein et al., 2012; Dormanesh et al., 2015). S. aureus has a wide variety 
of host niches which suggests that this microorganism is able to adapt and survive in changing 
environments and establish infections (Burnside et al., 2010). Bacteraemia, a bloodstream 
infection is prominently associated with S. aureus. Risk factors include: surgeries, intravascular 
devices and patients with immunodeficiencies (de-Smidt et al., 2015). Food poisoning is also 
associated with enterotoxigenic S. aureus (Mossong et al., 2015). Staphylococcal food 
poisoning (SFP), associated with an enterotoxigenic strain of S. aureus, was ranked as the first 
cause of foodborne outbreaks in France, is (Mossong et al., 2015).  
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2.5.1 Methicillin-resistant Staphylococcus aureus 
Previously, penicillin was used to treat bacterial infections caused by staphylococci, however, 
by the mid-1940s S. aureus strains soon exhibited resistance to penicillin (Green et al., 2012). 
Methicillin, a semi-synthetic antibiotic, was introduced in 1959 as an alternative antibiotic for 
the treatment of S. aureus mediated infections (Rahimi and Shokoohizadeh, 2016).  However, 
by 1962, S. aureus developed resistance to methicillin, spread globally and became known as 
Methicillin Resistant Staphylococcus aureus (MRSA) (Ventola, 2015). MRSA isolates have 
also exhibited resistance to other antibiotics such as macrolides, lincosamides, 
fluoroquinolones, aminoglycosides and trimethoprim-sulfamethoxazole (Green et al., 2012).  
MRSA was first associated with hospital environments and was therefore regarded as hospital-
acquired MRSA (HA-MRSA) (Goldstein et al., 2012).  However, in the 1990s, healthy people 
without risk factors were infected with community-acquired MRSA (CA-MRSA) (Goldstein 
et al., 2012). CA-MRSA differs from HA-MRSA as it causes infections in people that are not 
exposed to a health care setting due to a change in epidemiology (David et al., 2014; Venniyil 
et al., 2016). 
The risk factors for CA-MRSA include individuals with diabetes mellitus, malignancies, 
cardiovascular renal failure and use of intravenous drugs (Pathare et al., 2015). CA-MRSA 
affects a distinct population compared to HA-MRSA and has distinct clinical syndromes 
(David and Daum, 2010). CA-MRSA infections occur in younger patients when compared to 
HA-MRSA which occurs in older patients (David and Daum, 2010). In infancy, this may be 
passed from the mother (Schaumburg et al., 2014). They are associated with skin and soft tissue 
infections and may also cause necrotizing pneumonia and severe sepsis (David and Daum, 
2010). HA-MRSA causes pneumonia, bacteraemia, and invasive infections and occur in 
patients that may be infected with another condition (David and Daum, 2010). Studies have 
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shown that S. aureus colonization risk factors in Africa include people with HIV infections, 
those living in rural areas and those that are hospitalized (David and Daum, 2010).  
Methicillin resistant strains are becoming more common in hospitals and communities 
compared to methicillin susceptible strains (Pathare et al., 2015). The transmission of MRSA 
from individual to individual, leading to the spread of the microorganism has become a public 
health concern (Pathare et al., 2015). Sources of community acquired MRSA (CA-MRSA) 
include schools, prisons, slaughterhouses and retail meat and improperly treated wastewater 
effluent (Goldstein et al., 2012; Abidatul et al., 2018; Sato et al., 2017). 
2.5.2 MRSA in WWTPs and receiving rivers 
Goldstein et al. (2012) suggests that WWTPs may serve as a reservoir for MRSA. MRSA 
strains may be disseminated into the environment through hospital wastewater, sewage 
systems, as well as into surface waters through improper waste management (Thompson et al., 
2013). Another contributing factor is rainfall which may contribute to the spread of MRSA as 
the combination of storm water and sanitary sewers could potentially result in an overflow of 
untreated wastewater that is discharged into rivers and lakes (Thapaliya et al., 2017). The 
release of these strains may contribute to the gene pool of multidrug resistant bacteria in the 
environment (Thompson et al., 2013). 
Goldstein et al. (2012) revealed the presence of MRSA in 22/44 (50%) of WWTPs in the 
United States of America. This is alarming considering water shortages in certain areas of 
South Africa may allow for a greater amount of treated wastewater effluent to be used for 
agriculture, industry and groundwater recharge (Goldstein et al., 2012). Börjesson et al. (2010) 
reported strains of MRSA with great genetic diversity in wastewater. This study showed that a 
specific strain did not survive the treatment indicating that new strains of MRSA might be 
evolving in wastewater. It may also be implied that even though wastewater treatment may 
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reduce the total number of strains present in wastewater, it may also select for strains with more 
extensive antibiotic resistance characteristics (Börjesson et al., 2010). 
The presence of MRSA in wastewater and treated wastewater effluent poses risk for the health 
of the WWTP workers and individuals who are exposed to this water (Goldstein et al., 2012). 
WWTP workers may be exposed to MRSA through epidermal exposure or inhalation. It is 
important that the WWTP workers practice proper hygiene methods by frequent washing of 
hands and wearing gloves when working in the plant (Goldstein et al., 2012). Treated 
wastewater may also be reused as spray irrigation in agricultural areas, public parks and golf 
courses (Goldstein et al., 2012). Public exposure to these areas requires strict regulations for 
treated wastewater reuse to be implicated (Goldstein et al., 2012).  
2.6 Antibiotic Resistance   
Antibiotics are used to combat microbial infections but also used for agricultural and livestock 
farming (Zaman et al., 2017). They have been used successfully in the treatment or prevention 
of infections in patients with chronic diseases, those receiving chemotherapy and those who 
have undergone surgery (Ventola, 2015). In developing countries, antibiotics have helped 
decrease the morbidity and mortality rates caused by food and water-borne diseases (Ventola, 
2015). However, the overuse and misuse of antibiotics and lack of new drug development have 
led to antibiotic resistance amongst bacteria which has become a global threat (Zaman et al., 
2017). The World Health Organization (WHO) describes antibiotic resistance as the 
development of a microorganism that is no longer affected by a drug it was originally sensitive 
to (WHO, 2014). Epidemiological studies have revealed that development and dissemination 
of antibiotic resistance bacteria is directly related to antibiotic consumption (Ventola, 2015). 
Antibiotic resistant bacteria can be transmitted from animals to humans through the food chain 
as animals may receive antibiotics in their feed to be used as growth promoters (Zaman et al., 
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2017). Multi-drug resistant bacteria are responsible for many deaths (Zaman et al., 2017). 
Falagas et al. (2006) defines multi-drug resistance as a microorganism’s ability to exhibit 
resistance towards 3 or more classes of antibiotics.  The development of multidrug resistant 
strains limits the treatment options for bacterial infections (Rahimi and Shokoohizadeh, 2016).  
Reports have shown that 63 000 patients die from hospital-acquired bacterial infections in the 
USA every year and 25 000 patients die due to multi-drug resistance bacterial infection Europe 
every year (Zaman et al., 2017). Resistance towards antimicrobial agents make bacterial 
infections harder to control, increases the risk of the spread of infection from one person to 
another, prolongs illness and hospital stays, increases economic costs and the risk of death 
(WHO, 2014). Therefore, it is important the new policies are implemented and research efforts 
are made to control the emergence of antibiotic resistance in this era. 
2.7 Mechanisms of antibiotic resistance in MRSA 
The dissemination of antibiotic resistance genes is caused through horizontal gene transfer and 
can be associated with mobile genetic elements such as gene cassettes, integrons and plasmids 
(Wan and Chou, 2015).  
Integrons are defined by the occurrence of an integrase gene (intI) and a proximal primary 
recombination site (attI). They are divided into classes based on their amino sequence of the 
integrases. Integrons have two conserved segments that can be separated by a variable region 
which consists of mobile cassettes with antibiotic resistance genes (Wan and Chou, 2015). The 
5’-conserved segment harbours the integrase gene and attachment site which allows for the 
class 1 integrons to apprehend and express resistant genes. The 3’-conserved segment encodes 
for the resistance to quaternary ammonium compounds and sulphonamides used in 
disinfectants (Wan and Chou, 2015).   Class 1 integrons were detected in MRSA and have been 
abundantly associated to aqueous environments, including wastewater (Wan and Chou, 2015). 
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Wan and Chou (2015) expressed the abundance of integrase genes present in wastewater of 
municipal WWTPs and swine slaughterhouse. These integrons survived the treatment process 
and were released in the treated effluent. The study suggested that wastewater serves as a 
hotspot for class 1 integrons and may be a potential source for antibiotic resistant MRSA 
infections in humans and animals (Wan and Chou, 2015). 
Plasmids are disseminated between bacteria through horizontal gene transfer by bacteria. 
Plasmids are circular DNA structures which replicate independently of chromosomes. They 
are responsible for distributing antibiotic resistance genes amongst various strains of bacteria 
(San Millan, 2018). The plasmids present in Staphylococci range in size from 1.2 kb to 100 kb. 
Based on their size and mechanism of replication they are classified into three classes (Kuntová 
et al., 2012). In Staphylococci, it has been demonstrated that plasmids detected harbour genes 
that allow for an increased tolerance towards antiseptics such as quaternary ammonium 
compounds, which are commonly used in environmental disinfectants (Wan and Chou, 2015). 
Kuntová et al. (2012) showed that 89% of the MRSA strains studied contained 
extrachromosomal plasmids suggesting that the plasmids contribute to the fitness of the MRSA 
strains. Studies also showed even though the MRSA population evolve, most plasmids circulate 
in the population for years (Kuntová et al., 2012). This was shown by the sequence analysis of 
the plasmids pDLK1 and pDLK2 and the restriction profile of the enterotoxin D plasmid, which 
showed structural stability and evolutionary importance (Kuntová et al., 2012). This was 
supported by Shahkarami et al (2015) which showed that plasmid profiles show genetic 
relatedness of bacterial isolates. 
Efflux pumps are another antibiotic resistance mechanism which play a role in drug extrusion 
(Sun et al., 2014). Bacterial efflux systems can be specific by removing a single antibiotic or 
class of antibiotics, or may be multidrug resistance efflux pumps and remove several classes 
of antimicrobial compounds (Costa et al., 2013). The presence of efflux pumps has been 
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detected in most bacterial species. The genes that encode for these proteins are located on 
plasmids or chromosomes. Based on their energy sources, substrates and transmembrane 
spanning regions efflux pumps are grouped into five classes: the resistance-nodulation-division 
family, the major facilitator superfamily, the ATP (adenosine triphosphate)-binding cassette 
superfamily, the small multidrug resistance family and the multidrug and toxic compound 
extrusion family (Sun et al., 2014). The regulation of efflux pumps is based on the chemical 
and physical stress response and the pathogenicity of S.aureus. More than ten efflux pumps 
have been reported for S. aureus (Costa et al., 2013).  In MRSA, it has been reported that efflux 
pump removes antibiotics such as tetracyclines and macrolides, antiseptics and play a role in 
transfer of antibiotic resistance genes (Zmantar et al., 2013). Efflux pumps contribute to low 
level antibiotic resistance and emergence of multidrug resistant pathogens (Costa et al., 2013). 
 
WWTPs play an important role in the development and spread of antibiotic resistance genes 
and antibiotic resistant bacteria. The accumulation of antibiotics, with continued activity, in the 
environment may result in in vitro or horizontal gene transfer of antibiotic resistance genes 
(using these mechanisms) amongst bacteria including, S. aureus, in wastewater effluent and 
receiving surface waters (Börjesson et al, 2009; Börjesson et al., 2010). Amongst these 
resistance genes, include the presence of mecA which has been detected in hospital and 
municipal wastewater through cultivation and molecular methods carried out by Börjesson et 
al., 2010. 
 
2.8 Antibiotic resistance genes in MRSA 
Infections caused by MRSA are difficult to treat as studies have reported antimicrobial 
resistance to many other antibiotic classes such as aminoglycosides, fluoroquinolones, 
lincosamides and macrolides (Kaur and Chate, 2015). Detection of antibiotic resistance genes 
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is carried out by PCR which allows for rapid and accurate diagnosis, therefore preventing and 
controlling the spread of infections (Duran et al., 2012). Studies by Amoako et al. (2016) 
showed the antibiotic resistance genes present in MRSA strains from the private health sector 
in South Africa were mecA (100%), blaZ (100%), ermC (48.2%) and aac(6′)/aph(2′′) (92.6%). 
Other studies reported the presence of tetK (89.18%) and msr (56.75%) in clinical samples of 
MRSA (Dormanesh et al., 2015). 
2.8.1 mecA 
Amplification of the mecA gene is routinely used to identify MRSA strains because the mecA 
gene confers resistance to methicillin in the S. aureus (Al-Abbas, 2012; Rahimi and 
Shokoohizadeh, 2016). The mecA gene encodes for a penicillin binding protein (PBP2 and 
PBP2a) which is a cell wall transpeptidase (David and Daum, 2010), allowing for cell wall 
synthesis to continue while in the presence of β-lactam antibiotics (Paterson et al, 2014).  mecA 
translation increases with exposure to β-lactam antibiotics (David and Daum, 2010). The 
expression of the mecA gene is controlled by the MecI regulator which is a DNA binding 
repressing protein and the MecR1 regulator which is a sensor/signal transducer as shown in 
Figure 2.1 (Chovanová et al., 2016). 
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Figure 2.1: Mechanism of action for mecA induction (as adapted from Arêde et al., 2012) 
MecR1 is activated in the presence of β-lactam antibiotics. This induces the expression of 
mecA and mecR1-mecI-mecR2. The MecR2, an anti-repressor, is needed to allow for the 
induction of mecA as it promotes the inactivation of MecI by proteolytic cleavage. If the β-
lactams are absent then the MecR1 won’t be activated (Arêde et al., 2012). 
2.8.2 Staphylococcal Chromosomal Cassette mec genetic elements (SCCmec) 
The expression of the mecA gene is regulated by the mecR1 and mecI genes which are carried 
by SCCmec elements (David and Daum, 2010). Most MRSA strains contain the SCCmec 
element which is integrated into a chromosomal site known as orfx (David and Daum, 2010). 
Research has shown that SCCmec developed from coagulase negative Staphylococcus species 
and carries the mecA gene (David and Daum, 2010). The SCCmec are the only vectors that are 
responsible for the transfer of the mecA gene amongst species (Rahimi and Shokoohizadeh, 
2016). The SCCmec genetic elements are characterized by mec and ccr gene complexes which 
serves as two genetic markers (Dormanesh et al., 2015). These elements are classified based 
 25 
 
on the nature of the mec and ccr genes into types I-VII (Valsesia et al., 2010). The distribution 
of the SCCmec elements is important for molecular typing of MRSA strains (Dormanesh et al., 
2015).  
SCCmec types I-III are larger and are present in HA-MRSA strains. These may have been 
transferred from a commensal staphylococcal species (David and Daum, 2010). The SCCmec 
types IV and V are smaller and have been associated with MRSA infections in patients with 
the absence of HA-MRSA risk factors (David and Daum, 2010). Type II and III SCCmec 
elements have sites that allow for the insertion of genes that encode non-β-lactam resistance 
phenotypes to the S. aureus strains therefore are associated with multidrug phenotypes (David 
and Daum, 2010). Type IV, V and VII are susceptible to most non-β-lactam antibiotics 
(Valsesia et al., 2010). SCCmec types IV and V are also mobile therefore the distribution of 
MRSA in a community may be accomplished through transfers from carriers to other 
individuals (David and Daum, 2010). The smaller SCCmec elements may also be passed from 
MRSA strains to MSSA strains (David and Daum, 2010). 
Even though the mecA gene is used as the gold standard to detect MRSA, studies worldwide 
have reported the presence of MRSA strains lacking the mecA gene (Olayinka et al., 2009). A 
study from Nigeria reported S. aureus strains that exhibited phenotypic resistance to methicillin 
however lacked the mecA gene, the five major SCCmec types and the gene product of PBP2A 
(Olayinka et al., 2009). However, the study reported hyperproduction of β-lactamase which 
may have resulted in methicillin resistance (Olayinka et al., 2009). Ba et al. (2014) also showed 
alterations in the different amino acids present in the PBP cascades resulting in the methicillin 
resistance. These findings suggest other mechanisms may be responsible for β-lactam 
resistance of MRSA and that amplification of the mecA gene is not enough to confirm MRSA 
strains.  
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2.8.3 blaZ 
Resistance to penicillin is mediated by the blaZ gene which encodes β-lactamase (Zmantar et 
al., 2013). β-lactamase is an extracellular enzyme that is synthesized after the exposure of 
Staphylococci to β-lactam antibiotics (Zmantar et al., 2013). blaZ hydrolyzes the β-lactam ring 
which causes the β-lactam to become inactive (Zmantar et al., 2013). Regulation of the blaZ is 
achieved by two regulatory genes which are blaR1, the anti-repressor and blaI, the repressor 
(Zmantar et al., 2013). The signalling pathway that controls the synthesis of the β-lactamase 
requires the sequential cleavage of the regulatory proteins BlaR1 and BlaI so after the exposure 
of β-lactams, the transmembrane sensor transducer cleaves itself (Zmantar et al., 2013). The 
expression of mecA is also controlled by β-lactamase regulators, BlaI and BlaR1, which are 
structurally and functionally similar. MecI and BlaI co-repress the transcription of mecA and 
blaZ (Chovanová et al., 2016). These regulators are alike and can therefore replace each other 
(Chovanová et al., 2016). MecI and BlaI can bind to the promoter region of the mecA and blaZ, 
as homodimers (Chovanová et al., 2016). Upon exposure to antibiotics, a signal transduction 
brings about sensing through the two transmembrane inducers, MecR1 and BlaR1, which 
causes proteolytic autocleavage of the cytoplasmic domains of these proteins (Chovanová et 
al., 2016). This is carried out by the transducers undergoing acylation by the antibiotic which 
results in conformational changes in the molecule (Chovanová et al., 2016). This is followed 
by cleavage of the cognate repressors, MecI and Bla then inducing mecA and blaZ transcription 
(Chovanová et al., 2016). 
2.8.4 Macrolide resistance genes: ermC and msrA 
Macrolide-lincosamide-streptogramin (MLS) antibiotics are used in the treatment of S. aureus 
infections which include bovine mastitis in cattle (Li et al., 2015). Antibiotics known as MLS 
include: clindamycin, erythromycin and spiramycin. Different mechanisms contribute MLS 
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resistance and includes: 1) the modification of target sites caused by methylation or mutation, 
2) efflux pumps and 3) drug inactivation (Li et al., 2015). 
Erythromycin is classified as a macrolide which is effectively used against Gram-positive and 
some Gram-negative bacteria however, the widespread utilization of this macrolide antibiotic 
has resulted in an increase in the resistance of S. aureus (Ding et al., 2012; Goudarzi et al., 
2015). Ribosome methylases are enzymes synthesized by S. aureus which are encoded by one 
or more erythromycin resistant methylase genes (erm) (Ding et al., 2012).  Methylation of 23s-
rRNA occurs and this is followed by changes on the binding site for macrolide-
lincosamidestreptogramin B (MLSB) antibiotics (Ding et al., 2012). ermA, erm B and ermC 
are the main methylase genes that have been found in S. aureus (Ding et al., 2012).  Adenine 
at position 2058 of 23s-rRNA undergoes N6-dimethylation due to the production of methylase 
(Ding et al., 2012). It overcomes the inhibitory effect of macrolide on protein synthesis due to 
conformation changes in the P-site of 23s-rRNA which prevents the binding of macrolides 
(Ding et al., 2012). 
msrA is also involved in resistance towards macrolides-streptogramins as it encodes macrolide 
efflux pumps which belongs to the ABC transporter family (Ding et al., 2012). This induces 
resistance and exports 14-15 membered macrolides and streptogramins A antibiotics from the 
cells. (Ding et al., 2012; Li et al., 2015).  This allows for the antibiotic concentration within 
the cell to remain at a sub-toxic level which does not disturb the bacterial cell growth 
(Piątkowska et al., 2012) 
2.8.5 aac(6′)/aph(2′′) 
Aminoglycosides are broad-spectrum antibiotics used against aerobic Gram-negative bacilli, 
staphylococci and some mycobacteria (Yuan et al., 2013). Aminoglycosides irreversibly bind 
to the 30S ribosomal subunit of bacteria resulting in the inhibition of protein synthesis. 
However, MRSA has become resistant to aminoglycosides by altering the structure of 
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aminoglycosides by aminoglycoside-modifying enzymes (AMEs) (Yuan et al., 2013). There 
are three classes of enzymes which are responsible for the structural modification of 
aminoglycosides (Yuan et al., 2013). These include: aminoglycoside acetyltransferases 
(AACs), aminoglycoside phosphotransferases APHs) and aminoglycoside 
adenylyltransferases (ANTs) (Yuan et al., 2013). The two most common AMEs in MRSA are 
the ANT, encoded by ant(4′)-Ia and AAC(6′)/APH(2′′), which is encoded by aac(6′)/aph(2′′), 
a bifunctional enzyme (Yuan et al., 2013). The modifying enzymes encoded by the 
aac(6′)/aph(2′′) gene confers resistance to gentamicin. Most of these enzymes are carried on 
plasmids or transposons and may be combined into SCCmec genetic elements (Shokravi et al., 
2015).  
2.8.6 tetK 
Tetracycline is used in human and animal medicine and is considered a broad-spectrum 
antibiotic (Hedayatianfard et al., 2014). It was discovered in the 1940s. Tetracyclines are 
bacteriostatics used as preventive treatment against infections, including skin infections caused 
by S. aureus in both, humans and animals (Ong et al., 2017). However, tetracycline resistance 
as a result of drug overuse was first reported against Shigella dysenteriae (Ong et al., 2017) 
Sequentially, this spread to commensal, opportunistic and pathogenic bacteria due to transfer 
of tetracycline resistance genes (tet) (Ong et al., 2017). Tetracyclines prevent the association 
between the bacterial ribosome and aminoacyl-tRNA, inhibiting protein synthesis (Ullah et al., 
2012). Mechanisms which confer tetracycline resistance to bacteria are ribosomal protection 
proteins, enzymatic inactivation or active efflux pumps (Adwan et al., 2014). 
According to Hedayatianfard et al. (2014) there are 40 different tetracycline resistance genes 
that have been identified. Amongst these genes, tetK, tetM, tetO and tetS are commonly 
reported in Gram-positive bacteria whereas tetA, tetB, tetD, tetE and tetG are reported in Gram-
negative bacteria (Hedayatianfard et al., 2014). tetK and tetO encode for energy-dependent 
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membrane-associated efflux proteins. They are responsible for preventing the accumulation of 
tetracycline within the cell (Ullah et al., 2012). tetM and tetO encode for ribosomal protection 
proteins, which reduces the bonds between tetracycline and the ribosome (Ullah et al., 2012). 
2.9 Virulence determinants of MRSA 
Virulence factors contributes to the ability of MRSA strains to cause diseases and colonize the 
host (Alfatemi et al., 2014). These factors include haemolysins, exotoxins, leukocidins and 
superantigens (Burnside et al., 2010). The transcription of virulence genes in S. aureus is 
regulated by one component transcriptional regulators and two-component systems (Burnside 
et al., 2010).  Examples include the complex accessory gene regulatory system (agrABCD) 
which allows for the superantigens, cytotoxins and secreted enzymes to be upregulated and the 
transcription of cell wall proteins (protein A) to be repressed (Burnside et al., 2010). The 
pathogenicity of S. aureus depends on the production of surface proteins which allows the 
bacterium to adhere to host tissues, secrete extracellular toxins and enzymes which will destroy 
the host cell, escape the host immune defence and allow for the growth of bacteria in host cells 
(Kong et al., 2016). The toxins produced are secreted during the post-exponential and early 
stationary phases, into the extracellular matrix where they will penetrate and invade the host 
(Kong et al., 2016). These toxins are cytolytic and acquire important nutrients from lysed cells 
promoting bacterial growth (Kong et al., 2016). The bacterium may also secrete enzymes 
which include coagulase and protease which allow for it to evade, invade and penetrate the host 
cells. S. aureus surface proteins may also help with bacterial adhesion (Kong et al., 2016). 
2.9.1 Staphylococcal enterotoxins 
There are nine major serological types of staphylococcal enterotoxins. This includes: SEA, 
SEB, SEC, SED, SEE, SEG, SEH, SEI and SEJ and their associated genes sea, seb, sec, sed, 
see, seg, seh, sei and sej respectively (Kadariya et al., 2014). These staphylococcal enterotoxins 
have similar structure and biological activity but differ in antigen characteristics (Alfatemi et 
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al., 2014). Staphylococcal enterotoxins are stable and resistant to various environmental 
conditions such as heat, freezing and drying (Kadariya et al., 2014). They are resistant to 
proteolytic enzymes which include pepsin and trypsin and low pH which enables the 
enterotoxins to function after ingestion (Kadariya et al., 2014). They also belong to a family of 
pyrogenic toxin superantigens which are responsible for superantigenic activity such as 
immunosuppression and nonspecific T-cell proliferation (Kadariya et al., 2014). It is 
hypothesized that this activity helps facilitate the entry of the toxins to enter the bloodstream 
allowing it to interact with T-cells and antigen-presenting cells leading to superantigen activity 
(Kadariya et al., 2014). 
They are commonly found in dairy products and raw vegetables and cause nausea, vomiting, 
diarrhoea and muscular and abdominal pain in humans (Alfatemi et al., 2014). The enterotoxin 
genes are carried and distributed by different mobile genetic elements such as plasmids, 
prophages, pathogenicity islands and staphylococcal cassette chromosome (Schelin et al., 
2011). 
2.9.2 Staphylococcal enterotoxin A 
The staphylococcal enterotoxin A, encoded by sea, is mainly responsible for staphylococcal 
food-borne disease. SEA is highly resistant to proteolytic enzymes (Kadariya et al., 2014). The 
sea gene is carried by temperate bacteriophages that have a polymorphic nature (Schelin et al., 
2011). The bacteriophage is inserted as a prophage into the bacterial chromosome and acts as 
part of the bacterial genome (Schelin et al., 2011). When an environmental stress such as food 
preservation conditions is induced, replication of the phage genome is induced and new 
bacteriophages are released (Schelin et al., 2011). The transcription of sea depends on the 
lifecycle of the SEA-encoding prophages compared to non-phage encoded enterotoxin genes 
such as sed. SEA trains can be grouped into SEA1 and SEA2 based on sequence analysis. It has 
an endogenous promoter region, P1 found in both groups and a second phage related latent 
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promoter, P2, which allows for sea to be expressed after second phage related promoter 
(Schelin et al., 2011). Schelin et al. (2011) also showed that the SEA1 group produced high 
amounts of SEA and the SEA2 group produced low amounts of SEA 
2.9.3 Haemolysins 
Another virulence factor harboured by MRSA are haemolysins (Monecke et al., 2014). 
Haemolysins are proteins that lyse red blood cells allowing the bacterium to scavenge iron 
compounds. There are three major haemolysins which include alpha, beta and delta (Monecke 
et al., 2014). 
2.9.3.1 Haemolysin alpha  
The alpha haemolysin is encoded by the hla gene and is situated around base positions 
1,110,000 to 1,230,000 in the staphylococcal chromosome genome (Monecke et al., 2014). The 
alpha toxin is a pore forming toxin which is secreted as a water-soluble 33-kDa monomeric 
protein which binds to surface receptors on target cells (Kwak et al., 2012). The pore is a 
polymeric ring which has a diameter of 1-2 nm and is made of seven 33kDa protein molecules 
which penetrate the host cell membrane (Monecke et al., 2014). This causes osmotic swelling, 
rupture, lysis followed by cell death. The haemolysin alpha toxin is also neurotoxic and causes 
necrosis of the skin (Monecke et al., 2014).   
The alpha toxin is regulated by the agr and saeR/S systems as the deletion of saeRS and agr 
results in a weakened expression (Monecke et al., 2014). This was also shown in sarA/Z which 
indicated that the alpha toxins are upregulated during the dissemination phase however are 
downregulated during the stationary phase when the factors promote biofilm formation and 
adhesion (Monecke et al., 2014). Invasive and non-invasive isolates do not differ in the 
presence or absence of this gene because the hla gene is present in most isolates and lineages 
of S. aureus (Monecke et al., 2014). 
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The intestinal cells form a selectively permeable epithelial barrier which prevents the entry of 
potentially harmful microorganisms and antigens from the intestinal lumen into internal tissues 
and blood (Kwak et al., 2012). The tight junctions, which consist of transmembrane proteins 
promote physical barrier function, regulating the solutes and ions that diffuse between adjacent 
cells and help maintain cell polarity (Kwak et al., 2012). Adherence junction proteins play an 
important signalling role which contributes to the mechanical strength of the junctional 
complexes (Kwak et al., 2012). The interaction between these tight junctions and adherence 
junctions is important to maintain the epithelial structure and barrier function (Kwak et al., 
2012). Enteropathogenic bacteria modify ion transport and disrupt the tight and adherence 
junctions and cytoskeleton via their toxins and proteases (Kwak et al., 2012). Calcium ions 
(Ca2+) promotes different cellular functions such as regulation of gene expression, cytoskeletal 
rearrangements and apoptosis (Kwak et al., 2012). The alpha toxin from S. aureus induces an 
increase of cytosolic free Ca2+ in the human airway epithelial cells and endothelial cells (Kwak 
et al., 2012). However, more research needs to be done to determine the effect of the alpha 
toxin on human intestinal Caco-2 cells (Kwak et al., 2012). Studies by Kwak et al. (2012), 
showed that free staphylococcal alpha-toxins in the bloodstream causes an intestinal epithelial 
barrier dysfunction and could worsen the septic condition by discharging intestinal bacteria 
into underlying tissue and the blood. 
2.9.3.2 Haemolysin delta 
The delta haemolysin toxin is encoded by the hld gene and is a 26 amino acid peptide. Ninety-
seven percent of S. aureus isolates produce this toxin (Burnside et al., 2010). This toxin lyses 
erythrocytes, mammalian cells and sub cellular structures which include membrane bound 
organelles (Burnside et al., 2010). The structural gene is encoded within RNAIII which 
activates virulence factors such as enterotoxins, toxins and toxic shock syndrome toxins and it 
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represses cell surface proteins (Burnside et al., 2010). More investigation needs to be carried 
out on the contribution to virulence by hld (Burnside et al., 2010).                             
2.9.4 Leukotoxins 
MRSA strains may also produce Panton-Valentine Leukocidin (PVL) which is leukotoxin 
(Motamedi et al., 2015). PVL is a bicomponent leukotoxin that is encoded by bacteriophages 
(Boakes et al., 2011). PVL is encoded by lukS-PV and lukF-PV genes which are co-localized 
and co-expressed (Monecke et al., 2013). The lukS-PV and lukF-PV can be found in the genome 
of the icosahedral or elongated head shaped temperate bacteriophages (Boakes et al., 2011). 
This increases the virulence and may result in severe necrotic pneumonia and skin and soft 
tissue infections (Motamedi et al., 2015). PVL is a pore forming toxin which targets the host’s 
leukocytes (Motamedi et al., 2015), disrupts leuckocyte membrane and causes tissue necrosis 
(Shrestha et al., 2014). The presence of PVL in S. aureus has resulted in highly virulent and 
transmissible strains (Shrestha et al., 2014). PVL related infections may spread to the lungs 
and may cause necrotizing pneumonia which rapidly destroys lungs tissue (Shrestha et al., 
2014). It has proven to be lethal and is emerging as a global health threat (Shrestha et al., 2014). 
Studies by Breurec et al. (2011) showed that western and central African countries have a 57% 
prevalence rate of PVL positive MRSA serving as a challenge for the control of diseases and 
infections. The presence of the pvl gene serves as a genetic marker for HA-MRSA and CA-
MRSA (Motamedi et al., 2015). 
The PVL encoding gene are relatively conserved however twelve single nucleotide 
polymorphisms have been identified such as a nonsynonymous change which allows the 
conversion of histidine to arginine at amino acid 176 (Boakes et al., 2011).  The consequence 
of this change has not been characterized however it is assumed that it does not weaken 
leukotoxicity (Boakes et al., 2011).  
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The transfer of different PVL phages between strains of S. aureus is limited by phage/bacteria 
specificity factors such as restriction modification systems (Boakes et al., 2011). Infection 
occurs followed by lysogeny of the bacterial chromosome though the integrative pathway 
however the loci at which lysogeny of the PVL phage occurs and the attachment mechanism is 
unknown (Boakes et al., 2011).  
2.10 Concluding Remark 
Water, an important and precious resource, is needed for domestic use, irrigation and food 
production. In order to support sustainable development and improve the quality of life, in both 
developed and developing countries, safe drinking water should be accessible to all people. 
The disposal of improperly treated wastewater effluents into natural water bodies due to poor 
wastewater management has posed a threat to public and environmental health. Studies by 
Thapaliya et al. (2017) have shown that WWTPs serve as a hotspot for antibiotic resistant 
bacteria and antibiotic resistance genes. Improperly treated effluent may serve as reservoirs for 
MRSA. This may be discharged into receiving surface waters which may have detrimental 
consequences to individuals and animals who come into contact with this water. Exposure to 
MRSA in this water may result in skin and soft tissue infections, necrotizing pneumonia, 
bacteraemia and severe sepsis. Emerging resistance to commonly used antibiotics may result 
in ineffective treatment of MRSA infections and poses a cause for concern. Therefore, it is 
important that proper wastewater management practice and regulations be implemented to 
improve the quality of wastewater released into receiving surface waters and to prevent the 
dissemination of MRSA and outbreaks of MRSA infections.  
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Abstract 
Release of improperly treated effluent from municipal wastewater treatment plants may result 
in detrimental consequence on public and environmental health. The presence of Methicillin-
resistant Staphylococcus aureus (MRSA), a well-known causative agent of many hospital-
acquired infections, is particularly worrisome as MRSA may easily colonize and infect 
individuals who encounter the contaminated water. This study aimed to determine the impact 
of treated effluent of two wastewater treatment plants (WWTPs) in Durban, KwaZulu-Natal 
on the physico-chemical parameters and prevalence of MRSA in the respective receiving 
surface waters. Correlation studies of selected physico-chemical parameters to the prevalence 
of MRSA was also carried out. The prevalence of MRSA ranged variously as follows: 11.45-
85.63% (Influent), 16.28-39.36% (Before Chlorination), 2.16- 5.07% (After chlorination), 
1.06-7.24% (Downstream) and 4.95-14.09% (Upstream) in WWTP1. Similarly, at WWTP2, 
the prevalence of MRSA ranged from 48.25-86.18%, 23.73-93.75 %, 4.28-48.82 %, 1.74-
19.31% and 5.90-28.78% in the influent, before chlorination, after chlorination, downstream 
and upstream samples, respectively. The study revealed a reduction in the prevalence of MRSA 
and mecA in the treated effluent as compared to the influent samples of both WWTPs. 
However, MRSA and mecA was still detected in the effluent samples after the treatment 
process, indicating the resistance of selective strains of MRSA to the wastewater treatment 
process. This finding therefore suggests that the WWTPs investigated in this study may serve 
as a reservoir for MRSA dissemination into the environment. 
Keywords: methicillin-resistant Staphylococcus aureus, prevalence, quantification of mecA, 
real-time PCR, wastewater treatment, wastewater treatment plants 
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3.1 Introduction 
Globally, water is considered a precious resource (Pitman, 2011). It is required for drinking, 
preparation of food, sanitation and hygiene as well as agricultural and industrial purposes 
therefore, it is important that a sufficient and safe supply of water is easily accessed by people 
(Hunter et al., 2010). In 2017, the World Health Organization reported that 842 000 deaths 
were due to lack of clean drinking water and proper sanitation and the child mortality rate 
reached 361 000 due to waterborne diseases (WHO and UNICEF, 2017). Access to an 
inadequate quality of water have led to many infections and disease caused by bacteria, 
protozoa and viruses, including: Vibrio cholerae, Salmonella spp., Shigella spp., Escherichia 
coli, Cryptosporidium parvum, Adenovirus 3 and Leptospira that are responsible for causing 
vomiting, nausea, diarrhea, abdominal pain and fever (Pandey et al., 2014). The lack of potable 
water is compounded by rapid urbanization, a growing population, poor service delivery, lack 
of proper infrastructure and lack of proper wastewater management (Naidoo and Olaniran, 
2013; Bateganyaa et al., 2015). This is a cause for major concern in industries, agriculture, 
municipalities and the environment (Kumar et al., 2015). Water scarcity can be combatted by 
wastewater reuse in agriculture and industry (Jhansi and Mishra, 2013) 
Olaniran and Naidoo (2013) define wastewater as industrial or domestic sewage or storm 
runoff. However, the release of improperly treated wastewater from wastewater treatment 
plants (WWTPs) may result in the release of organic compounds and nutrients into receiving 
surface waters, with dire negative impact on the micro and macro-fauna present in the 
environment (Naidoo and Olaniran, 2013). Chemical agents detected in water, such as lead, 
copper and nitrate, have also been reported to induce vomiting, skin rashes, cancer, abnormal 
pregnancies and neurocognitive diseases (Hunter et al., 2010; Rahmaninan et al., 2015). The 
presence of other pollutants such as pesticides, trihalomethanes and pharmaceuticals have been 
reported to have adverse health effects on the end-user (Hunter et al., 2010). Wastewater is 
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also a source for potentially pathogenic microorganisms, including: Vibrio cholerae, 
Salmonella spp., Shigella spp. and Escherichia coli (Almagro-Moreno and Taylor, 2013).  
Staphylococcus aureus (S. aureus) is also commonly detected in wastewater and is responsible 
for a variety of infections which include septicaemia, pneumonia and skin infections (Goldstein 
et al., 2012; Almagro-Moreno and Taylor, 2013). Treatment of infections caused by this 
microorganism has become difficult due to strains becoming resistant to commonly prescribed 
antibiotics such as methicillin (Goldstein et al., 2012). Methicillin-resistant Staphylococcus 
aureus (MRSA) is known to induce infections in hospital and community settings (San Sit et 
al., 2017). The presence of the mecA in MRSA, carried on the Staphylococcal cassette 
(SCCmec), encodes for a penicillin-binding protein (PBP2a), that induces resistance to β-
lactam antibiotics (San Sit et al., 2017). MRSA is commonly found within healthcare-settings, 
which allows for its potential spread into the environment through hospital wastewater 
(Börjesson et al., 2010; Thompson et al., 2013). Wastewater has been identified as a potential 
source for MRSA as S. aureus has been found to transfer antibiotic resistance genes in vitro, 
via horizontal gene transfer (Börjesson et al. 2009; Goldstein et al., 2012).  
South Africa is regarded as a semi-arid country, receiving an average rainfall of 465 mm 
(Pitman, 2011). Thus, water shortages in South Africa remain a crisis, resulting in the use of 
treated wastewater in agriculture and industries. It is therefore important to characterize the 
chemical, biological and physical parameters of treated wastewater in order to determine the 
impact of the discharge of improperly treated effluent on the environment (Naidoo and 
Olaniran, 2013). By making use of the established parameters and guidelines, the quality of 
water can be assessed to determine if it is acceptable to be used domestically and to improve 
the wastewater management system. Numerous studies have implicated treated wastewater as 
a reservoir of potentially pathogenic microorganisms, including MRSA (Börjesson et al., 2010; 
Goldstein et al., 2012). However, to the best of our knowledge, no studies have been carried 
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out to investigate the prevalence of MRSA in treated effluent of wastewater treatment plants 
in Durban, South Africa and the consequential impact on the receiving surface waters. This 
study was therefore carried out to determine the efficiency of two WWTPs in the removal of 
MRSA in the received influent and to establish the impact of the treated effluent discharge 
from these WWTPs on the prevalence of MRSA in the receiving rivers.  
3.2 Materials and Methods 
3.2.1 Collection of water samples 
Wastewater samples were collected from two wastewater treatment plants (designated as 
WWTP1 and WWTP2) in Durban, KwaZulu-Natal. Sample collection was carried out three 
times for each plant at different points of the WWTP. These points included: (1) influent, (2) 
before chlorination, (3) after chlorination, (4) upstream of the receiving river and (5) 
downstream of the receiving river. The water samples were collected in 5 L sterile bottles which 
were washed with de-ionized water and 70% (v/v) ethanol. To maintain sterility, the ethanol 
was left in the container and was rinsed using the water sample at the point of collection. The 
mouth of the container was placed against the water current, if it existed, to permit water to 
flow into the container. If a current did not exist then water samples were collected using a 
sampling stick and then poured into each container. Containers were sealed and stored away 
from sunlight. The samples were stored on ice and transported to the University of KwaZulu-
Natal (Westville campus) where it was stored at 4 ˚C. Sample analysis was carried out within 
48 h of collection. 
3.2.2 Determination of the physico-chemical parameters 
The temp. (temperatures) of the water samples were measured on site using a mercury-in-glass 
thermometer (Lloyds register quality company, U.K.). Other parameters that were tested 
included: turbidity, using a 2100 P turbidimeter (HACH), pH, using a Hanna HI11310 Edge® 
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pH meter, BOD/5 (biological oxygen demand), resistivity, EC (electrical conductivity), salinity 
and TDS (total dissolved solids) using a HQ 40d multi meter and parameter specific probes 
(HACH) and COD (chemical oxygen demand) using a Spectroquant NOVA 60 (Merck). 
3.2.3 Enumeration and presumptive identification of S. aureus and MRSA 
Wastewater samples were serially diluted with sterile distilled water. Thereafter, 100 ml of 
each dilution was filtered using a 0.45 µm cellulose nitrate filter in triplicate. Each filter was 
then placed on Mannitol Salt Agar (MSA) (Remel, ThermoFisher, USA) containing 6 µg/ml 
of cefoxitin to select for MRSA, and without cefoxitin to select for S. aureus. Control plates 
were incubated at 37ᵒC for 24 h while plates containing cefoxitin were incubated at 37℃ for 
48 h. The presence of yellow colonies on MSA (with and without antibiotic) were considered 
presumptive MRSA and S. aureus, respectively. These were enumerated and expressed as 
colony forming units per millilitre (CFU/ml).  
 
3.2.4 Data analysis 
 
The prevalence of MRSA was calculated using the equation described by Tao et al. (2010), 
where A represents the number of presumptive MRSA and B represents the total number of 
presumptive S. aureus. 
𝑃𝑟𝑒𝑣𝑎𝑙𝑒𝑛𝑐𝑒 (%) =
𝐴
𝐵
 × 100 
The removal efficiency of MRSA for each WWTP was calculated according to the equation 
below (Tao et al., 2010), where B represents the number of presumptive MRSA in the influent 
and A represents the number of presumptive MRSA in the treated effluent (after chlorination). 
𝑅𝑒𝑚𝑜𝑣𝑎𝑙 𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦 (%) =
𝐵 − 𝐴
𝐵
 × 100 
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3.2.5 Quantification of mecA using Real Time-PCR 
3.2.5.1 Preparation of chemical competent E. coli DH5α cells  
The chemical competent E. coli DH5α cells were prepared as previously described (Sambrook 
and Russel, 2001; Li et al., 2010). Briefly, a single colony of E. coli DH5α cells was inoculated 
into 5 ml of Luria Bertani (LB) broth and was incubated at 37 ℃ while shaking for 24 h. This 
was followed by inoculating 1 ml of the broth into 100 ml of fresh LB broth and was incubation 
with shaking at 37 ℃ until the cells reached an OD reading of 0.8 at 610 nm. The culture was 
transferred into sterile 50 ml tubes and centrifuged at 5000 × g for 10 min at 4℃ and the 
supernatant was discarded. While on ice, 25 ml of cold CaCl2 was added to resuspend the cells 
and this was left to stand for 10 min on ice. This was centrifuged at 5000 × g for 10 min at 4℃, 
the supernatant was discarded and 25 ml of CaCl2 was added to resuspend the cells again. This 
was then left to stand on ice for 45 min before centrifuging at 5000 × g for 10 min at 4℃ and 
1 ml of CaCl2 with 20% glycerol was mixed with these cells. 50 µl of these competent cells 
were transferred into 1.5 ml Eppendorf tubes and stored at -80℃. The competent cells were 
plated on LB agar plates and LB plates with 100 mg/ml Ampicillin to check the presence of 
contaminations.  
3.2.5.2 Cloning of mecA into pJET1.2/blunt vector 
The mecA gene (insert) was prepared by amplifying the gene using 25 µl of High Fidelity 
Mastermix (0.04 U/μL Phusion High Fidelity DNA Polymerase, 2× Phusion HF Buffer and 
400 μM of each dNTP) (Thermo Scientific), 400 µM of mec A forward primer, 400 µM of 
mecA Reverse primer, 18 µl of nuclease free water and 10 µl of DNA. The primer sets used to 
detect the mecA gene included Forward: CCTAGTAAAGCTCCGGAA and Reverse: 
CTAGTCCATTCGGTCCA (Thompson et al., 2013). The PCR cycling conditions were: 
Initial denaturation at 95℃, 35 cycles of denaturation at 95℃ for 2 min, annealing at 58℃ for 
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1 min and extension at 72℃ for 1 min. This was followed by a final extension at 72℃ for 10 
min. The amplified product ran on a 1.2% agarose gel at 60V for 90 min. It was excised and 
then extracted using the gel extraction kit (Thermo Scientific).  
This insert was ligated into the vector (pJET1.2/blunt, ThermoFisher, USA). The ligation 
reaction was done on ice and consisted of 2 µl of 10x reaction buffer, 1µl of T4 DNA Ligase, 
3µl of nuclease free water, 1µl of pJET 1.2 BR plasmid and 13 µl of DNA. This was briefly 
vortexed, centrifuged for 3-5 s and then incubated at 22℃ in the T100 Thermal Cycler (Bio-
Rad, USA) for 30 min.  
The 5µl of ligation reaction mixture was added into the 50 µl of DH5α E. coli cells for the 
transformation of ligated insert and vector. This was left to stand on ice for 30 min followed 
by heat shock where the mixture was incubated at 42℃ for 1 min in a water bath and then was 
left to stand on ice for 10 min. To this mixture, 750 µl of Luria Broth was added and this 
incubated at 37℃ for 1 h in the shaker. This was centrifuged at 12 000 × g and 100 µl of the 
supernatant was left in the Eppendorf tube while the rest was discarded. The cells were mixed 
with the supernatant and 100 µl of the cells were spread plated on LB plates with ampicillin 
(50 µg/ml) and were incubated at 37℃ for 16 h.  
This procedure was followed by colony PCR where the PCR reaction consisted of: 12.55 µl 
distilled water, 1× PCR buffer, 250 µM of dNTPs, 3 mM of MgCl2, 0.1 µM of mecA forward 
and mecA reverse Primers, 2 U Taq polymerase and the cloned colony. PCR amplification 
occurred under the following conditions: Initial denaturation at 95℃ for 5 min, 25 cycles of 
denaturation at 95℃ for 2 min, annealing at 58℃ for 1 min and extension at 72℃ for 1 min. 
This was followed by a final extension at 72℃ for 10 min. The amplified product was 
confirmed on a 1.2% agarose at 60V for 90 min.  
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Following the success of colony PCR amplification, the positive colony was sub-cultured in 5 
ml of LB broth with ampicillin and was left to incubate at 37 ℃ with shaking for 16 h. The 
broth was centrifuged at 12 000 × g for 1 min and the supernatant was discarded. This was 
followed by plasmid isolation using the plasmid isolation kit (ThermoFisher, USA). Gel 
electrophoresis on a 1.2% gel was carried out to confirm the cloned gene on the isolated 
plasmid where three bands were observed. Further confirmation included enzyme restriction 
using the enzymes XbaI and XhoI. The plasmid was stored at -20℃. 
3.2.5.3 Real-time PCR 
The iCycler iQ System (Bio-Rad) was used to run the real-time PCR assay. The total volume 
of the PCR mastermix was 10 µl which consisted of 5 µl of SYBR Green Premix (Thermo 
Scientific), 0.5 mM of mecA forward and reverse primer, 3 µl of nuclease free water and 1 µl 
of DNA template. The PCR cycling conditions were: initial denaturation at 95℃ for 2 min, 35 
cycles of denaturation at 95℃ for 5 s, annealing at 58℃ for 1 min and elongation at 95℃ for 
15 s. A standard curve was constructed using plasmid DNA, of a known concentration, from 
the cloned mecA genes obtained through10-fold serial dilutions of the plasmid DNA. This 
diluted DNA was used to run the real-time PCR assay for the standard curve to obtain the 
equation: 𝑦 = 𝑚𝑥 + 𝑐. The standard curve that generated a regression value of 0.99 was used 
in calculating mecA concentration in the samples.  
The real-time PCR assay was carried out in triplicates using the DNA isolated from the 
wastewater samples using the PowerWater Kit (DNeasy PowerWater Kit, Qiagen). The 
threshold cycle (Ct) value for each sample was determined and the gene copy numbers were 
then calculated using the formula: 𝑐𝑜𝑝𝑦 𝑛𝑢𝑚𝑏𝑒𝑟 = 10(
10(𝐶𝑡−𝑐)
𝑚
) (Herrara et al., 2009). 
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3.3 Results 
3.3.1 Physico-chemical Profiles of the Wastewater Samples 
The averages and standard deviations of selected physicochemical parameters of water samples 
obtained from both wastewater treatment plants (WWTPs) are depicted in Tables 3.1 and 3.2. 
In WWTP1, the temperature for the water samples ranged as follows: 20.33- 27.33 ℃ in 
influent (INF); 19.33- 25.67℃ before chlorination (BC); 18.00- 28.33℃ after chlorination 
(AC); 18.00- 27.33 ℃ downstream (DS); and 16.00-26.00 ℃ upstream (US). The pH ranged 
from 7.18-7.81 across all points, over all the three sampling periods. A steady decrease in 
turbidity was observed from the INF (487.67 ± 12.74; 486.33 ± 3.51 and 212.67 ± 4.04) to the 
AC points (12.40 ± 1.06; 13.34 ± 22.3 and 35.87 ± 5.26) during all three sampling periods, 
respectively. However, there was a slight increase in turbidity in the DS and US points of the 
receiving river, except, for the DS point during sampling period 3. Electrical conductivity (in 
µs/cm) ranged as follows: INF 724.00 - 1002.00, BC 514.00-750.00, AC 563.00-860.67, DS 
432.67- 860.00 and upstream 257.67- 837.67, while the TDS (in mg/L) ranged from 414.67-
483.67 (INF), 352.33- 366.67 (BC), 396.00-424.33 (AC), 400.67-421.33 (DS) and 257.67-
410.00 (US). The resistivity ranged from 1006.30-1869.70 Ω/m and the salinity ranged from 
0.35- 0.67% for all points in all three sampling periods. The COD values (in mg/L) ranged 
from 504.00-1002.00 (INF), 77.33-302.00 (BC), 73.00-306.00 (AC), 59.00-307.33 (DS) and 
193.33-294.00 (US). The BOD5 values (in mg/L) ranged from 143.00-230.67 for INF, 52.50-
128.83 for BC, 91.67- 184.50 for AC, 7.54-23.72 for DC and 17.45-129.83 for US. 
In WWTP2, the temperature for the water samples ranged as follows: 18.67- 25.33 ℃ in 
influent (INF); 18.33- 25.00℃ before chlorination (BC); 19.00- 24.67℃ after chlorination 
(AC); 18.67- 25.00 ℃ downstream (DS); and 17.33-23.33 ℃ upstream (US). The pH ranged 
from 7.01-7.88 across all points, over all the three sampling periods. A steady decrease in 
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turbidity was observed from the INF (454.33 ± 12.50; 314.33 ± 32.51 and 339.00 ± 1.00) to 
the AC points (95.00 ± 2.65; 100.33 ± 32.33 and 117.33 ± 5.26) during all three sampling 
periods, respectively. However, there was a slight increase in turbidity in the AC during 
sampling period 3. A slight increase in turbidity in the DS and US points of the receiving river 
was observed, except, for the DS point during sampling period 3. Electrical conductivity (in 
µs/cm) ranged as follows: INF 750.00 - 879.00, BC 532.33-799.00, AC 528.67-753.33, DS 
379.00- 608.00 and upstream 317.67- 345.00, while the TDS (in mg/L) ranged from 366.67-
436.33 (INF), 25.33- 390.67 (BC), 256.00-364.00 (AC), 182.37-300.00 (DS) and 152.20-
345.00 (US). The resistivity ranged from 2.92-3150.00 Ω/m and the salinity ranged from 0.15- 
0.44% for all points in all three sampling periods. The COD values (in mg/L) ranged from 
644.50-825.00 (INF), 256.00-289.33 (BC), 260.00-296.00 (AC), 222.67-276.33 (DS) and 
212.00-269.00 (US). The BOD5 values (in mg/L) ranged from 139.67-268.33 for INF, 58.50-
178.25 for BC, 10.00- 199.33 for AC, 23.14-24.93 for DC and 21.10-24.90 for US. 
The correlation matrices of the selected physico-chemical parameters with S. aureus population 
for WWTP1 and WWTP2 are shown in Tables 3.3 and 3.4, respectively. For WWTP1, 
resistivity and salinity had no significant correlations to other parameters in the WWTP. 
Temperature show significant negative correlation with the electrical conductivity (-0.699 at 
p<0.01), while pH negatively correlated with turbidity (-0.671 at p<0.01), COD (-0.585 at 
p<0.05) and BOD (-0.563 at p<0.05). Significant positive correlations were shown between 
MRSA and turbidity (0.563 at p<0.01) and between electrical conductivity and total dissolved 
solids (0.773 at p<0.01). There was also a positive correlation between BOD and COD (0.998), 
BOD and S. aureus (0.932), and S. aureus and COD (0.924) at p<0.01 (Table 3.4).  
For WWTP2, S. aureus, total dissolved solids and pH had no significant correlations to other 
parameters in the WWTP (Table 3.4). A significant negative correlation was shown between 
temperature and resistivity (-0.591 at p<0.05). Turbidity showed a significant positive 
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correlation with electrical conductivity (0.805), salinity (0.811), COD (0.899) and BOD 
(0.706) at p<0.01 and MRSA (0.530 at p<0.05). Electrical conductivity showed a significant 
positive correlation with salinity (0.999 at p<0.01), COD (0.622 at p<0.05) and BOD (0.805 at 
p<0.01). Salinity showed a significant positive correlation with COD (0.633 at p<0.05) and 
BOD (0.801 at p<0.01). Significant positive correlations were shown between BOD and COD 
(0.504 at p<0.05) and between BOD and MRSA (0.561 at p<0.05).  
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Table 3.1 Physico-chemical parameters of water samples from WWTP1 and receiving surface waters 
 Sample 
Point 
Temperature 
(℃) 
pH Turbidity 
(NTU) 
EC 
(µs/cm) 
TDS 
(mg/L) 
Resistivity 
(Ω/m) 
Salinity 
(%) 
COD 
(mg/L) 
BOD 
(mg/L) 
S
A
M
P
L
IN
G
 P
E
R
IO
D
 
1
 
INF 27.33 ± 0.58 7.19  487.67 ± 12.74 724.00 ± 5.29 414.67 ± 1.53 1387.33 ± 8.96 0.42 ± 0.01 504.00 ± 165.46 143.00 ± 76.92 
BC 25.67 ± 0.58 7.51  20.63 ± 1.74 514.00 ± 7.00 364.00 ± 2.65 1869.70 ± 156.51 0.37 ± 0.01 77.33 ± 15.95 52.50 ± 27.58 
AC 28.33 ± 0.58 
 
7.62 12.40 ± 1.06 563.00 ± 36.51 424.33 ± 3.79 1154.00 ± 10.44 0.43 ±0.01 222.00 ± 3.00 184.50 ± 0.71 
DS 27.33 ± 0.58 7.68 17.60 ± 0.35 618.00 ± 39.13 432.67 ± 1.15 1818.00 ± 22.87 0.67 ± 0.01 306.33 ± 2.08 23.72 ± 0.17 
US 26.00 ± 0.00 
 
7.70  7.73 ± 1.56 340.33 ± 1.15 257.67 ± 18.77 1134.33 ± 2.89 0.43 ± 0.01 193.33 ± 25.58 25.19 ± 0.87 
S
A
M
P
L
IN
G
 P
E
R
IO
D
 
2
 
INF 20.33 ± 0.58 
 
7.41  486.33 ± 3.51 1002.00 ± 18.56 483.67 ± 0.58 1006.30 ± 19.35 0.48 ± 0.00 731.50 ± 31.22 230.67 ± 28.38 
BC 19.33 ± 0.58 
 
7.69  17.57 ± 0.15 750.00 ± 1.73 366.67 ± 0.58 1333.00 ± 2.65 0.37 ± 0.01 151.00 ± 18.73 128.83 ± 6.52 
AC 18.00 ± 0.00 7.42  13.40 ± 0.46 860.67 ± 2.31 421.67 ± 0.58 1112.67 ± 87.20 0.42 ± 0.00 73.00 ± 7.81 91.67 ± 6.58 
DS 18.00 ± 0.00 7.81  22.3 ± 0.30 860.00 ± 5.29 421.33 ± 3.06 1163.70 ± 7.37 0.42 ± 0.00 59.00 ± 31.00 7.54 ± 1.53 
US 16.00 ± 0.00 7.52  29.97 ± 0.67 837.67 ± 0.58 410.00 ± 0.00 1194.33 ± 0.58 0.41 ± 0.00 223.67 ± 9.29 129.83 ± 5.03 
S
A
M
P
L
IN
G
 P
E
R
IO
D
 3
 INF 21.33 ± 0.58 
 
7.18  212.67 ± 4.04 871.67 ± 2.52 427.67 ± 1.53 1142.70 ± 4.16 0.43 ± 0.00 1002.50 ± 19.92 170.42 ± 5.38 
BC 21.33 ± 0.58 7.57  367.67 ± 20.11 721.67 ± 2.08 352.33 ± 0.58 1385.70 ± 3.21 0.35 ± 0.00 302.00 ± 1.00 87.92 ± 25.03 
AC 21.00 ± 1.00 7.62  35.87 ± 5.26 808.67 ± 10.41 396.00 ± 5.29 1261.00 ± 33.40 0.39 ± 0.01 306.00 ± 2.65 10.00 ± 0.00 
DS 19.00 ± 0.00 
 
7.60  30.00 ± 5.09 818.33 ± 3.06 400.67 ± 1.53 1222.70 ± 5.03 0.40 ± 0.01 307.33 ± 0.58 23.01 ± 0.63 
US 17.33 ± 0.58 
 
7.54  40.87 ± 4.32 812.67 ± 0.58 398.00 ± 0.00 1230.67 ± 0.58 0.41 ± 0.02 294.00 ± 2.65 17.45 ± 0.45 
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Table 3.2 Physico-chemical parameters of water samples from WWTP2 and receiving surface waters 
 Sample 
Point 
Temperature 
(℃) 
pH Turbidity 
(NTU) 
EC 
(µs/cm) 
TDS 
(mg/L) 
Resistivity 
(Ω/m) 
Salinity 
(%) 
COD 
(mg/L) 
BOD 
(mg/L) 
S
A
M
P
L
IN
G
 P
E
R
IO
D
 
1
 
INF 25.33 ± 0.58 7.11  454.33 ± 12.50 879.00 ± 6.24 436.33 ± 2.31 1125.00 ± 6.08 0.44 ± 0.00 825.00 ± 31.18 173.33 ± 55.99 
BC 25.00 ± 0.00 7.30  102.00 ± 3.61 753.33 ± 0.58 368.00 ± 0.00 1328.00 ± 0.00 0.37 ± 0.00 289.33 ± 14.05 178.25 ± 2.00 
AC 24.67 ± 0.58 
 
7.72  95.00 ± 2.65 745.33 ± 33.65 364.00 ± 16.64 1344.00 ± 62.22 0.36 ± 0.02 260.00 ± 21.17 162.83 ± 5.77 
DS 25.00 ± 0.00 7.81 41.00 ± 1.00 608.00 ± 8.66 300.00 ± 6.08 1620.70 ± 32.35 0.30 ± 0.01 222.67 ± 41.88 23.14 ± 0.23 
US 23.33 ± 0.58 
 
7.59  14.00 ± 2.00 345.00 ± 7.00 345.00 ± 7.00 2900.00 ± 60.83 0.17 ± 0.01 212.00 ± 21.79 23.55 ± 0.16 
S
A
M
P
L
IN
G
 P
E
R
IO
D
 
2
 
INF 18.67 ± 0.58 
 
7.38  314.33 ± 32.15 814.67 ± 5.51 399.00 ± 3.00 1227.67 ± 8.50 0.40 ± 0.00 644.50 ± 53.36  268.33 ± 7.37 
BC 18.33 ± 0.58 
 
7.35  280.67 ± 27.39 799.00 ± 3.00 390.67 ± 1.53 1252.00 ± 5.00 0.39 ± 0.00 274.33 ± 4.04 170.58 ± 1.26 
AC 19.00 ± 0.00 7.01 100.33 ± 32.33 650.33 ± 2.52 316.33 ± 1.53 1538.67 ± 5.51 0.32 ± 0.00 287.33 ± 2.08 126.00 ± 5.34 
DS 18.67 ± 0.58 7.52  38.33 ± 5.51 509.00 ± 3.61 246.67 ± 1.53 1964.00 ± 12.77 0.25 ± 0.01 276.33 ± 6.81 23.42 ± 1.32 
US 18.33 ± 0.58 7.43  18.67 ± 2.08 343.00 ± 1.00 164.70 ± 0.36 2.92 ± 0.02 0.16 ± 0.00 239.00 ± 1.00 21.1 ± 0.60 
S
A
M
P
L
IN
G
 P
E
R
IO
D
 3
 INF 22.00 ± 0.00 
 
7.40  339.00 ± 1.00 750.00 ± 12.29 366.67 ± 5.86 1333.33 ± 21.73 0.37 ± 0.01 764.00 ± 27.01 139.67 ± 11.85 
BC 22.00 ± 0.00 7.25  76.67 ± 2.08 532.33 ± 6.66 258.33 ± 3.06 1878.30 ± 22.81 0.26 ± 0.01 256.00 ± 14.00 58.50 ± 1.32 
AC 22.00 ± 0.00 7.32  117.33 ± 1.53 528.67 ± 7.09 256.00 ± 3.61 1892.00 ± 25.24 0.26 ± 0.01 296.00 ± 3.00 199.33 ± 2.47 
DS 21.00 ± 0.00 
 
7.88  44.33 ± 0.58 379.00 ± 6.56 182.37 ± 3.37 2640.00 ± 45.83 0.18 ± 0.00 263.33 ± 29.14 24.93 ± 0.13 
US 21.00 ± 0.00 
 
 
7.66  26.67 ± 6.35 317.67 ± 1.53 152.20 ± 0.82 3150.00 ± 17.32 0.15 ± 0.00 269.00 ± 27.97 24.90 ± 0.12 
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Table 3.3 Correlation coefficients for the selected physico-chemical parameters and S. aureus population at WWTP1 
  Temp. pH Turbidity   EC  TDS  Resistivity   Salinity COD  BOD  MRSA  S. aureus  
Temp. 1 -0.078 0.097 -0.699** -0.193 0.473 0.363 -0.020 -0.027 0.406 -0.096 
Ph  1 -0.671** -0.330 -0.358 0.113 0.080 -0.585* -0.563* -0.569* -0.504 
Turbidity    1 0.373 0.337 -0.183 -0.038 0.184 0.142 0.563* -0.005 
EC    1 0.773** -0.396 -0.067 0.230 0.211 -0.015 0.106 
TDS      1 -0.140 0.369 0.192 0.169 0.117 0.015 
Resistivity       1 0.298 -0.185 -0.176 0.135 -0.079 
Salinity       1 0.030 0.012 0.043 -0.083 
COD         1 0.998** 0.033 0.924** 
BOD         
 
1 0.011 0.932** 
MRSA           1 -0.059 
S. aureus            1 
**. correlation is significant at the 0.01 level (2-tailed). 
*. correlation is significant at the 0.05 level (2-tailed). 
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Table 3.4 Correlation coefficients for the selected physico-chemical parameters and S. aureus population at WWTP2 
  Temp.  pH Turbidity   EC  TDS  Resistivity   Salinity COD  BOD  MRSA  S. aureus  
Temp. 1 -0.020 -0.236 -0.367 -0.172 -0.591* -0.379 -0.162 -0.289 -0.091 -0.039 
pH  1 -0.495 -0.465 0.046 0.426 -0.476 -0.394 -0.508 -0.134 -0.100 
Turbidity    1 0.805** -0.048 -0.391 0.811** 0.899** 0.706** 0.530* 0.477 
EC     1 -0.125 -0.506 0.999** 0.622* 0.805** 0.410 0.319 
TDS      1 0.325 -0.110 -0.046 -0.088 -0.008 -0.030 
Resistivity      1 -0.495 -0.301 -0.395 -0.222 -0.217 
Salinity       1 0.633* 0.801** 0.408 0.315 
COD         1 0.540* 0.622* 0.438 
BOD          1 0.561* 0.185 
MRSA           1 0.234 
S. aureus            1 
*. correlation is significant at the 0.05 level (2-tailed). 
**. correlation is significant at the 0.01 level (2-tailed). 
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3.3.2 Prevalence of MRSA in the wastewater samples based on presumptive MRSA count   
The prevalence of MRSA in WWTP1 ranged from 11.45- 85.63% in INF, 16.28-39.36% in 
BC, 2.16-5.07% in AC, 1.06-7.24% in DS and 4.95-14.09% in US (Fig. 3.1). WWTP1 showed 
the highest percentage of presumptive MRSA at the INF (85.63%) for sampling period 1. 
However, the highest prevalence was observed at BC for sampling periods 2 (22.06%) and 3 
(39.36%). The percentage prevalence decreased during all 3 sampling periods at AC (2.82%, 
5.07 and 2.16, respectively). An increase in percentage prevalence was noted in DS (7.23%) 
and US (4.95%) during sampling period 1. A lower percentage prevalence was reported at DS 
(2.61% and 1.06%) as compared to US (14.09% and 5.38%) for sampling periods 2 and 3, 
respectively. 
The prevalence of MRSA in WWTP2 ranged from 48.25- 86.18% in INF, 23.73- 93.75% in 
BC, 4.28- 48.82 % in AC, 1.74- 19.31 % in DS and 5.90- 28.78% in US (Fig. 3.1).  WWTP2 
showed a highest percentage prevalence of presumptive MRSA at the INF (68.38%) for 
sampling period 1. The percentage prevalence showed to be higher at BC (93.75% and 60.11%) 
for sampling periods 2 and 3 respectively. The percentage prevalence decreased at AC (4.28% 
and 4.80) at sampling periods 1 and 2, respectively. However, during sampling period 3, 
percentage prevalence decreased to 48.82% at AC, which was lower than the percentage 
prevalence at BC but slightly higher than INF. A decrease in percentage prevalence was noted 
in DS (1.74 and 19.31%) during sampling periods 1 and 3 but an increase (18.19%) during 
sampling period 2. The percentage prevalence of MRSA at US was recorded to be 5.90%, 
28.78% and 14.98. 
The removal efficiency rate of MRSA ranged from 98.91-99.17% and 90.71-99.96% in 
WWTP1 and WWTP2, respectively during the sampling periods. 
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Fig. 3.1 Prevalence of presumptive MRSA in wastewater and receiving rivers at WWTP1 and 
WWTP2 
 
3.3.3 Profiles of 16S rRNA and mecA genes in the wastewater samples 
 
The standard curve for the 16S rRNA generated a formula of 𝑦 = −10.555𝑥 + 109.54 with 
an r2 value of 0.97, while that for mecA generated a formula of 𝑦 = −4.06𝑥 + 45.54 with an 
𝑟2 value of 0.99. The copy number for 16S rRNA at WWTP1 ranged from 72.52-76.38 (INF), 
73.77-76.72 (BC), 74.74-77.65 (AC), 75.31-77.24 (DS) and 76.42-77.25 (US) for all three 
sampling periods (Fig. 3.2a). The copy number for 16s rRNA at WWTP2 ranged from73.46-
75.43 (INF), 74.65-76.91 (BC), 75.69-77.56 (AC), 76.29-77.42 (DS) and 77.10-77.25 (US).   
Fig. 3.2a also showed the copy number for mecA at WWTP1 that ranged from, for INF 46.17- 
54.91, BC 46.41- 47.84, AC 41.67- 48.91, DS 44.61- 48.17 and US 44.24- 49.56, for all three 
sampling periods. Higher concentration of mecA was noted at the INF (copy number 54.91 and 
46.63) at sampling periods 1 (copy number 54.91) and 2 (copy number 46.63), while BC 
recorded the higher copy number (47.84) during sampling period 3. At the AC, a slight decrease 
0
10
20
30
40
50
60
70
80
90
100
Inf BC AC DS US Inf BC AC DS US Inf BC AC DS US Inf BC AC DS US Inf BC AC DS US Inf BC AC DS US
Sampling Period
1
Sampling Period
2
Sampling Period 3 Sampling Period
1
Sampling Period
2
Sampling Period
3
P
re
va
le
n
ce
 o
f 
p
re
su
m
p
ti
ve
 M
R
SA
 (
%
)
Sampling Points
 65 
 
in the copy number of the mecA was also recorded (48.91, 45.97 and 41.67) during all 3 
sampling periods, respectively. However, there was a lower copy number at the DS point 
(48.17) but a higher copy number at the US point (49.56). Lower copy numbers for the mecA 
gene was recorded at DS (45.42) and US (45.46) during sampling period 2 but higher copy 
numbers were recorded at DS (44.61) and US (44.24) during sampling period 3. 
Fig. 3.2b showed the copy number for mecA at WWTP2 ranged from, for INF 44.32- 45.83, 
BC 39.54- 44.91, AC 41.27- 47.96, DS 43.62- 46.07 and US 42.79- 46.49, for all three 
sampling periods. Higher concentration of mecA was noted at the INF (copy number 44.78 and 
45.83) at sampling periods 1 and 2 and AC recorded the higher copy number (47.96) during 
sampling period 3. At AC, a slight increase in the copy number of the mecA was recorded 
(41.27, 43.96 and 47.97) during all 3 sampling periods, respectively, when compared to BC. 
However, there was a higher copy number at DS (44.45) during sampling period 1 but there 
was a lower copy number at the DS point (43.62 and 46.07) at sampling periods 2 and 3 
respectively. The copy numbers at US were 46.49, 42.79 and 44.23 for sampling periods 1, 2 
and 3 respectively. 
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a) 
 
 
b)  
 
Fig. 3.2 Average copy number of 16S rRNA and mecA genes in a) WWTP1 and b) WWTP2 
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3.4 Discussion 
The quality of water is measured by assessing its physical, chemical and bacteriological 
parameters (Reda, 2016). Therefore, it is important that treated effluent complies with the 
relevant discharge standards before it is released into the environment, to protect the health of 
the environment and the general public (Bateganyaa et al., 2015). 
The physico-chemical parameters of the water samples were determined and represented in 
Tables 3.1 and 3.2 for WWTP1 and WWTP 2, respectively. The temperature of water is 
important as it influences the biochemical reactions of organisms present in the water by 
increasing their rate of activity (Lokandhe et al., 2011). However, water temperature may vary 
depending on the location of the water source, the time of day that samples are collected and 
the season of the year (Shukla et al., 2013). For WWTP1, the highest temperatures recorded 
were during the first sampling period and ranged from 25.67- 28.33℃. Warmer temperatures 
observed at the upstream and downstream points at WWTP1 could be attributed to the fact 
these points are situated near an industrial area. Lokhande et al. (2011) explained that water 
sources may be used for industrial cooling systems, which may result in warm water 
temperatures. The highest temperature recorded at WWTP2 was 25.33℃ at the influent, also 
during the first sampling period. For the rest of the sampling periods, at both plants, the water 
temperatures were within the acceptable limit of 25℃ (DWAF, 1984).  
pH measures acidity or alkalinity of water samples (Rahmanian et al., 2015) and is set to range 
between 5.5-7.5 (DWAF, 1984). It is important that water is not extremely acidic or alkaline 
as this may have a negative impact on aquatic life and may also affect the operation of WWTPs 
(Kavitha et al., 2012). The pH of the water samples ranged from 7.18- 7.81 and 7.01- 7.88 for 
WWTP1 and WWTP2, respectively. A slight increase in pH was noted at the upstream and 
downstream points of the receiving rivers. These results were similar to that of a study which 
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recorded an average pH of 7.82 for domestic wastewater and the receiving river water (Popa et 
al., 2012). The pH results show that the treated effluent from these WWTPs and water from 
the receiving river is safe for reuse in irrigation (Kavitha et al., 2012). 
Turbidity is defined as cloudiness of a liquid due to the various particles suspended in that 
sample (Rahmanian et al., 2015). According to DWAF (1996), the turbidity of domestic water 
should range from 0-1 NTU. The turbidity of the influent and after chlorination samples ranged 
from 212.67- 487.68 NTU and 12.40-35.87 NTU, respectively at WWTP1, while it ranged 
from 314.33-454.33 NTU (influent) and 38.33-117.33 NTU (after chlorination) at WWTP2. 
Even though the turbidity of the water decreased from influent to treated effluent in both 
WWTPs, the turbidity of water did not meet the acceptable range of <1 NTU. At the receiving 
rivers, the turbidity at the downstream points of WWTP1 (17.60- 30.00 NTU) and WWTP2 
(38.33-44.33 NTU), and upstream points (7.73- 40.87 NTU) of WWTP1 and (14.00-26.67 
NTU) WWTP2 were higher than the recommended limit.  DWAF (1996) reported that this may 
have devasting effects on the taste, odour and appearance of the water, and that consumption 
of this water may result in infections due to disease causing agents and chemicals present in 
the water. As shown in Tables 3.3 and 3.4, there is a positive correlation between MRSA and 
turbidity at both WWTPs. This may be due to the suspension of organic or inorganic matter in 
the water which provides food and shelter for microorganisms, including MRSA (Altaher and 
Alghamdi, 2011). 
Electrical conductivity is defined as the ability of water to conduct an electric current due to 
the presence of ionic solids such as magnesium, chloride and calcium (Reda, 2016). The 
electrical conductivity should not exceed 2500 µs/cm (250 ms/m) in wastewater (DWAF, 
1984). The electrical conductivity (EC) for both plants fell below the limit of 2500 µs/cm and 
ranged between 340.33-1002.00 and 317.67-879.00 for WWTP1 and WWTP2, respectively. 
Although EC might not have a direct negative impact on human health, it is used to evaluate 
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the purity of water (Rahmanian et al., 2015; Reda, 2016). The industrial plant situated near the 
downstream point of the receiving river of WWTP1 may have contributed to the increase in 
the EC of surface waters near this point as compared to the downstream point of the receiving 
rivers of WWTP2. The release of industrial waste effluent downstream of the river may cause 
a change in mineral content, impacting the EC (Rahmanian et al., 2015). This may have a 
negative effect on pipes and metal items near or in the water as high EC is the cause of corrosion 
(Rahmanian et al., 2015). 
The total dissolved solids (TDS) measures salinity by measuring the organic and low 
concentrations of inorganic matter present in the water (Rahmanian et al., 2015; Surti, 2016). 
TDS measures salts such as bicarbonate, carbonate, sodium, potassium and manganese. High 
amounts of these substances may change the density of water, lower the solubility of oxygen 
and change the osmoregulation of organisms present in the water (Surti, 2016). With the 
exception of the influent for the second sampling period (483.67 NTU) at WWTP1, the TDS 
values of all sampling points from both WWTPs as well as downstream and upstream points 
of the respective receiving rivers were below the acceptable limits of 450 mg/L (DWAF, 1996). 
Higher values of TDS (1308 mg/l) have been reported in treated effluent (Kavitha et al., 2012).  
Chemical oxygen demand (COD) can be defined as the amount of oxygen needed to oxidize 
organic and inorganic compounds in the water (Popa et al., 2012; Surti, 2016). According to 
the Department of Water and Forestry, the COD should not exceed 30 mg/L (DWAF, 1984). 
The COD ranged from 504.00-1002.50 mg/L and 644.50- 825.00 (in the INF) to 73.00- 306.00 
and 260.00- 296.00 (in the AC) for waters at WWTP1 and WWTP2, respectively. As observed 
in Tables 3.1 and 3.2, the COD for both WWTPs exceeded the acceptable limit of 30 mg/L 
across all sampling points. The COD of the treated effluent from both WWTPs (except for 
sampling period 2 at WWTP2) was much higher than findings by Kavitha et al. (2012) which 
reported COD values of 99 mg/L. This current study also reported high COD values for 
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downstream (59.00-307.33 mg/L for WWTP1 and 222.67-276.33 mg/L for WWTP2) and 
upstream points (193.33- 294.00 mg/L for WWTP1 and 212.00-269.00 mg/L for WWTP2) of 
the river. High COD values in the receiving rivers was attributed to industrial waste and 
external sources of domestic waste (Kavitha et al., 2012). The high COD value shows that the 
treated effluent and receiving river shows the presence toxic substances and biologically 
resistant substances (Kavitha et al., 2012).  
The BOD values for INF to AC, ranged from 143.00-230.67 mg/L and 10.00-184.50 mg/L for 
WWTP1 and 139.67- 268.33 mg/l and 126.00-199.33 mg/L for WWTP2, respectively. BOD 
values ranged from 7.54-23.72 mg/L and 23.14-24.93 (DS) and from 17.45-129.83 mg/L and 
21.10-24.90 mg/L (US) at WWTP1 and WWTP2, respectively. These values were much higher 
than the maximum value of 5 mg/L, as stipulated by the South African guidelines (DWAF, 
1999). Even though the BOD values do not fall within the acceptable limit, this result suggests 
that both WWTPs are not the only contributors to the BOD of the receiving rivers. This may 
be due to the industrial area near the receiving river of WWTP1. This can be supported by a 
study which showed high BOD values of 535.8, 604.8 and 776.2 mg/L for the effluent samples 
from paint, engineering and dye industries, respectively (Lokhande et al., 2011). Similarly, 
WWTP2 and its receiving river are situated near a nature reserve, which may contribute to the 
high BOD values. This is supported by Lokhande et al. (2011) who stated that other sources of 
high BOD values may be caused by the leaves, woody debris, animal waste and dead animal 
or plant matter. The observed positive correlation between BOD and MRSA may be evidence 
that these sources may serve as reservoirs of MRSA contributing to their prevalence in the 
waters.  
The high BOD values indicated the depletion of oxygen in the water, lowering the availability 
of oxygen to organisms present in the water which may result in the death of the aquatic life 
(Lokhande et al., 2011) 
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The spread of MRSA in clinical and environmental settings has posed a global threat to public 
health (Kim et al., 2012). This study was undertaken to determine the prevalence of MRSA in 
the treated effluent from two WWTPs and to ascertain if treated effluents from these plants 
contribute to the dissemination and spread of MRSA into their respective receiving rivers. The 
decrease in MRSA population revealed a removal efficiency of 98.91- 99.17% and 90.71-
99.79%during the sampling periods in WWTP1 and WWTP2, respectively.  As shown in Fig. 
3.1, the highest prevalence of MRSA for each sampling period was recorded to be 85.63% at 
INF (for sampling period 1) and 22.06% and 39.36% at BC (for sampling period 2 and 3, 
respectively) at WWTP1 and 68.38 at INF (for sampling period 1) and 93.75% and 60.11% at 
BC (for sampling period 2 and 3, respectively) at WWTP2. The influent and before chlorination 
are the primary and secondary stages of the treatment process. There is a decrease in the 
prevalence of MRSA in the after-chlorination point at both WWTPs, however both plants were 
not able to completely remove MRSA in the treated effluent. Results varied to a study carried 
out by Börjesson et al. (2009) which showed that high number of MRSA could be isolated 
from the influent whereas no MRSA could be isolated from the effluent. Goldstein et al. (2012) 
also demonstrated a steady decrease of ten MRSA isolates found in the influent to one MRSA 
isolate found in the treated effluent. Börjesson et al. (2009) suggested that a decrease in MRSA 
in the effluent is due to treatment efficiency of the plant or, that in wastewater, the strains may 
enter the viable but non-culturable state. Another reason for the reduction of MRSA in the 
receiving rivers of WWTP1 may be due to the discharge of chemicals and heavy metals, from 
the nearby factories, which may hinder the growth of the MRSA present at this point of the 
river. 
Quantitative PCR is a rapid but highly sensitive method to detect the prevalence of MRSA in 
water samples (Kim et al., 2012). This is done by rapid detection of the mecA gene which 
encodes for methicillin resistance (San Sit et al., 2017).  Figs. 3.2a and b showed the average 
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copy number of the 16S rRNA and mecA at each sampling point of both WWTPs and their 
receiving rivers. 16S rRNA served as the standard for the total bacteria present at all sampling 
points of WWTPs and receiving surface waters (Mao et al., 2015). The number of cells carrying 
the mecA gene in the influent ranged from 46.17-54.91 and 44.32-45.83 during all three 
sampling periods for WWTP1 and WWTP2, respectively. The number of cells that carried the 
mecA gene in the treated effluent ranged from 41.67-48.91 and 41.27-47.96 for WWTP1 and 
WWTP2, respectively. A decrease in these cells from the influent to the treated effluent was 
observed for all three sampling periods in WWTP1 and for two of the sampling periods at 
WWTP2. This was similar to the findings of Börjesson et al. (2009) showing a reduction in the 
concentration of the mecA gene from the influent to the treated effluent. The findings of the 
current study indicate that both treatment plants were able to reduce the concentration of the 
mecA gene in the water. The third sampling period showed an increase in cells with the mecA 
gene in the treated effluent. This finding shows that both WWTPs may play a role in the spread 
of mecA to receiving surface waters as previously reported (Börjesson et al., 2009).  
Results from this study show that the treatments in both WWTPs are effective in reducing the 
prevalence of MRSA from the influent to the treated effluent. However, no significant decrease 
in the concentration of mecA was observed for each sampling period from the INF to treated 
effluent. The low reduction of mecA may be due to disinfection and tertiary treatment, which 
could result in cell destruction and subsequent release of DNA into the water (Quach-Cu et al., 
2018). Studies have reported an increase in antibiotic resistance genes (ARGs) in treated 
effluent even if the microbial population was reduced during the wastewater treatment (Quach-
Cu et al., 2018). This suggests that treated wastewater effluent may potentially cause the spread 
of ARGs into receiving surface waters of the WWTPs. This finding is supported by Czekalski 
et al. (2012) who reported an accumulation of ARGs in receiving surface waters due to 
wastewater discharge.  
 73 
 
Higher prevalence of MRSA was detected in US (14.09% and 5.38%) for sampling periods 2 
and 3 at WWTP1 and in US (5.90% and 28.78%) for sampling periods 1 and 2 at WWTP2. 
Similar results were reported for the mecA gene at this point. This shows that both WWTPs are 
not the only source of antibiotic resistant bacteria or ARGs in the receiving rivers. Animal 
waste carrying gastrointestinal bacteria, may be discharged into the water through drainage 
ditches (Xiong et al., 2015). Genetic information may be exchanged between these bacteria 
and the indigenous bacteria present in the waters, including ARGs, such as mecA (Xiong et al., 
2015). 
The receiving river of WWTP1 is situated in a recreational area while that of WWTP2 is 
situated near a nature reserve that are habitats of many animals and birds. Thus. the animals 
could serve as a reservoir for MRSA and contribute to the spread of microorganisms in the 
environment (Thapaliya et al., 2017). Even though both WWTPs may have shown to decrease 
the amount of MRSA from the influent to the effluent, the remaining strains may be released 
into the receiving surface waters, suggesting that WWTPs may potentially select for MRSA 
strains that will eventually be released into receiving rivers (Börjesson et al., 2010).  
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3.5 Conclusion 
The enumeration of MRSA and the quantification of the mecA gene showed that both WWTPs 
were able to reduce the MRSA load in the treated effluent before releasing it into the receiving 
rivers. Since both mecA and S. aureus exist in the same environment, Börjesson et al. (2009) 
suggests that horizontal gene transfer may occur in wastewater and give rise to MRSA. The 
results from this study show that the treated effluent from the WWTPs under investigation act 
as a reservoir for MRSA and may contribute to its spread in the environment. This is quite 
alarming as studies by Börjesson et al. (2009) showed that people who use such treated effluent 
for irrigation had a high prevalence of S. aureus infections. This may also be a concern to the 
people who work at the WWTPs through exposure to reclaimed water. They may be exposed 
to MRSA through direct skin contact with the water (Goldstein et al., 2012) as they may be 
exposed to MRSA. Wearing gloves and hand washing by workers of the WWTPs and those 
that live near contaminated receiving rivers, is advised to reduce MRSA infections. 
Furthermore, this study showed that although these WWTPs may reduce the number of bacteria 
present in wastewater, it may not efficiently remove ARGs from the water. This could lead to 
the spread of ARGs amongst various strains of bacteria, contributing to the spread and survival 
of multi-drug resistant bacteria, including MRSA.  
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Abstract 
Municipal wastewater treatment plants (WWTPs) may serve as a reservoir for potentially 
pathogenic and antibiotic resistant bacteria. The discharge of improperly treated wastewater 
effluent may lead to the spread of these bacteria, including methicillin-resistant Staphylococcus 
aureus (MRSA) which is responsible for causing pneumonia, septicaemia and skin and soft 
tissue infections, into the receiving surface waters. This study aimed to determine the 
antibiogram and virulence gene profiles of MRSA isolates recovered from treated wastewater 
effluent and receiving surface waters. Genetic fingerprinting of the isolates was also carried 
out to determine the phylogenetic relationship between the isolates and selected antibiogram 
profiles. Eighty MRSA isolates were obtained from treated effluent and receiving rivers of two 
WWTPs in Durban, KwaZulu-Natal. Antibiotic resistance was observed towards lincomycin 
(100%), oxacillin (98.75%), cefoxitin and penicillin (97.50%), and ampicillin (96.25%). In 
addition, 72.50%, 66.25%, 52.50%, 40% and 33.75% of isolates showed resistance against 
cefozolin, azithromycin, amoxicillin/clavulanic acid, erythromycin and vancomycin, 
respectively. Antibiotic resistance genes detected in the isolates tested in this study: 
aac(6ꞌ)/aph(2ꞌꞌ) (56.25%), ermC (62.50%), msrA (22.50%), and blaZ and tetK (70%). The 
frequency of virulence genes: hla and sea was 57.50%, hld was 1.25%, while lukS P/V was 
0%. Pulse Field Gel Electrophoresis analysis generated 13 pulsotypes (designated A-M) 
showing a correlation to their respective antibiograms. Findings from this study showed the 
presence of potentially pathogenic, multi-drug resistant MRSA in the treated effluent and 
receiving surface waters. This may have detrimental effects on the health of individuals who 
come into contact with these water resources.  
Keywords: Methicillin-resistant Staphylococcus aureus, wastewater treatment plants, 
antibiograms, antibiotic resistance genes, virulence genes, pulse field gel electrophoresis 
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4.1 Introduction 
Staphylococcus aureus is a Gram-positive bacterium that may cause infections which can lead 
to fatal diseases such as skin and soft tissue infections, pneumonia, food poisoning and toxic 
shock (Zmanter et al., 2013; Alfatemi et al., 2014; Velasco et al., 2015). Antibiotics have 
played a major role in the treatment of staphylococcal infections; however, antibiotic resistance 
has emerged due to the misuse and overuse of antibiotics as well as the evolvement of bacterial 
strains harbouring antibiotic resistance genes (ARGs) (Ong et al., 2017). Methicillin-resistant 
Staphylococcus aureus (MRSA) was first isolated in the 1960s in the hospital environment 
therefore referred to as hospital-acquired MRSA (HA-MRSA) (Goldstein et al., 2012). 
However, in the 1990s, infections appeared in individuals with no risk factors and were 
regarded as community-acquired MRSA (CA-MRSA) (Goldstein et al., 2012).  
Methicillin-resistance in MRSA is caused by the mecA gene which is carried on the 
staphylococcal cassette chromosome mec (SCCmec) in all MRSA strains (Zmantar et al., 
2013).  The mecA gene encodes for a penicillin binding protein (PBP) which induces resistance 
to β-lactam antibiotics in MRSA (Thompson et al., 2013; Ong et al., 2017). MRSA have been 
reported to show resistance to multiple antibiotics, including: aminoglycosides, lincosamides, 
tetracyclines and macrolides. Increasing resistance has been shown against vancomycin which 
is used as an ultimate option for treatment of MRSA infections (Ong et al., 2017). Many studies 
have shown that ARGs are responsible for causing antibiotic resistance in MRSA. Commonly 
reported ARGs found in MRSA are those that encode resistance towards macrolides, 
macrolide– lincosamide–streptogramin B, tetracyclines, β-lactams and aminoglycosides 
(Zmantar et al., 2013; Dormanesh et al., 2015). These ARGs can be transferred between species 
through horizontal gene transfer and integrated into the host’s DNA influencing the evolution 
of the strains (Mkize et al., 2017). This may be due to the various mobile genetic elements 
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found in MRSA which include transposons, plasmids, gene cassettes and bacteriophages 
(Mkize et al., 2017). 
A variety of virulence factors in MRSA have been reported to be responsible for its 
colonization and pathogenicity in a host. S. aureus produce low molecular weight toxins, which 
include staphylococcal enterotoxins (A-Q) associated with their respective genes. The group 
of staphylococcal enterotoxins A-E are related to food poisoning (Alfatemi et al., 2014). Other 
toxins include haemolysins (alpha, beta and delta) which are known to lyse red blood cells 
(Burnside et al., 2010). Leukocidal toxins are caused by the Panton-Valentine Leukocidin 
(PVL) which serves as a virulence marker in many community-acquired MRSA infections 
(Thapilya et al.,2017). This toxin has also been associated with skin and soft tissue infections, 
and systemic infections (Dormanesh et al., 2015). Therefore, it is important to identify potential 
environmental sources of MRSA to prevent and control the spread of infections. Börjesson et 
al. (2009) detected the presence of the mecA gene in hospital and municipal wastewater. This 
suggests that wastewater treatment plants may play a role as a reservoir and dissemination of 
MRSA into receiving surface waters and its surrounding environment. The use of improperly 
treated wastewater in agricultural and industrial applications, due to water shortages (Goldstein 
et al., 2012), may bear harmful consequences to the end-users as they may be exposed to 
potentially pathogenic and multi-drug resistant MRSA.  
This study aimed to characterize MRSA strains recovered from treated wastewater effluent and 
receiving surface waters of two WWTPs in Durban and to determine their antibiogram and 
virulence gene profiles. Genetic fingerprinting was carried out on selected isolates, based on 
their antibiograms, to ascertain their genetic relatedness using pulsed field gel electrophoresis.  
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4.2 Materials and Methods 
4.2.1 Source of Methicillin Resistant Staphylococcus aureus isolates and culture 
conditions 
Presumptive Methicillin Resistant Staphylococcus aureus (MRSA) strains were isolated from 
the treated effluent, upstream and downstream points of receiving rivers of two wastewater 
treatment plants (WWTPs) in the Durban area. The isolates were grown on Mannitol Salt Agar 
(MSA) (Biolab, Merck) supplemented with cefoxitin. Isolates which grew as yellow colonies 
were considered presumptive MRSA and were subjected to biochemical testing. Isolates that 
were catalase positive, oxidase negative and coagulase positive were screened for the presence 
of the mecA gene to confirm them as MRSA. Eighty confirmed MRSA isolates were stored as 
glycerol stock at -80°C for further characterization.  
4.2.2 Molecular confirmation of the MRSA isolates via PCR detection of mecA gene 
DNA was isolated using the boiling method where 5 colonies were suspended in 70µl of 
distilled water. The suspension was boiled for 10 minutes then centrifuged at 13 000 rpm. 50 
µl of the supernatant was removed and stored at -20ºC (Bai et al., 2010). PCR amplification of 
the mecA gene was performed using the method described by Thompson et al. (2013). The 25 
µl PCR assay mixture contained: 10.55 µl of distilled water, 1× PCR buffer, 3 mM of MgCl2, 
250 µM of dNTPs, 0.1 µM of each of forward and reverse primers, 2 U Taq polymerase 
(SuperTherm) and 2µl of DNA template.  The primer sets used to detect the mecA gene 
included Forward: CCTAGTAAAGCTCCGGAA and Reverse: CTAGTCCATTCGGTCCA 
(Thompson et al., 2013).The PCR cycle was performed in a T100 Thermal Cycler (Bio-Rad, 
USA) under the following conditions: Initial denaturation at 95°C for 5 min, 35 cycles of 
denaturation at 95°C for 2 min, amplification at 58°C for 1 min, elongation at 72°C for 1 min 
and final elongation at 72°C for 10 min.  The amplified product was resolved on a 1.5% agarose 
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gel (Seakem) at 60 V for 90 min. The gel was stained with 1% Ethidium bromide for 15 min 
and viewed under UV light (420 nm) using the Chemigenius Bioimaging System (Syngiene). 
4.2.3 Antibiotic resistance profiling of MRSA isolates 
4.2.3.1 Antibiotic susceptibility testing 
Antibiotic susceptibility tests were performed using the Kirby-Bauer disc diffusion assay 
according to the Clinical and Laboratory Standards Institute guidelines (CLSI, 2014). All the 
isolates were inoculated in nutrient broth (Biolab, Merck) and incubated at 37°C for 24 h. Each 
isolate was standardized to 0.5 McFarland standard and swabbed onto Mueller-Hinton (Biolab, 
Merck) agar plates. Thereafter, the plates were allowed to dry for about 30 min before placing 
5 antibiotic discs equidistant from each other on each plate. Each isolate was tested in duplicate. 
The plates were incubated at 37 °C for 24 h and thereafter screened for the presence/absence 
of clear zones. The clear zones diameter, where inhibition of growth around the disc occurs, 
was observed and measured (in mm). The isolates were then classified as being either 
susceptible, intermediate or resistant based on the CLSI (2014) guidelines.  Isolates that are 
resistant to three or more classes of antibiotic were considered as being multi-drug resistant 
(Falagas et al., 2006). E. coli 25922 was used as a control strain.  
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4.2.3.2 Detection of antibiotic resistance genes  
All isolates were screened for the presence of the following antibiotic resistance genes: 
aac(6ꞌ)/aph(2ꞌꞌ), blaZ, ermC, msrA and tetK. The 25 µl PCR assay mixture contained: 5.9 µl of 
distilled water, 1 µM of each forward and reverse primer, 200 µM of dNTPs, 1.5 mM of MgCl2, 
1× PCR buffer, 1 U Taq polymerase and 5 µl of bacterial DNA as template. The primers used 
for the PCR amplification of these antibiotic resistance genes are shown in Table 4.1. 
Table 4.1 Primers used for PCR amplification of antibiotic resistance genes 
Gene Target Sequence (5ˈ           3ˈ) Product 
Size  
(bp) 
Reference 
aac(6ꞌ)/aph(2ꞌꞌ)- F 
 
aac(6ꞌ)/aph(2ꞌꞌ)- R 
TAATCCAAGAGCAATAAGGGC 
GCCACACTATCATAACCACTA 
227 Kuntová et 
al. (2012) 
blaZ- F 
blaZ- R 
ACTTCAACACCTGCTGCTTT 
TGACCACTTTTATCAGCAAC 
173 Kuntová et 
al. (2012) 
ermC- F 
ermC- R 
CTTGTTGATCACGATAATTTCC 
ATCTTTTAGCAAACCCGTATTC 
190 Kuntová et 
al. (2012) 
msrA- F 
msrB- R 
GGCACAATAAGAGTGTTTAAAGG 
AGTTATATCATGAATAGATTGTCCTGTT 
940  Dormanesh 
et al. (2015) 
tetK- F 
tetK- R 
GTAGCGACAATAGGTAATAGT 
GTAGTGACAATAAACCTCCTA 
360 Dormanesh 
et al. (2015) 
 
The PCR cycle was performed in a T100 Thermal Cycler (Bio-Rad, USA). The PCR 
amplification for the aac(6ꞌ)/aph(2ꞌꞌ), blaZ and ermC was performed under the following 
conditions: initial denaturation at 94°C for 5 min, 30 cycles of denaturation at 94°C for 2 min, 
annealing at 55°C for 30 s, elongation at 72°C for 1 min and a final elongation at 72°C for 7 
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min (Kuntová et al., 2012).  The PCR amplification for msrA was performed under the 
following conditions: initial denaturation at 94℃ for 6 min, 34 cycles of denaturation at 95℃ 
for 1 min, annealing at 50℃ for 1 min 10 s, elongation at 72℃ for 1 min 10 s and a final 
elongation at 72℃ for 8 min (Dormanesh et al., 2015). The PCR amplification of tetK was 
performed under the following conditions: initial denaturation at 94℃ for 5 min, 25 cycles of 
denaturation at 94℃ for 1 min, annealing at 55℃ for 1 min 10 s, elongation at 72℃ for 1 min 
and a final elongation was done at 72℃ for 10 min (Dormanesh et al., 2015). The amplified 
product was resolved on a 2% agarose gel (SeaKem) at 60 V for 90 min.  
4.2.4 PCR Amplification of virulence genes 
PCR amplification was carried out to screen for the presence of the hla, hld, lukS/F PV and sea 
genes. The PCR assay was carried out in a 25 µl reaction mixture, containing 0.9 µl of distilled 
water, 1 µM of each forward and reverse primer for each gene, 200 µM of dNTPs, 1.5 mM of 
MgCl2, 1× PCR buffer, 1 U Taq polymerase and 5 µl of bacterial DNA as template. The 
primers used are shown in Table 4.2. 
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Table 4.2 Primers used for PCR amplification of virulence genes 
 
The PCR cycle was performed in a T100 Thermal Cycler (Bio-Rad, USA) under the following 
conditions: Initial denaturation at 94°C for 5 min, 30 cycles of denaturation at 94°C for 30 s, 
elongation at 72°C for 1 min and a final elongation step at 72°C for 7 min (Alfatemi et al., 
2014).  The amplified products were resolved in a 2% agarose gel (Seakem) at 60 V for 90 
min.  
4.2.5 Pulse field gel electrophoresis 
Twenty-one isolates were subjected to pulsed field gel electrophoresis (PFGE) based on their 
antibiograms. PFGE was performed according to the protocol described by the Center for 
Disease Control and Prevention (CDC, 2011) with minor modifications. Colonies from 
Gene Target Sequence (5ˈ          3ˈ) Product 
Size 
(bp) 
Annealing 
Temperature 
(℃) 
Reference 
hla- F CTGATTACTATCCAAGAAA
TTCGATTG 
 
209 
 
58 
 
Alfatemi et 
al. (2014) 
hla- R CTTTCCAGCCTACTTTTTTA
TCAGT 
hld- F AAGAATTTTTATCTTAATTA
AGGAAGGAGTG 
 
111 
 
58 
 
Alfatemi et 
al. (2014) hld- R TTAGTGAATTTGTTCACTGT
GTCGA 
lukS/F PV- F ATCATTAGGTAAAATGTCT
GGACATGATCCA 
 
403 
 
60 
 
Alfatemi et 
al. (2014) lukS/F PV- R GCATCAAGTGTATTGGATA
GCAAAAGC 
sea- F GGTTATCAATGTGCGGGTG
G 
 
102 
 
60 
 
Alfatemi et 
al. (2014) sea- R CGGCACTTTTTTCTCTTCGG 
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overnight cultures, grown on nutrient agar at 37℃, were suspended into TE buffer and adjusted 
to an OD reading of 0.9-1.1 at a wavelength of 610 nm. This was followed by the addition of 
2µl of lysostaphin (Sigma, St Louis, MO, USA) and 200 µl of adjusted cell suspension into 
200 µl of 1.8% low melting Seakem agarose (Thermo Scientific). The mixture was dispensed 
into a plug mould and left to solidify for 10-15 min at room temperature. After the plugs were 
removed from the moulds, they were placed into 500 ml of EC lysis buffer and 20 µl of 
Proteinase K (Thermo Scientific) and left to incubate overnight at 55 ℃. The lysis buffer was 
discarded and the plugs were washed 4-5 times with TE buffer and then stored at 4 ℃. The 
plugs were cut and restricted with SmaI (Thermo Scientific) for 3 h. After digestion, the plugs 
were loaded into the wells of a 1% agarose gel (SeaKem Gold). PFGE was carried out in the 
CHEF-DR III system (Bio-Rad Laboratories, Inc, CA, USA) according to the following 
conditions: 6 V, temperature 14 °C, initial switch time 5 s, final switch time 40 s, included angle 
120, with a run time of 20 h. The gel was stained in Ethidium bromide for 30 min and destained 
in distilled water for 30-45 min. Salmonella branderup strain was used as a control and was 
digested using XbaI (Thermo Scientific). Bionumerics software v.53 (Applied Maths and 
Scientific Software Development, Saint-Martens-Latem, Belgium) was used to perform cluster 
analysis using the Dice coefficient.  
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4.3 Results 
4.3.1 Confirmation of Methicillin Resistant Staphylococcus aureus 
A number of isolates that grew as yellow colonies on Mannitol Salt Agar supplemented with 
Cefoxitin were recovered from the discharge point of the treated effluent as well as upstream 
and downstream points of receiving surface waters of two wastewater treatment plants in 
Durban, KwaZulu-Natal. Biochemical tests and PCR amplification of the mecA gene (Fig. 4.1) 
resulted in 80 confirmed Methicillin Resistant Staphylococcus aureus (MRSA) isolates.  
 
Fig. 4.1 Representative gel of amplified mecA gene in the MRSA isolates 
Lane 1 contains the 100 bp marker, lane 2 contains the positive control (314 bp), lane 3 contains 
the negative control and lanes 4-8 contains environmental samples with amplification of mecA 
(314 bp).  
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4.3.2 Antibiogram analysis 
4.3.2.1 Antibiotic resistance profiles of the MRSA isolates 
The antibiotic resistance profiles of the MRSA isolates are shown in Table 4.3. The highest 
resistance was observed against lincomycin (100%), oxacillin (98.75%), followed by cefoxitin 
and penicillin (97.50%) and ampicillin (96.25%). Additionally, 72.50%, 66.25%, 52.50%, 40% 
and 33.75% showed resistance to cefozolin, azithromycin, amoxicillin/clavulanic acid, 
erythromycin and vancomycin, respectively. Lower resistance was observed against 
clindamycin and rifampicin (22.50%), sulfamethoxazole/trimethoprim (17.50%), tetracycline 
(11.25%), gentamicin, imipenem and chloramphenicol (5.00%) and amikacin (2.50%) 
respectively. None of the isolates was resistant to ciprofloxacin. Intermediate resistance was 
observed for clindamycin (53.75%), sulfamethoxazole/trimethoprim (21.25%), erythromycin 
and norfloxacin (15.00%), cefozolin (13.75%), chloramphenicol (12.5%) and tetracycline 
(11.25%). The isolates were susceptible to amikacin (95%), gentamicin (93.75%), 
ciprofloxacin (91.25%), imipenem (90.00%), chloramphenicol (82.50%), tetracycline 
(77.50%), norfloxacin and rifampicin (75%), vancomycin (66.25%) and 
sulfamethoxazole/trimethoprim (61.25%). All isolates showed resistance to three or more 
antibiotic classes and are therefore regarded as multi-drug resistant. 
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Table 4.3 Antibiotic resistance profile of MRSA isolates (n=80) 
 
 
 
 
 
 
 
Antibiotic Class 
 
Antibiotic (concentration) 
Number of isolates (%) 
Susceptible Intermediate Resistant 
Aminoglycosides Amikacin (30 µg) 76 (95.00) 2 (2.50) 2 (2.50)  
Gentamicin (10 µg) 75 (93.75) 1 (1.25) 4 (5.00) 
β-lactam/β-lactamase inhibitor combination Amoxicillin/clavulanic acid (30 µg) 38 (47.50) 0 (0.00) 42 (52.50) 
β-lactam Ampicillin (10 µg) 3 (3.75) 0 (0.00) 77 (96.25) 
Oxacillin (1 µg) 1 (1.25) 0 (0) 79 (98.75) 
Penicillin (10 U) 2 (2.50) 0 (0) 78 (97.50) 
Carbapenem Imipenem (30 µg) 72 (90.00) 4 (5.00) 4 (5.00) 
Cephalosporin  Cefoxitin (30 µg) 2 (2.50) 0 (0) 78 (97.50) 
Cefozolin (30 µg) 11 (13.75) 11 (13.75) 58 (72.50) 
Fluoroquinolones Ciprofloxacin (5 µg) 73 (91.25) 7 (8.75) 0 (0) 
Norfloxacin (10 µg) 60 (75.00) 12 (15.00) 8 (10.00) 
Glycopeptides Vancomycin (30 µg) 53 (66.25)  0 (0) 27 (33.75) 
Lincosamide Clindamycin (2 µg) 19 (23.75) 43 (53.75) 18 (22.50) 
Lincomycin (2 µg) 0 (0) 0 (0) 80 (100) 
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Table 4.3 continued…  
 
 
  
 
Antibiotic Class 
 
Antibiotic (concentration) 
Number of isolates (%) 
Susceptible Intermediate Resistant 
Macrolide Azithromycin (15 µg) 21 (26.25) 6 (7.50) 53 (66.25) 
Erythromycin (15µg) 36 (45.00) 12 (15.00) 32 (40.00) 
Phenicols Chloramphenicol (30 µg) 66 (82.50) 10 (12.50) 4 (5.00) 
Rifamycin B derivative Rifampicin (5 µg) 60 (75.00)  2 (2.5) 18 (22.5) 
Sulfonamide/methoprim Sulfamethoxazole/trimethoprim (1.25+23.75µg) 49 (61.25) 17 (21.25) 14 (17.50) 
Tetracycline Tetracycline (30 µg) 62 (77.50) 9 (11.25) 9 (11.25) 
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4.3.2.2 Antibiotic resistance gene signatures of the MRSA isolates  
Detection of antibiotic resistance genes: aac(6’)/aph(2’’), blaZ, ermC, msrA and tetK via PCR 
revealed the presence of these genes in some of the isolates (Fig. 4.2). Of the 80 MRSA isolates 
tested, aac(6ꞌ)/aph(2ꞌꞌ) was detected in 45 (56.25%) of the isolates, blaZ in 56 (70.00%), ermC 
in 50 (62.50%), msrA in 18 (22.50%) and tetK gene in 56 (70.00%) of the isolates. 
 
 
 
Fig. 4.2 Representative gel of amplified antibiotic resistance genes in the MRSA isolates  
Lane 1 and 17 show the 100 bp marker. Lane 2 shows the positive control for aac(6ꞌ)/aph(2ꞌꞌ) 
(227 bp), lane 3 shows the negative control and lane 4 shows aac(6ꞌ)/aph(2ꞌꞌ) detected in the 
representative environmental isolate (227 bp). Lane 5 shows the positive control for blaZ (173 
bp), lane 6 shows the negative control and lane 7 shows blaZ detected in the representative 
environmental isolate (173 bp). Lane 8 shows the positive control for ermC (190 bp), lane 9 
shows the negative control and lane 10 shows ermC detected in the representative 
environmental isolate (190 bp). Lane 11 shows the positive control for msrA (940 bp), lane 12 
shows the negative control and lane 13 shows msrA present in the representative environmental 
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isolate (940 bp). Lane 14 shows the positive control for tetK (360 bp), lane 15 shows the 
negative control and lane 16 shows tetK present in the representative environmental isolate 
(360 bp). 
4.3.2.3 Genotypic and phenotypic characterization of antibiotic resistance amongst the 
MRSA isolates 
The phenotypic and genotypic resistance patterns observed amongst the MRSA isolates are 
shown in Table 4.4. Fifty-one antibiotic resistance patterns were observed, of which 36 were 
represented by single isolates. Six of the MRSA isolates demonstrated the same phenotypic 
antibiotic resistance pattern against: amoxicillin/clavulanic acid, oxacillin, ampicillin, 
cefoxitin, penicillin and lincomycin with an antibiotic resistance index (ARI) of 0.30. Of these 
isolates, 3 harboured aac(6ꞌ)/aph(ꞌꞌ), 4 harboured blaZ and 5 harboured ermC and tetK. Five 
isolates have the same phenotypic antibiotic resistance pattern against: vancomycin, 
amoxicillin/clavulanic acid, oxacillin, ampicillin, cefoxitin, clindamycin, erythromycin, 
penicillin, rifampicin, cefozolin, lincomycin and azithromycin with an ARI of 0.60. Of the 4 
isolates, aac(6ꞌ)/aph(2ꞌꞌ) and tetK were detected in 1, and blaZ and msrA in 2 of the isolates.  
Four isolates showed antibiotic resistance pattern against oxacillin, ampicillin, cefoxitin, 
penicillin and lincomycin with ARI of 0.25. Of these 4 isolates, aac(6ꞌ)/aph(2ꞌꞌ) and blaZ were 
detected in 3, and ermC and tetK in 4 isolates. Four isolates showed the same antibiotic 
resistance pattern against: oxacillin ampicillin, cefoxitin, penicillin, cefozolin, norfloxacin, 
lincomycin and azithromycin (ARI: 0.40). Three of the isolates harboured the aac(6ꞌ)/aph(2ꞌꞌ) 
and ermC genes, while blaZ and tetK were detected in all 4. 
 97 
 
 
Table 4.4 Distribution of antibiotic resistance phenotype and genotype and multiple antibiotic resistance index amongst isolates (n=80)  
Key: AK- Amikacin; AMC- Amoxicillin/clavulanic acid; AMP- Ampicillin; AZM- Azithromycin; C- Chloramphenicol; CN- Gentamicin; DA- Clindamycin; E- Erythromycin; FOX- Cefoxitin; IPM- Imipenem; KZ- 
Cefozolin; MY- Lincomycin; NOR- Norfloxacin; OX- Oxacillin; P- Penicillin; RD- Rifampicin; SXT- Sulfamethoxazole/trimethoprim; TE- Tetracycline; VA- Vancomycin 
 
 
    Antibiotic resistance genes 
 
Phenotype 
 
No. of 
isolates 
 
Resistance profiles 
Antibiotic 
resistance 
index 
aac(6ꞌ)/ 
aph(2ꞌꞌ) 
blaZ ermC msrA tetK 
A1 1 VA AMC OX AMP FOX P KZ MY 0.40 1 1 0 1 0 
A2 1 VA AMC OX AMP FOX P KZ MY AZM 0.45 0 1 1 1 1 
A3 2 VA AMC OX AMP FOX E P KZ MY AZM 0.50 1 1 1 1 0 
A4 2 VA AMC OX AMP FOX E P SXT KZ MY AZM 0.55 1 1 2 0 0 
A5 1 VA AMC OX AMP FOX DA E P SXT RD KZ MY 0.60 0 1 0 1 0 
A6 1 VA AMC OX AMP FOX DA E P RD IPM KZ MY AZM 0.65 0 0 0 0 1 
A7 1 VA AMC OX AMP FOX DA E P RD KZ MY  0.55 0 1 1 0 0 
A8 5 VA AMC OX AMP FOX DA E P RD KZ MY AZM 0.60 1 2 0 2 1 
A9 1 VA AMC OX TE AMP FOX E P KZ MY AZM 0.55 1 0 0 1 0 
A10 3 VA AMC OX TE AMP FOX DA E P RD KZ MY AZM 0.65 0 2 0 1 1 
A11 1 VA AMC C OX AMP FOX DA E P SXT RD IMP KZ MY AZM 0.75 0 0 0 0 1 
B1 1 VA OX AMP FOX P RD KZ MY AZM 0.45 1 1 0 1 1 
B2 2 VA OX AMP FOX P KZ MY 0.35 1 2 2 0 2 
B3 1 VA OX AMP FOX DA E P RD IPM KZ MY AZM 0.60 0 1 0 1 1 
B4 1 VA OX AMP FOX DA P RD MY AZM 0.45 0 0 0 1 1 
B5 1 VA OX AMP FOX E P KZ MY AZM 0.45 1 1 0 1 0 
B6 1 VA OX TE AMP FOX E P MY AZM 0.45 1 0 0 1 1 
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Table 4.4 continued… 
    Antibiotic resistance genes 
 
Phenotype 
 
No. of 
isolates 
 
Resistance profiles 
Antibiotic 
resistance 
index 
aac(6ꞌ)/ 
aph(2ꞌꞌ) 
blaZ ermC msrA tetK 
B7 1 VA OX CN FOX P RD KZ NOR MY 0.45 0 0 0 0 0 
C1 1 C OX AMP FOX P KZ MY AZM  0.40 1 1 1 0 1 
C2 1 C OX AMP FOX P MY AZM 0.35 1 1 1 0 1 
D1 1 KZ MY AZM  0.15 1 1 0 0 1 
E1 1 AMC OX AMP FOX P SXT KZ NOR MY AZM 0.50 1 1 0 0 1 
E2 1 AMC OX AMP FOX P SXT KZ MY 0.40 1 1 1 0 1 
E3 1 AMC OX AMP FOX P SXT MY AZM 0.40 1 1 1 0 1 
E4 2 AMC OX AMP FOX P KZ MY  0.35 2 0 2 0 2 
E5 3 AMC OX AMP FOX P KZ MY AZM 0.40 3 2 2 0 3 
E6 3 AMC OX AMP FOX P MY AZM 0.35 2 1 1 0 2 
E7 6 AMC OX AMP FOX P MY 0.30 3 4 5 0 5 
E8 1 AMC OX AMP FOX E P KZ MY AZM 0.45 0 1 1 1 0 
E9 1 AMC OX AMP FOX DA P SXT MY 0.40 1 1 1 0 1 
E10 1 AMC OX TE AMP AK CN FOX DA P RD KZ NOR MY 0.65 0 0 0 0 0 
E11 1 AMC OX TE AMP FOX DA E P KZ MY AZM 0.55 1 1 1 0 1 
E12 1 AMC C OX AMP FOX P KZ MY AZM 0.45 1 1 1 0 1 
F1 1 OX AMP FOX P MY AZM 0.30 0 0 1 0 1 
Key: AK- Amikacin; AMC- Amoxicillin/clavulanic acid; AMP- Ampicillin; AZM- Azithromycin; C- Chloramphenicol; CN- Gentamicin; DA- Clindamycin; E- Erythromycin; FOX- Cefoxitin; IPM- Imipenem; KZ- 
Cefozolin; MY- Lincomycin; NOR- Norfloxacin; OX- Oxacillin; P- Penicillin; RD- Rifampicin; SXT- Sulfamethoxazole/trimethoprim; TE- Tetracycline; VA- Vancomycin 
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Table 4.4 continued…  
    Antibiotic resistance genes 
 
Phenotype 
 
No. of 
isolates 
 
Resistance profiles 
Antibiotic 
resistance 
index 
aac(6ꞌ)/ 
aph(2ꞌꞌ) 
blaZ ermC msrA tetK 
F2 4 OX AMP FOX P MY  0.25 3 3 4 0 4 
F3 2 OX AMP FOX P KZ MY  0.30 2 2 2 0 2 
F4 2 OX AMP FOX P KZ MY AZM 0.35 2 1 2 0 2 
F5 4 OX AMP FOX P KZ NOR MY AZM 0.40 3 4 3 0 4 
F6 1 OX AMP FOX P NOR MY AZM 0.35 1 1 1 0 0 
F7 1 OX AMP FOX P SXT KZ MY 0.35 1 1 1 0 1 
F8 1 OX AMP FOX E P KZ MY 0.35 1 1 1 0 1 
F9 2 OX AMP FOX E P KZ MY AZM 0.40 0 2 2 2 2 
F10 1 OX AMP FOX E P MY AZM 0.35 0 1 1 0 0 
F11 1 OX AMP FOX E P SXT KZ MY  0.40 0 1 1 0 0 
F12 1 OX AMP FOX E P SXT KZ MY AZM 0.45 0 1 1 1 0 
F13 1 OX AMP FOX DA P SXT KZ MY AZM 0.45 0 1 1 0 1 
F14 1 OX AMP AK CN FOX E P KZ MY AZM 0.50 1 1 1 0 1 
F15 1 OX AMP CN FOX E P MY AZM 0.40 1 1 1 1 1 
F16 2 OX AMP E P SXT KZ MY 0.35 1 2 1 0 1 
G1 1 OX FOX KZ MY AZM 0.25 1 1 1 0 1 
H1 1 OX TE AMP FOX P KZ MY AZM 0.40 1 0 1 0 1 
Key: AK- Amikacin; AMC- Amoxicillin/clavulanic acid; AMP- Ampicillin; AZM- Azithromycin; C- Chloramphenicol; CN- Gentamicin; DA- Clindamycin; E- Erythromycin; FOX- Cefoxitin; IPM- Imipenem; KZ- 
Cefozolin; MY- Lincomycin; NOR- Norfloxacin; OX- Oxacillin; P- Penicillin; RD- Rifampicin; SXT- Sulfamethoxazole/trimethoprim; TE- Tetracycline; VA- Vancomycin
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4.3.3 Virulence gene signatures of the MRSA isolates 
PCR amplification of virulence genes: hla, hld, lukS/F PV and sea revealed their presence in 
some of the isolates as shown in Fig. 4.3 Of the four virulence genes, hla, hld, lukS/F PV and 
sea, hld and sea were found to be most prevalent, as they were detected in 46 (57.50%) isolates. 
The hla gene was only detected in 1 (1.25%) isolate while lukS/F PV was not detected in any 
of the isolates.  
 
Fig. 4.3 Representative gel of amplified virulence genes  
Lanes 1 and 13 show the 100 bp marker. Lane 2 shows the positive control for the hla gene 
(209 bp), lane 3 shows the negative control and lane 4 shows hla present in the representative 
environmental isolate (209 bp). Lane 5 shows the positive control for the hld (111 bp), lane 6 
shows the negative control and lane 7 shows hld gene present in the representative 
environmental isolate (111 bp). Lane 8 shows the positive control for lukS/F PV (443 bp) and 
lane 9 shows the negative control. Lane 10 shows the positive control for sea (102 bp), lane 11 
shows the negative control and lane 12 shows sea present in the representative environmental 
isolates (102 bp). 
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The co-existence of three virulence genes:  hla, hld and sea genes was only noted in 1 isolate 
recovered from DS of WWTP1. This isolate was also found to harbour all the five antibiotic 
resistance genes tested: aac(6ꞌ)/aph(2ꞌꞌ), blaZ, ermC, msrA and tetK  
4.3.4 Genetic Fingerprinting of selected multi-drug resistant MRSA isolates 
The pulse field gel electrophoresis (PFGE) profiles and dendrogram of 21 selected MRSA 
isolates are shown in Fig. 4.4. Of the 21 isolates, PFGE grouped the MRSA isolates into 13 
pulsotypes designated as A-M with 80% similarity, correlating the isolates to their respective 
antibiograms. The largest cluster consisted of three isolates with the same pattern. Only 
pulsotypes J and L had the same patterns amongst the isolates, which also exhibited the same 
antibiogram profiles. The isolates were clustered into major pulsotypes: A (2/21; %), C (2/21; 
%), E (2/21; %), G (2/21; %), H (2/21; %), J (2/21; %) and L (3/21). Pulsotypes B, D, F, I, K 
and M were represented by single isolates.  
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Fig. 4.4 PFGE-based dendrogram, antibiotic resistance profiles and source of selected MRSA isolates recovered from treated wastewater 
effluent and receiving surface waters                                                                                                                                                                                                    
Key: SP- Sampling point; PT- Pulsotype; AC- After chlorination; DS- Downstream; US- Upstream; AK- Amikacin; AMC- Amoxicillin/clavulanic acid; AMP- Ampicillin; AZM- Azithromycin; C- Chloramphenicol; 
CN- Gentamicin; DA- Clindamycin; E- Erythromycin; FOX- Cefoxitin; IPM- Imipenem; KZ- Cefozolin; MY- Lincomycin; NOR- Norfloxacin; OX- Oxacillin; P- Penicillin; RD- Rifampicin; SXT- 
Sulfamethoxazole/trimethoprim; TE- Tetracycline; VA- Vancomycin; Black indicates resistance and white indicates intermediate or susceptible.
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4.4 Discussion 
Improperly treated wastewater may serve as a reservoir of bacteria, including Methicillin 
Resistant Staphylococcus aureus (MRSA), which may have negative consequences on public 
and environmental health (Bateganyaa et al., 2015). These MRSA may be potentially 
pathogenic causing infections in humans which are difficult to treat due to the emergence of 
antibiotic resistance (Goldstein et al., 2012). In MRSA, the mecA gene encodes for a penicillin 
binding protein (PBP2A/PBP2ꞌ) resulting in resistance to β-lactam antibiotics (Marais et al., 
2009; Naquin et al., 2014). Through detection of the mecA gene by PCR, a total of 80 MRSA 
strains were confirmed from the treated effluent and receiving surface waters of both WWTPs 
in Durban. Previous study also confirmed the presence of MRSA in treated wastewater effluent 
(Goldstein et al., 2012).  
Antibiotic resistance profiles of the MRSA isolated in this study were determined against 20 
antibiotics that are commonly used to treat MRSA associated infections. As shown in Table 
4.3, all isolates were resistant to lincomycin. This differed from studies by Dormanesh et al. 
(2015) which reported that only 6.75% (5/74) of tested clinical MRSA strains were resistant to 
lincomycin. The increased number of lincomycin resistant strains in this study supports the 
replacement of lincomycin by clindamycin to treat Gram-positive bacterial infections due to 
its improved pharmacological and therapeutic effects (Li et al., 2015). Resistance to oxacillin, 
ampicillin and penicillin was observed in 98.75%, 97.50% and 96.25% of the MRSA isolates, 
respectively. This is similar to the observations in previous studies in which all MRSA isolates 
isolated from poultry (n=30) tested were reported to exhibit resistance towards Oxacillin, 
Ampicillin and Penicillin (New et al., 2016). This is not surprising since these antibiotics are 
β-lactam antibiotics which the mecA gene confers resistance to. It was also observed that 
although all 80 presumptive MRSA isolates grew on Mannitol Salt Agar supplemented with 
cefoxitin, 78/80 (97.50%) isolates exhibited resistance to cefoxitin. This corroborates a study 
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by Thompson et al. (2013) which showed that cefoxitin resistance is used to help detect the 
presence of MRSA as it suggests methicillin resistance. Thompson et al. (2013) reported on 
antibiotics resistance of MRSA isolated from wastewater of two hospitals and its receiving 
sewage treatment plant. In hospital 1, 55%, 65% and 90% of isolates (n=35) were resistant to 
amikacin, chloramphenicol and gentamicin, respectively. In hospital 2, 60%, 65% and 75% of 
isolates (n=46) exhibited resistance to amikacin, chloramphenicol and gentamicin, 
respectively. The reduced number of isolates showed resistance to amikacin, chloramphenicol 
and gentamicin. This corroborates the finding in this study as a low number of isolates 
exhibited resistance against amikacin (2.50%), chloramphenicol (5%) and gentamicin (5.00%) 
by the MRSA isolates. No resistance was observed against ciprofloxacin and low resistance 
was observed against imipenem (5.00%). Findings by Dormanesh et al. (2015) also showed 
low resistance against ciprofloxacin (24.32%) and imipenem (2.70%) amongst the 70 MRSA 
isolates tested. High susceptibility to imipenem was expected as it is commonly used to treat 
human clinical MRSA infections (Dormanesh et al., 2015). Antibiotic resistance was observed 
against clindamycin (22.50%), erythromycin (40%) and tetracycline (11.25%). Dehkordi et al. 
(2017) reported higher levels of resistance against clindamycin (48.64%), erythromycin 
(86.48%) and tetracycline (100%) in MRSA (n=37) isolated from hospital food samples. 
Notable resistance was observed in this study against vancomycin (33.75%) differing from 
Goldstein et al. (2012) which reported 0% resistance against vancomycin from MRSA (n=84) 
isolated from WWTPs.  This is worrisome as vancomycin, a glycopeptide antibiotic, is used as 
a last resort treatment in severe MRSA infections (Ong et al., 2017). This is of concern as 
penicillin, ampicillin, clindamycin, tetracycline and erythromycin are used to globally treat 
MRSA infections due to affordability and accessibility (Rong et al., 2017). The observed low 
resistance to rifampicin (22.50%) in this study is expected as this antibiotic is used in 
combination with other antibiotics (such as fusidic acid) to treat MRSA infections (Tang et al., 
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2013). Amoxicillin/clavulanic acid is a combination of β-lactam and β-lactamase inhibitor that 
prevents the staphylococcal strain from hydrolysing the β-lactam (Mhmoud et al., 2014). This 
antibiotic is used to treat MRSA infections as it displays good activity against this strain 
(Mhmoud et al., 2014). However, 42 (52.50%) MRSA strains in this study exhibited resistance 
to this antibiotic. This is of concern, as resistance to this antibiotic may lead to challenges in 
the treatment of MRSA associated infections.  
The prevalence of antibiotic resistance genes (ARGs) amongst the MRSA isolates was 
determined in this study. The blaZ gene, detected in 56 (70.00%) of the isolates, confers 
resistance to β-lactam antibiotics (Zmanter et al., 2013). It encodes for the β-lactamase, which 
is responsible for hydrolysing the β-lactam ring upon exposure to β-lactam antibiotics, leaving 
the antibiotic inactive (Zmanter et al., 2013). The tetK gene, commonly found in Gram-positive 
bacteria, confers resistance to tetracycline (Zmantar et al., 2013; Ong et al., 2017) and encodes 
for efflux proteins which prevents the build-up of tetracycline inside the cell (Ullah et al., 2012; 
Ong et al., 2017). The high prevalence of blaZ and tetK observed in 70% of isolates in this 
study is similar to the findings of Dehkordi et al. (2017) which showed the presence of tetK in 
72.97% (n=27) of MRSA isolated from hospital food in Iran. However, Mkhize et al. (2017) 
detected the presence of blaZ and tetK in only 10.3% and 24% of MRSA (n= 104) respectively, 
isolated from faecal samples from commercial broiler chickens. Clinical isolates of MRSA 
strains showed the presence of tetK in 63.6% (n=55) (Adwan et al., 2014) and blaZ in 100% 
(n= 39) of MRSA isolated from the nasal cavity of paediatric service (Zmanter et al., 2013). 
The aac(6ꞌ)/aph(2ꞌꞌ) gene, which encodes for resistance against aminoglycosides, was found in 
56.25% of isolates. Aminoglycosides are also used to treat MRSA infections as they exhibit 
anti-staphylococcal activity and inhibit protein synthesis by binding to the 30S ribosomal unit 
(Gade and Qazi, 2014). The combination of Gentamicin and Tobramycin, belonging to the 
aminoglycoside antibiotic class, are most effective in treating Staphylococcal infections (Gade 
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and Qazi, 2014). The aac(6ꞌ)/aph(2ꞌꞌ) gene encodes for aminoglycoside modifying enzymes 
which induces drug inactivation (Gade and Qazi, 2014). A study by Duran et al. (2012) 
revealed the presence of aac(6ꞌ)/aph(2ꞌꞌ) in 20.9% (n= 139) of coagulase positive S. aureus 
from a clinical environment. The result in this study differed from that of Gomes et al. (2015) 
which revealed a slightly lower prevalence of the aac(6ꞌ)/aph(2ꞌꞌ) gene (44.0%) in 56 MRSA 
strains isolated from bloodstream infections. Erythromycin belongs to the antibiotic class 
macrolides, which are used to treat MRSA infections exhibiting effective pharmacokinetic 
properties by inhibiting protein synthesis (Prabhu et al., 2011). However, due to the increased 
exposure to macrolides, MRSA strains are acquiring resistance (Prabhu et al., 2011).  The ermC 
confers resistance to macrolides by modifying the antibiotic target site in the MRSA strain 
(Prabhu et al., 2011). This study showed the presence of the ermC gene in 62.5% of isolates, 
whereas it was only detected in 31% of the 41 MRSA isolates tested by Zarfel et al. (2013). 
The msrA gene also confers resistance to macrolides and streptogramin B antibiotics by 
encoding for efflux mechanisms that pumps these antibiotics from the cells (Zmanter et al., 
2013; Li et al., 2015).  msrA was detected in 22.50% of MRSA isolates in this study, whereas 
Zarfel et al. (2013) did not detect this gene in any of the 41 MRSA tested. Adwan et al. (2014) 
showed the presence of ermC in only 54.5% (n=55) of clinically isolated MRSA strains. 
However, in MRSA strains isolated from the nasal cavities of paediatric service, lower levels 
of ermC (22.0%) but higher levels of msrA (36.0%) was detected in 39 MRSA isolates 
(Zmanter et al., 2013).  
As indicated in Table 4.4 a total of 51 antibiotic resistant phenotypes were generated, with 6/80 
isolates found to be resistant to a combination of the following antibiotics: 
Amoxicillin/clavulanic acid, Oxacillin, Ampicillin, Cefoxitin, Penicillin and Lincomycin. All 
isolates in this study exhibited resistance to three or more different antibiotic classes and were 
classified as multidrug resistant strains as defined by Falagas et al. (2006). Similarly, Goldstein 
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et al. (2012) reported that 93% (78/84) MRSA isolates from WWTPs were multi-drug resistant. 
This could serve as a potential threat as end-users of the treated wastewater effluent and water 
from receiving rivers may be at risk of contracting MRSA infections that are multidrug resistant 
therefore posing challenges to treatment using conventional antibiotics. Multi-drug resistant 
MRSA infections may be challenging to treat in children, elders and immunocompromised 
patients (Akanbi et al., 2017). The multi-drug resistant MRSA in poorly treated wastewater 
and effluents may also leach into seawater through the receiving surface waters (Akanbi et al., 
2017). This may be fatal to those who engage in recreational activities at the beach especially 
those with skin lesions (Akanbi et al., 2017). 
The resistance phenotype observed did not correlate with the presence of ARGs as shown in 
Table 4.4. It was observed that the presence of aac(6ꞌ)/aph(2ꞌꞌ) was present in 56.25% (45/80) 
but four showed phenotypic resistance to an aminoglycoside antibiotic, ermC was present in 
62.5% (50/80) but 32 showed phenotypic resistant to erythromycin and tetK was present in 
70% (56/80) but only nine showed resistance to tetracycline. These results indicate that the 
presence of resistance genes (aac(6ꞌ)/aph(2ꞌꞌ), ermC and tetK did not translate into phenotypic 
resistance. A possible explanation could be that these ARGs are silent and therefore do not 
confer resistance to the host strain (Vaz-Moreira et al., 2014). This was similar to a study by 
Amoako et al. (2016) which revealed the presence of aac(6ꞌ)/aph(2ꞌꞌ) and ermC genes in 
MRSA isolates but did not confer phenotypic resistance to aminoglycosides and erythromycin, 
respectively. However, silent ARGs may be potentially dangerous as they can be transferred 
from one strain to another via horizontal gene transfer or may be potentially expressed when 
exposed to an increased concentration of the antibiotics (Zhu et al., 2013). 
One the other hand, blaZ was detected in 70% (56/80) but 98.75% (79/80) exhibited phenotypic 
resistance towards a β-lactam antibiotic and msrA was present in 22.50% (18/80) but 53 showed 
resistance to a tested macrolide antibiotic. Higher number of isolates were phenotypically 
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resistant towards β-lactam and macrolide antibiotics even though the prevalence of the blaZ 
and msrA gene was low. This may be due to the presence of the mecA gene which generally 
confers resistance to β-lactam antibiotics. Other possible reasons for resistance towards the β-
lactam and macrolide classes may be the presence of specific ARGs that were not screened for 
in this study (Shaikh et al., 2015). 
Investigation of the virulence gene signatures of the MRSA isolates in this study indicated that 
none of the isolates harboured the lukS/F PV gene. This gene encodes for Panton-Valentine 
leukocidin (PVL), a leukotoxin that result in necrotizing pneumonia which destroys lung tissue 
(Monecke et al., 2014). This is contradictory to the study of Goldstein et al. (2012) where 
lukS/F PV gene was detected in 68% (n=236) of MRSA strains isolated from a WWTP in the 
USA. This PVL toxin is used as a molecular marker to detect the presence of CA-MRSA 
(Velasco et al., 2015). Kane et al. (2018) reported that majority of HA-MRSA lack this gene 
as compared to CA-MRSA. This was confirmed in a study that compared the presence of 
virulence genes in both CA-MRSA (present in 92% of isolates) and HA-MRSA (absent in all 
isolates) in Colombia (Portillo et al., 2013). This suggests that MRSA present in the wastewater 
of these two plants could be HA-MRSA. MRSA may be present in blood, body fluids and 
secretions from skin and soft tissue infections which may be disposed without proper treatment 
in the hospital waste which eventually ends up in the WWTPs and can be spread into the 
environment (Thompson et al., 2013). The hla and hld genes encode for alpha-haemolysin and 
delta-haemolysin respectively, which result in the lysis of red blood cells (Burnside et al., 
2010). These haemolysins can be responsible for tissue injury, blood infections, renal 
parenchyma infections which is caused by blood carrying the bacteria (Doughari et al., 2011) 
and may cause the bacteria to scavenge iron compounds present in blood (Monecke et al., 
2014). It was observed that 1/80 (1.25%) contained the hla gene while 46/80 (57.50%) 
contained the hld gene. These results differed from that of Alfatemi et al. (2014) which showed 
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the presence of hla and hld in 100% and 84.24% (n=146) of clinical MRSA strains.  Contrarily, 
Xie et al. (2016) also detected the presence of hla and hld in 100% and 0% (n=62) of HA-
MRSA and CA-MRSA. The hla gene is produced at high levels in CA-MRSA and has been 
observed to increase the strains pathogenicity (Day et al., 2012). Tavares et al.  (2014) showed 
that the expression of hla in CA-MRSA is higher than in HA-MRSA. This supports the 
suggestion that the MRSA isolates detected in these WWTPs originated from hospitals due to 
improper treated hospital wastewater. A possible suggestion for the high prevalence of the hld 
gene is because it encodes for haemolysin that are associated with blood (Burnside et al., 2010). 
This suggests that these MRSA strains are from effluents from hospitals or slaughter houses 
that enters these WWTPs. (Thompson et al., 2013; Abidatul et al., 2018). The sea gene encodes 
for staphylococcal enterotoxin A which is responsible for food-borne disease, which may result 
in nausea, vomiting and diarrhoea (Kadariya et al., 2014). The sea gene showed to be present 
in 46/80 (57.50%) isolates which is higher than that of Alfatemi et al. (2014) where sea gene 
was detected in 27.39% of clinical MRSA isolates. However, results from this study are similar 
to findings of Xie et al. (2016) which detected sea in 59.7% (n=62) of HA-MRSA and CA-
MRSA. In the United States, the staphylococcal enterotoxin A was detected in 77.8% of S. 
aureus strains that were responsible for food-borne diseases (Kadariya et al., 2014). MRSA 
screened positive for staphylococcal enterotoxin A, isolated from stool samples of people 
affected with gastrointestinal illness (Kadariya et al., 2014). In this study, the high prevalence 
of sea gene could be due to the consumption of food contaminated with MRSA, resulting in 
these MRSA strains finding their way into the WWTPs through faecal wastes. This may include 
the water used to wash the raw material for food processing or the waste from animal slaughter. 
One of the isolates had the hla, hld and sea genes and also showed the presence of the antibiotic 
resistance genes: mecA, aac(6ꞌ)/aph(2ꞌꞌ), blaZ, ermC, msrA and tetK. This isolate showed 
phenotypic resistance to the following antibiotics: Oxacillin, Penicillin, Ampicillin, 
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Gentamicin, Erythromycin, Cefoxitin, Lincomycin and Azithromycin. This can be regarded as 
the most dangerous strain collected in this study. 
The PFGE profiles and dendrograms of 21 selected isolates as shown in Fig. 4.4 revealed the 
presence of thirteen pulsotypes. This was similar to the 12 pulsotypes obtained for 22 MRSA 
isolates recovered from wastewater (Goldstein et al., 2012). Two isolates have pulsotype J and 
three isolates showed to have pulsotype M. These isolates also exhibited identical antibiotic 
resistant phenotypes which portrays their genetic relatedness. Also, isolates that belonged to 
the same pulsotype exhibited similar antibiotic resistance patterns. Similar findings were 
reported by Moghadam et al. (2017) based on investigation of the genetic relatedness of MRSA 
strains isolated from burn patients using PFGE. Pulsotypes G, H and J showed isolates were 
from the same sampling point suggesting that these points are the origin of these MRSA strains. 
However, isolates belonging to the same pulsotypes were not necessarily isolated from the 
same sampling point of the WWTP (as observed in pulsotypes A, C and L) as these strains 
were found in the treated effluent and downstream points of the river. This suggests that the 
treated effluent discharge may be responsible for MRSA strains in the receiving rivers and this 
may pose challenges to environmental and human health (Naidoo and Olaniran, 2013). 
Pulsotype E was found in the treated effluent and upstream points of the river, suggesting that 
the treated effluent is not the only source for the MRSA isolates as previously indicated (Sabri 
et al., 2018).  
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4.5 Conclusion 
This study showed that treated effluent from WWTPs located in Durban, KwaZulu-Natal, can 
potentially serve as a source of genetically diverse, multi-drug resistant and virulent strains of 
MRSA in the receiving surface waters. This is in agreement with previous study which showed 
the occurrence of MRSA in treated wastewater effluent and receiving rivers (Goldstein et al., 
2012). These findings suggest that better wastewater treatment options should be explored to 
prevent the spread of multi-drug resistant bacteria in the environment and MRSA infections to 
end-users.  
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5.1 General Discussion and Conclusion 
Water is essential for the existence of life as it is required for drinking, preparation of food, 
sanitation, agricultural and industrial purposes. Unfortunately, access to low quality water for 
drinking and sanitation have led to the spread of many water-borne infections and diseases 
(Pandey et al., 2014; WHO and UNICEF, 2017).  Influencing factors include: urbanization, 
over-population, improper infrastructure and improper wastewater treatment (Naidoo and 
Olaniran, 2013; Bateganyaa et al., 2015). Improperly treated wastewater that is released into 
receiving rivers may potentially carry contaminants such as chemical agents and 
microorganisms (Hunter et al., 2010). These microorganisms may potentially cause diseases 
in end-users of this water. Also, they may be resistant to antibiotics that are commonly used in 
the treatment of infections, posing serious treatment challenges.  
The presence of methicillin-resistant Staphylococcus aureus (MRSA) detected in hospital and 
municipal wastewater suggest that wastewater treatment plants (WWTPs) may serve as a 
reservoir in the dissemination of MRSA into receiving surface waters and its surrounding 
environment (Börjesson et al., 2009). The presence of MRSA in treated effluent and its 
receiving surface waters may present a health risk to those who rely on this water for domestic 
and agricultural purposes (Goldstein et al., 2012). This is problematic as many strains of multi-
drug resistant MRSA have been reported to induce diseases and infections which include: 
septicaemia, pneumonia and skin infections (Almagro-Moreno and Taylor, 2013; Goldstein et 
al., 2012). This poses negative consequences on those with weakened immune systems and 
promotes the dissemination of antibiotic resistant and virulent MRSA strains in receiving water 
bodies. To the best of our knowledge, no studies have reported on the characterization of 
antibiotic resistance and virulence gene attributes of MRSA isolates obtained from the treated 
effluent of WWTPs and receiving rivers in Durban, South Africa. This project aimed to 
determine the prevalence of MRSA, quantify the mecA gene and correlate it to the microbial 
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counts of MRSA in the influent, treated wastewater effluent and receiving rivers of two 
independent (WWTPs) in Durban, Kwa-Zulu Natal. The study also aimed isolate MRSA from 
the treated effluent and receiving rivers of both WWTPs and to characterize the antibiograms, 
virulence gene profiles and genetic fingerprints of MRSA isolates. This provided insight of the 
potential pathogenicity of these MRSA isolates, if they were multi-drug resistant and if they 
were genetically related.  
The physico-chemical parameters of the wastewater samples and receiving surface waters were 
determined and results presented in chapter three. For most of the sampling periods, the 
temperature and pH for both WWTPs were within the acceptable limits (DWAF, 1984). 
Slightly warmer temperature observed at the downstream point of the river (for WWTP1) may 
be attributed to the industrial activities near-by which may have resulted in the discard of 
industrial waste into the rivers or use it for industrial cooling (Lokhande et al., 2011). The 
results showed a decrease in total dissolved solids, electrical conductivity and turbidity from 
the influent to treated effluent of both WWTPs, with values obtained in the treated effluent 
falling within the acceptable limits (DWAF, 1996). Majority of the results for the chemical 
oxygen demand (COD) and biological oxygen demand (BOD) decreased from influent to 
treated effluent in both WWTPs. However, both COD and BOD of the treated effluent 
exceeded the acceptable limits across all sampling points. The observed high BOD and COD 
of the rivers suggest that both WWTPs are not the only contributors. High COD values in the 
receiving rivers may be attributed to toxic substances from the industrial area located near 
WWTP1. High BOD values may be attributed to leaves, woody debris, animal waste and dead 
animal or plant matter as rivers of WWTP1 and WWTP2 are situated in a park and nature 
reserve, respectively (Lokhande et al., 2011). These findings suggest that water from the treated 
effluent and receiving rivers of both WWTPs should not be used for domestic purposes 
(DWAF, 1996). 
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The prevalence of MRSA was determined to assess if the treated effluent from the two WWTPs 
contribute to the dissemination and spread of MRSA into their respective receiving rivers. 
Removal efficiencies of 98.91- 99.17% and 90.71-99.96% was recorded for WWTP1 and 
WWTP2, respectively over the sampling periods. Results as presented in chapter three also 
revealed highest prevalence of MRSA in the primary or secondary stages of each WWTP for 
all 3 sampling periods. A decrease in the prevalence of MRSA in treated effluent was observed 
for both WWTPs for all sampling periods and this corroborates the findings of Goldstein et al. 
(2012). This decrease suggests the high efficiency of treatment at both WWTPs or that some 
strains may enter the viable but non-culturable state (Börjesson et al., 2009). Lower levels of 
MRSA at the downstream points of the river of WWTP1 (as compared to influent and before 
chlorination) may be due to near-by located factories that discharge chemicals and heavy 
metals which may hinder growth of the MRSA. Higher prevalence of MRSA was detected in 
upstream points (as compared to downstream) for sampling periods 1 and 2 at both WWTPs. 
This suggests that other sources may also be responsible for the spread of MRSA into the 
receiving waters. This could include gastrointestinal bacteria present in animal waste being 
discharged into the river (Xiong et al., 2015).  
In addition to enumeration of presumptive MRSA through plate count, quantitative PCR was 
also used to quantify mecA (which encodes for methicillin resistance in S. aureus) in treated 
effluent and receiving surface waters of both WWTPs (Kim et al., 2012; San Sit et al., 2017). 
A slight decrease in the concentration of mecA was observed from the influent to the treated 
effluent for all three sampling periods in WWTP1 and for the first two sampling periods at 
WWTP2. The third sampling period (at WWTP2) showed an increase of mecA. The low 
reduction of mecA from the influent to the treated effluent show that both WWTPs may play a 
role in spreading the mecA to receiving surface waters (Börjesson et al., 2009). The chlorination 
process at both WWTPs may cause cell disruption releasing DNA into the water. This is in 
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agreement with the findings of Quach-Cu et al. (2018) indicating a decrease in microbial 
population, despite the influx of antibiotic resistance genes present in treated effluent. Eighty 
MRSA strains were isolated from the treated effluent and receiving waters of both WWTPs in 
Durban and identified through PCR amplification of the mecA gene, which induces resistance 
to β-lactam antibiotics by encoding for a penicillin binding protein (Marais et al., 2009; Naquin 
et al., 2014). 
The antibiograms of the MRSA isolates showing high resistance towards oxacillin, ampicillin 
and penicillin is reported in chapter four. This finding was supported by another study where 
all MRSA isolates (n=30) tested exhibited resistance to these antibiotics (New et al., 2016). 
This may be justified as the presence of mecA confers resistance to this class of antibiotics. 
This study showed that 78/80 (97.50%) isolates exhibited resistance to cefoxitin whilst all 80 
presumptive MRSA isolates grew on Mannitol Salt Agar that was supplemented with cefoxitin. 
This is expected because cefoxitin is used to help detect methicillin resistance in S. aureus 
(Thompson et al., 2013). No resistance was observed against ciprofloxacin and low resistance 
was observed against imipenem which was expected as these are used to treat MRSA infections 
in individuals. As expected, low resistance was observed against rifampicin as it is used in 
combination with other antibiotics to treat MRSA infections (Tang et al., 2013). However, low 
resistance was observed against amoxicillin/clavulanic acid (52.50%) and vancomycin 
(33.75%). This is not surprising as Amoxicillin/clavulanic acid has been reported to display 
good activity against MRSA and vancomycin is used as a resort treatment in severe MRSA 
infections (Mhmoud et al., 2014; Ong et al., 2017). These findings suggest that the continual 
development of resistance towards a broader category of antibiotic classes may pose a threat 
to the future treatment of MRSA associated infections. This study showed that all isolates were 
multi-drug resistant. The presence of multi-drug resistant MRSA in poorly treated wastewater 
is worrisome as the effluents may also leach into seawater through the receiving rivers and may 
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be fatal to those who engage in beach activities who may inhale the water or have skin lesions 
(Akanbi et al., 2017). Treatment of these infections may be challenging in children, elders and 
immunocompromised patients (Akanbi et al., 2017).  
Chapter four also revealed the distribution of selected antibiotic resistance genes amongst 
isolates. This includes: aac(6’)/aph(2”) (56.25%), blaZ (70.0%), ermC (62.5%), msrA 
(22.50%) and tetK (70.00%) which encode for resistance against aminoglycosides, β-lactams, 
erythromycin, macrolides and streptogramin B and tetracyclines, respectively. By observing 
the antibiotic phenotypes, many of these antibiotic resistance genes seem to be silent as they 
did not induce resistance in the host strain as previously reported (Amoako et al., 2016). These 
silent antibiotic resistance genes may be potentially dangerous as they could be transferred 
from one host to the next via horizontal gene transfer or upon exposure to a high concentration 
of antibiotics and may be potentially expressed (Zhu et al., 2013). 
The virulence gene profiles were also discussed in chapter four. It was observed that none of 
the isolates harboured the lukS/F PV gene which encodes for a leukotoxin that results in 
necrotizing pneumonia which destroys lung tissue (Monecke et al., 2014). Higher levels of this 
gene were detected by Goldstein et al. (2012). The PVL toxin (encoded by lukS/F PV) is used 
as a molecular marker to detect the presence of community acquired MRSA (CA-MRSA) as 
studies have shown the presence of lukS/F PV in CA-MRSA but absent in hospital acquired -
MRSA (HA-MRSA) strains (Portillo et al., 2013; Velasco et al., 2015). This suggests that 
MRSA present in both WWTPs may have originated from blood, body fluids and secretions 
from skin and soft tissue infections discarded in the hospital waste which eventually ends up 
in the WWTPs (Thompson et al., 2013). Lower detection of hla in 1/80 (1.25%) and hld in 
46/80 (57.50%) was observed in this study contrary to the findings of Alfatemi et al. (2014). 
The presence of the virulence genes in these MRSA is dangerous as these genes encode for 
haemolysins which are responsible for blood infections and renal parenchyma infections 
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(Doughari et al., 2011). Since haemolysins are associated with blood, it can be suggested that 
MRSA isolates detected in these WWTPs originated from hospital wastewater or slaughter 
houses. The sea gene was detected in 46/80 (57.50%) isolates which were similar to findings 
by Xie et al. (2016) which detected sea in 59.7% (n=62) of HA-MRSA and CA-MRSA. This 
gene encodes for the staphylococcal enterotoxin A which is responsible for food-borne diseases 
(Kadariya et al., 2014). MRSA isolated from stool samples of patients with gastrointestinal 
illness have screened positive for the staphylococcal enterotoxin (Kadariya et al., 2014). A 
possible explanation for the detection of the sea gene may be due to the consumption of food 
contaminated with MRSA amongst individuals resulting in the excretion of MRSA in faecal 
wastes. Other reasons include wastewater generated from food and agricultural industries that 
is contaminated with MRSA could be collected at these WWTPs.  
Chapter four also revealed the PFGE profiles and dendrograms of 21 selected isolates in which 
13 pulsotypes were generated. This was similar to a study that reported 12 pulsotypes of 22 
MRSA isolates recovered from wastewater environment (Goldstein et al., 2012). It was 
observed that isolates that belonged to the same pulsotype (suggesting genetic relatedness), had 
similar antibiotic resistance patterns, which was supported by the findings of Moghadam et al. 
(2017).  The results revealed that genetically related isolates were found in the treated effluent 
and downstream points of the river. This suggests that the treated effluent may be responsible 
for spread of MRSA strains downstream of the receiving rivers. This result shows that 
improperly treated wastewater may release MRSA into the receiving rivers bearing negative 
consequences on its surrounding environment (Naidoo and Olaniran, 2013). However, the 
same pulsotype was also found in the treated effluent and upstream points of the river, 
suggesting other sources of MRSA discharge into the rivers, including domestic wastewater 
and animal waste (Sabri et al., 2018).  
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This study revealed the inefficiency of the WWTPs for complete removal of MRSA and mecA 
in the influent received. This suggests that these WWTPs may serve as hotspot for the 
dissemination of antibiotic resistant bacteria and antibiotic resistance genes (ARGs) into the 
environment. The study also revealed the presence of multi-drug resistant and genetically 
diverse MRSA in treated effluent and receiving rivers.  These bacteria have the ability to 
transfer ARGs via horizontal gene transfer and cause severe diseases in infected individuals. 
Constant monitoring of the treated wastewater quality is recommended to ensure that these 
WWTPs comply with the set standards. Better treatment options should also be explored to 
protect the aquatic ecosystem health and safety of the end-users of this water.  
5.2 Potential for future development 
Microbial source tracking should be considered to investigate the source of these MRSA 
pathogens in the receiving rivers of both WWTPs. It is important to assess the chemical and 
microbial materials, including the presence of human body fluids, that could potentially be 
present in influent, treat effluent and receiving rivers of both WWTPs. This will help improve 
the quality of water in both these rivers which will benefit human and environmental health 
(Rahmanian et al., 2015). 
It is also important to evaluate the risk of multi-drug resistant MRSA infections from 
individuals exposed to reclaimed water and the receiving rivers. This could be assessed by 
increasing the number of virulence and antibiotic resistance genes (ARGs) characterized in the 
isolated MRSA strains (Goldstein et al., 2012). Further studies can help understand the 
mechanisms of virulence and antibiotic resistance expression in these isolates and the ability 
to acquire and transfer virulence and ARGs. This will help understand the pathogenicity of 
each strain and the need to explore rapid and more effective treatment options. 
 128 
 
Other molecular subtyping methods used for classification and epidemiological studies, 
including multi-locus sequence typing and spa typing (Holtfreter et al., 2016) can be explored 
in characterizing the MRSA strains isolated in this study. Whole genome sequencing analysis 
of multi-drug resistant and virulent MRSA strains detected in this study will provide an in-
depth understanding of the metabolic and functional capabilities of these isolates.  This will 
also assist in further differentiation of MRSA strains obtained from treated effluent and 
receiving rivers at a nucleotide level. It will also help to determine the hierarchical relationship 
of each strains, their transfer of genetic information and track the strains that could be 
responsible for outbreaks of infections (SenGupta et al., 2014).  
The most pathogenic and antibiotic resistant strain of the study showed to have the presence 
of: mecA, aac(6’)/aph(2’’), blaZ, ermC, msrA and tetK. It exhibited phenotypic resistance to 
the following antibiotics: Oxacillin, Penicillin, Ampicillin, Gentamicin, Erythromycin, 
Cefoxitin, Lincomycin and Azithromycin. A study by Yoshioka et al (2014) monitored the 
various stages of an MRSA infection using a mouse model. It is suggested to further investigate 
the pathogenicity of this strain using animal models. This technique can be applied to monitor 
the level of pathogenicity and understand the mechanisms of disease in a mouse model caused 
by this MRSA strain. This will evaluate current antibiotic therapy and encourage development 
of treatment options with better efficacy in infected individuals.  
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APPENDICES 
Table 1: Presumptive S. aureus from WWTP1 (Sampling Period 1)  
Dilution INF  BC  AC  DS  US  
 
Colony 
count 
CFU/ml Colony 
count 
CFU/ml Colony 
count 
CFU/ml Colony 
count 
CFU/ml Colony 
count 
CFU/ml 
1 TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
1 TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
1 TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
10-1 TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
10-1 TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
10-1 TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
10-2 TMTC 
 
328 328 TMTC 
 
TMTC 
 
259 259 
10-2 TMTC 
 
337 337 TMTC 
 
TMTC 
 
230 230 
10-2 TMTC 
 
304 304 TMTC 
 
TMTC 
 
216 216 
10-3 364 3640 47 470 145 1450 378 3780 29 290 
10-3 383 3830 42 420 117 1170 334 3340 28 280 
10-3 408 4080 50 500 122 1220 360 3600 16 160 
 
Key: INF- influent; BC- before chlorination; AC- after chlorination; DS- downstream; US- upstream; TMTC- too many to count; CFU/ml- 
colony forming units/ millilitre  
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Table 2: Presumptive MRSA from WWTP1 (Sampling Period 1)  
Dilution INF  BC  AC  DS  US  
 
Colony 
count 
CFU/ml Colony 
count 
CFU/ml Colony 
count 
CFU/ml Colony 
count 
CFU/ml Colony 
count 
CFU/ml 
1 TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
1 TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
1 TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
10-1 TMTC 
 
443 44.3 305 30.5 TMTC 
 
111 11.1 
10-1 TMTC 
 
514 51.4 235 23.5 TMTC 
 
83 8.3 
10-1 TMTC 
 
520 52 298 29.8 TMTC 
 
81 8.1 
10-2 TMTC 
 
58 58 42 42 198 198 17 17 
10-2 TMTC 
 
53 53 37 37 214 214 13 13 
10-2 TMTC 
 
43 43 22 22 260 260 9 9 
10-3 325 3250 9 90 2 20 27 270 1 10 
10-3 360 3600 10 100 8 80 33 330 1 10 
10-3 304 3040 4 40 4 40 28 280 2 20 
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Table 3: Presumptive S. aureus from WWTP1 (Sampling Period 2)  
Dilution INF  BC  AC  DS  US  
 
Colony 
count 
CFU/ml Colony 
count 
CFU/ml Colony 
count 
CFU/ml Colony 
count 
CFU/ml Colony 
count 
CFU/ml 
1 
  
TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
1 
  
TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
1 
  
TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
10-1 TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
10-1 TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
10-1 TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
10-2 TMTC 
 
289 289 152 152 65 65 288 288 
10-2 TMTC 
 
331 331 148 148 85 85 364 364 
10-2 TMTC 
 
326 326 132 132 78 78 320 320 
10-3 TMTC 
 
40 400 17 170 7 70 39 390 
10-3 TMTC 
 
32 320 11 110 9 90 48 480 
10-3 TMTC 
 
46 460 14 140 8 80 50 500 
10-4 78 7800 
        
10-4 61 6100 
        
10-4 68 6800 
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Table 4: Presumptive MRSA from WWTP1 (Sampling Period 2) 
Dilution INF  BC  AC  DS  US  
 
Colony 
count 
CFU/ml Colony 
count 
CFU/ml Colony 
count 
CFU/ml Colony 
count 
CFU/ml Colony 
count 
CFU/ml 
1 TMTC 
 
TMTC 
 
TMTC 
 
88 0,88 TMTC 
 
1 TMTC 
 
TMTC 
 
TMTC 
 
68 0,68 TMTC 
 
1 TMTC 
 
TMTC 
 
TMTC 
 
75 0,75 TMTC 
 
10-1 TMTC 
 
TMTC 
 
111 11,1 17 1,7 TMTC 
 
10-1 TMTC 
 
TMTC 
 
97 9,7 13 1,3 TMTC 
 
10-1 TMTC 
 
TMTC 
 
90 9 15 1,5 TMTC 
 
10-2 TMTC 
 
72 72 7 7 2 2 72 72 
10-2 TMTC 
 
78 78 8 8 2 2 55 55 
10-2 TMTC 
 
79 79 10 10 3 3 43 43 
10-3 91 910 9 90 0 0 0 0 6 60 
10-3 89 890 8 80 1 10 0 0 6 60 
10-3 74 740 7 70 0 0 1 10 4 40 
10-4 6 600 
        
10-4 9 900 
        
10-4 7 700 
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Table 5: Presumptive S. aureus from WWTP1 (Sampling Period 3) 
Dilution INF  BC  AC  DS  US  
 
Colony 
count 
CFU/ml Colony 
count 
CFU/ml Colony 
count 
CFU/ml Colony 
count 
CFU/ml Colony 
count 
CFU/ml 
1 
  
TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
1 
  
TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
1 
  
TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
10-1 TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
10-1 TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
10-1 TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
10-2 TMTC 
 
263 263 112 112 43 43 287 287 
10-2 TMTC 
 
250 250 105 105 37 37 252 252 
10-2 TMTC 
 
229 229 126 126 45 45 267 267 
10-3 140 1400 29 290 14 140 6 60 35 350 
10-3 152 1520 36 360 8 80 3 30 32 320 
10-3 120 1200 30 300 10 100 5 50 38 380 
10-4 27 2700 
        
10-4 17 1700 
        
10-4 16 1600 
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Table 6: Presumptive MRSA from WWTP1 (Sampling Period 3) 
Dilution INF  BC  AC  DS  US  
 
Colony 
count 
CFU/ml Colony 
count 
CFU/ml Colony 
count 
CFU/ml Colony 
count 
CFU/ml Colony 
count 
CFU/ml 
1 
  
TMTC 
 
TMTC 
 
59 0,59 TMTC 
 
1 
  
TMTC 
 
TMTC 
 
72 0,72 TMTC 
 
1 
  
TMTC 
 
TMTC 
 
62 0,62 TMTC 
 
10-1 TMTC 
 
TMTC 
 
45 4,5 10 1 137 13,7 
10-1 TMTC 
 
TMTC 
 
52 5,2 11 1,1 129 12,9 
10-1 TMTC 
 
TMTC 
 
48 4,8 6 0,6 142 14,2 
10-2 TMTC 
 
119 119 3 3 1 1 14 14 
10-2 TMTC 
 
117 117 4 4 0 0 13 13 
10-2 TMTC 
 
90 90 0 0 0 0 12 12 
10-3 34 340 8 80 0 0 0 0 3 30 
10-3 32 320 14 140 0 0 0 0 2 20 
10-3 27 270 12 120 0 0 0 0 2 20 
10-4 3 300 
        
10-4 2 200 
        
10-4 3 300 
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Table 7: Presumptive S. aureus from WWTP2 (Sampling Period 1) 
Dilution INF  BC  AC  DS  US  
 
Colony 
count 
CFU/ml Colony 
count 
CFU/ml Colony 
count 
CFU/ml Colony 
count 
CFU/ml Colony 
count 
CFU/ml 
1 
  
TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
1 
  
TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
1 
  
TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
10-1 TMTC 
 
TMTC 
 
118 11,8 201 20,1 TMTC 
 
10-1 TMTC 
 
TMTC 
 
121 12,1 221 22,1 TMTC 
 
10-1 TMTC 
 
TMTC 
 
95 9,5 266 26,6 TMTC 
 
10-2 TMTC 
 
250 250 6 6 22 22 26 26 
10-2 TMTC 
 
296 296 10 10 33 33 39 39 
10-2 TMTC 
 
224 224 17 17 23 23 31 31 
10-3 36 360 24 240 1 10 7 70 4 40 
10-3 47 470 18 180 2 20 3 30 7 70 
10-3 51 510 23 230 2 20 3 30 2 20 
10-4 0 0 
        
10-4 4 400 
        
10-4 6 600 
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Table 8: Presumptive MRSA from WWTP2 (Sampling Period 1) 
Dilution INF  BC  AC  DS  US  
 
Colony 
count 
CFU/ml Colony 
count 
CFU/ml Colony 
count 
CFU/ml Colony 
count 
CFU/ml Colony 
count 
CFU/ml 
1 
  
TMTC 
 
28 0,28 49 0,49 TMTC 
 
1 
  
TMTC 
 
27 0,27 52 0,52 TMTC 
 
1 
  
TMTC 
 
19 0,19 50 0,5 TMTC 
 
10-1 TMTC 
 
TMTC 
 
9 0,9 13 1,3 51 5,1 
10-1 TMTC 
 
TMTC 
 
4 0,4 7 0,7 41 4,1 
10-1 TMTC 
 
TMTC 
 
6 0,6 9 0,9 48 4,8 
10-2 337 337 50 50 1 1 1 1 3 3 
10-2 289 289 30 30 1 1 1 1 2 2 
10-2 305 305 57 57 2 2 0 0 1 1 
10-3 27 270 7 70 0 0 0 0 0 0 
10-3 31 310 6 60 0 0 0 0 0 0 
10-3 32 320 7 70 0 0 0 0 0 0 
10-4 0 0 
        
10-4 2 200 
        
10-4 5 500 
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Table 9: Presumptive S. aureus from WWTP2 (Sampling Period 2) 
Dilution INF  BC  AC  DS  US  
 
Colony 
count 
CFU/ml Colony 
count 
CFU/ml Colony 
count 
CFU/ml Colony 
count 
CFU/ml Colony 
count 
CFU/ml 
1 
  
TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
1 
  
TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
1 
  
TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
10-1 TMTC 
 
TMTC 
 
198 19,8 215 21,5 TMTC 
 
10-1 TMTC 
 
TMTC 
 
220 22 198 19,8 TMTC 
 
10-1 TMTC 
 
TMTC 
 
241 24,1 221 22,1 TMTC 
 
10-2 TMTC 
 
TMTC 
 
33 33 26 26 188 188 
10-2 TMTC 
 
TMTC 
 
38 38 34 34 214 214 
10-2 TMTC 
 
TMTC 
 
20 20 27 27 210 210 
10-3 TMTC 
 
136 1360 1 10 3 30 23 230 
10-3 TMTC 
 
154 1540 3 30 2 20 25 250 
10-3 TMTC 
 
158 1580 6 60 3 30 35 350 
10-4 41 4100 
        
10-4 34 3400 
        
10-4 48 4800 
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Table 10: Presumptive MRSA from WWTP2 (Sampling Period 2) 
Dilution INF  BC  AC  DS  US  
 
Colony 
count 
CFU/ml Colony 
count 
CFU/ml Colony 
count 
CFU/ml Colony 
count 
CFU/ml Colony 
count 
CFU/ml 
1 
  
TMTC 
 
74 0,74 TMTC 
 
TMTC 
 
1 
  
TMTC 
 
63 0,63 TMTC 
 
TMTC 
 
1 
  
TMTC 
 
68 0,68 TMTC 
 
TMTC 
 
10-1 TMTC 
 
TMTC 
 
17 1,7 46 4,6 TMTC 
 
10-1 TMTC 
 
TMTC 
 
12 1,2 44 4,4 TMTC 
 
10-1 TMTC 
 
TMTC 
 
15 1,5 39 3,9 TMTC 
 
10-2 TMTC 
 
TMTC 
 
4 4 4 4 62 62 
10-2 TMTC 
 
TMTC 
 
3 3 9 9 65 65 
10-2 TMTC 
 
TMTC 
 
3 3 6 6 68 68 
10-3 TMTC 
 
131 1310 0 0 0 0 9 90 
10-3 TMTC 
 
146 1460 0 0 0 0 7 70 
10-3 TMTC 
 
143 1430 0 0 1 10 6 60 
10-4 34 3400 
        
10-4 29 2900 
        
10-4 43 4300 
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Table 11: Presumptive S. aureus from WWTP2 (Sampling Period 3) 
 
Dilution INF  BC  AC  DS  US  
 
Colony 
count 
CFU/ml Colony 
count 
CFU/ml Colony 
count 
CFU/ml Colony 
count 
CFU/ml Colony 
count 
CFU/ml 
1 
  
TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
1 
  
TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
1 
  
TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
10-1 TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
10-1 TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
10-1 TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
10-2 TMTC 
 
264 264 272 272 85 85 85 85 
10-2 TMTC 
 
285 285 280 280 73 73 81 81 
10-2 TMTC 
 
253 253 301 301 90 90 92 92 
10-3 288 2880 33 330 32 320 6 60 4 40 
10-3 295 2950 26 260 21 210 4 40 9 90 
10-3 308 3080 28 280 27 270 7 70 7 70 
10-4 27 2700 
        
10-4 29 2900 
        
10-4 35 3500 
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Table 12: Presumptive MRSA from WWTP2 (Sampling Period 3) 
Dilution INF  BC  AC  DS  US  
 
Colony 
count 
CFU/ml Colony 
count 
CFU/ml Colony 
count 
CFU/ml Colony 
count 
CFU/ml Colony 
count 
CFU/ml 
1 
  
TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
1 
  
TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
1 
  
TMTC 
 
TMTC 
 
TMTC 
 
TMTC 
 
10-1 TMTC 
 
TMTC 
 
TMTC 
 
130 13 111 11,1 
10-1 TMTC 
 
TMTC 
 
TMTC 
 
115 11,5 103 10,3 
10-1 TMTC 
 
TMTC 
 
TMTC 
 
126 12,6 115 11,5 
10-2 TMTC 
 
140 140 106 106 14 14 19 19 
10-2 TMTC 
 
151 151 110 110 17 17 17 17 
10-2 TMTC 
 
125 125 101 101 13 13 14 14 
10-3 116 1160 21 210 18 180 3 30 0 0 
10-3 129 1290 19 190 15 150 0 0 0 0 
10-3 104 1040 23 230 16 160 1 10 2 20 
10-4 15 1500 
        
10-4 21 2100 
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Table 13: Physico-chemical parameters for WWTP1 (sampling period 1) 
 
SP. INF Ave. Std 
Dev 
BC Ave Std 
Dev 
AC Ave Std 
Dev. 
DS Ave Std 
Dev 
US Ave. Std 
Dev 
T
em
p
 (
℃
) 
 
1 27 27.33 0.58 25 25.67 0.58 29 28.33 0.58 27 27.33 0.58 26 26 0 
2 27 26 28 28 26 
3 28 26 28 27 26 
P
H
 
1 7.22 7.19 0.03 7.48 7.51 0.03 7.58 7.62 0.03 7.68 7.68 0.01 7.73 7.70 0.04 
2 7.17 7.50 7.63 7.68 7.70 
3 7.19 7.54 7.64 7.69 7.66 
T
u
rb
. 
1 494 487.67 12.74 19.3 20.63 1.74 13.6 12.4 1.06 17.5 17.6 0.35 6.32 7.73 1.56 
2 473 22.6 11.6 17.2 7.46 
3 496 20.0 12 18.1 9.41 
E
C
 µ
s/
cm
 
 
1 718 724.00 5.29 511 514.00 7.00 592 563.00 36.51 573 618 39.13 339 340.33 1.15 
2 726 509 575 637 341 
3 728 522 522 644 341 
T
D
S
  
(m
g
/L
) 
1 413 414.67 1.53 361 364 2.65 420 424.33 3.79 432 432.67 1.15 236 257.67 18.77 
2 415 365 426 432 268 
3 416 366 427 434 269 
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Key: INF- influent; BC- before chlorination; AC- after chlorination; DS- downstream; US- upstream; Ave- average; Std Dev- standard deviation 
 
 
 
 
SP. INF Ave. Std 
Dev 
BC Ave Std 
Dev 
AC Ave Std 
Dev. 
DS Ave Std 
Dev 
US Ave. Std 
Dev 
C
O
D
 
(m
g
/L
) 
1 442.5 504 165.46 95 77.33 15.95 225 222 3 308 306.33 2.0816
65999 
205 193.33 25.58 
2 621 73 219 307 164 
3 387 64 222 304 211 
R
es
is
t.
 
 
1 1392 1387.3
3 
8.96 1956 1869.6
7 
156.51 1166 1154 10.44 1844 1818 22.869
19325 
1136 1134.3
3 
2.89 
2 1377 1964 1149 1809 1136 
3 1393 1689 1147 1801 1131 
S
a
l(
%
) 
 
1 0.41 0.42 0.01 0.36 0.37 0.01 0.42 0.43 0.01 0.26 0.67 0.0057
73503 
0.43 0.43 0.01 
2 0.42 0.37 0.43 0.27 0.43 
3 0.42 0.37 0.43 0.27 0.44 
B
O
D
o
  (
m
g
/L
) 1 126 143 76.92 72 52.50 27.58 184 184.5 0.71 23.55 23.72 0.17 24.66 25.19 0.87 
2 227 38.5 185 23.73 24.72 
3 76 33 158.5 23.88 26.19 
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Table 14: Physico-chemical parameters for WWTP1 (sampling period 2) 
 
SP. INF Ave. Std 
Dev 
BC Ave Std 
Dev 
AC Ave Std 
Dev. 
DS Ave Std 
Dev 
US Ave. Std 
Dev 
T
em
p
 (
℃
) 
 
1 21 20.33  0.58 19 19.33 0.58  18 18  0  18 18  0  16 16  0  
2 20 19 18 18 16 
3 20 20 18 18 16 
P
H
 
1 7.39 7.41  0.04  7.7 7.69  0.01  7.46 7.42 0.03  7.84 7.81  0.03  7.6 7.52  0.07  
2 7.39 7.69 7.41 7.78 7.47 
3 7.46 7.68 7.4 7.8 7.49 
T
u
rb
. 
1 483 486.33 3.51 17.7 17.57 0.15  13.9 13.4  0.46 22 22.3  0.3  30.4 29.97 0.67  
2 486 17.6 13 22.3 30.3 
3 490 17.4 13.3 22.6 29.2 
E
C
 µ
s/
cm
 
 
1 1004 1002.3
3  
18.56  748 750  1.73  858 860.67 2.31 854 860  5.29 838 837.67  0.58 
2 983 751 862 862 838 
3 1020 751 862 864 837 
T
D
S
  
(m
g
/L
) 1 484 483.67  0.58  366 366.67  0.58  421 421.67  0.58  418 421.33  3.06  410 410  0  
2 484 367 422 422 410 
3 483 367 422 424 410 
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SP. INF Ave. Std 
Dev 
BC Ave Std 
Dev 
AC Ave Std 
Dev. 
DS Ave Std 
Dev 
US Ave. Std 
Dev 
C
O
D
 (
m
g
/L
) 1 706.5 731.5  31.22  166 151  18.73  77 73  7.81  35 59  31  216 223.67  9.29  
2 766.5 130 78 48 234 
3 721.5 157 64 94 221 
R
es
is
t.
 
 
1 984 1006.3
3  
19.35  1336 1333  2.65  1165 1112.6
7  
87.20  1172 1163.6
7  
7.37  1194 1194.3
3  
0.58  
2 1017 1331 1161 1161 1194 
3 1018 1332 1012 1158 1195 
S
a
l 
(%
) 
 
1 0.48 0.48  0  0.36 0.37  0.01  0.42 0.42  0  0.42 0.42  0  0.41 0.41  0  
2 0.48 0.37 0.42 0.42 0.41 
3 0.48 0.37 0.42 0.42 0.41 
B
O
D
o
  (
m
g
/L
) 1 256 230.67  28.38  126.25 128.83 6.52  99.25 91.67  6.58  9.12 7.54  1.53  131.25 129.83  5.03  
2 236 124 88.25 7.44 134 
3 200 136.25 87.5 6.06 124.25 
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Table 15: Physico-chemical parameters for WWTP1 (sampling period 3) 
 
SP. INF Ave. Std 
Dev 
BC Ave Std 
Dev 
AC Ave Std 
Dev. 
DS Ave Std 
Dev 
US Ave. Std 
Dev 
T
em
p
 (
℃
) 
 
1 22 21.33 0.58  22 21.33 0.58  22 21  1  19 19  0  18 17.33  0.58  
2 21 21 21 19 17 
3 21 21 20 19 17 
P
H
 
1 7.19 7.18 0.01  7.57 7.57  0.01  7.63 7.62  0.01  7.6 7.60  0.01  7.51 7.54  0.03  
2 7.17 7.58 7.61 7.59 7.55 
3 7.17 7.56 7.62 7.6 7.57 
T
u
rb
. 
1 217 212.67  4.04  390 367.67  20.11  29.8 35.87  5.26  24.3 30  5.09 37.4 40.87  4.32  
2 209 362 38.7 31.6 39.5 
3 212 351 39.1 34.1 45.7 
E
C
 µ
s/
cm
 
 
1 869 871.67  2.52  724 721.67  2.08 797 808.67  10.41  819 818.33  3.06  813 812.67  0.58  
2 872 721 812 821 812 
3 874 720 817 815 813 
T
D
S
  
(m
g
/L
) 1 426 427.67  1.53  353 352.33  0.58  390 396  5.29  401 400.67  1.53  398 398  0  
2 429 352 398 402 398 
3 428 352 400 399 398 
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SP. INF Ave. Std 
Dev 
BC Ave Std 
Dev 
AC Ave Std 
Dev. 
DS Ave Std 
Dev 
US Ave. Std 
Dev 
C
O
D
 (
m
g
/L
) 1 979.5 1002.5  19.918
58429  
303 302  1  307 306  2.6457
51311  
308 307.33
33333  
0.5773
50269  
291 294  2.6457
51311  
2 1014 301 303 307 295 
3 1014 302 308 307 296 
R
es
is
t.
 
 
1 1138 1142.6
7  
4.16 1382 1385.6
7  
3.21  1297 1261  33.41  1222 1222.6
7  
5.03  1230 1230.6
7  
0.58  
2 1144 1387 1255 1218 1231 
3 1146 1388 1231 1228 1231 
S
a
l 
(%
) 
 
1 0.43 0.43  0  0.35 0.35  0.00  0.38 0.39  0.01  0.41 0.40  0.01  0.44 0.41  0.02  
2 0.43 0.355 0.39 0.4 0.4 
3 0.43 0.35 0.4 0.4 0.4 
B
O
D
o
  (
m
g
/L
) 1 10 10  0  62.25 87.92  25.03  175.75 170.42  5.38  23.43 23.01  0.63 17.97 17.45  0.45 
2 10 89.25 165 22.29 17.19 
3 10 112.25 170.5 23.31 17.19 
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Table 16: Physico-chemical parameters for WWTP2 (sampling period 1) 
 
SP. INF Ave. Std 
Dev 
BC Ave Std 
Dev 
AC Ave Std 
Dev. 
DS Ave Std 
Dev 
US Ave. Std 
Dev 
T
em
p
 (
℃
) 
 
1 26 25.33 0.58 
 
25 25 
 
0 
 
24 24.67 
 
0.58 
 
25 25 
 
0 
 
24 23.33 
 
0.58 
2 25 25 25 25 23 
3 25 25 25 25 23 
P
H
 
1 7.11 7.11 
 
0.01 
 
7.28 7.303 
 
0.02 
 
7.71 7.72 
 
0.01 
 
7.73 7.81 
 
0.07 
 
7.58 7.59 
 
0.02 
 
2 7.11 7.31 7.72 7.86 7.58 
3 7.12 7.32 7.73 7.85 7.61 
T
u
rb
. 
1 440 454.33 
 
12.50 
 
105 102 
 
3.61 
 
93 95 
 
2.65 
 
42 41 
 
1 
 
12 14 
 
2 
 
2 460 103 98 41 16 
3 463 98 94 40 14 
E
C
 µ
s/
cm
 
 
1 886 879 
 
6.24 
 
754 753.33 
 
0.58 
 
707 745.33 
 
33.65 
 
603 608 
 
8.66 
 
337 345 
 
7 
 
2 877 753 759 618 348 
3 874 753 770 603 350 
T
D
S
  
(m
g
/L
) 1 435 436.33 
 
2.31 
 
368 368 
 
0 
 
345 364 
 
16.64 
 
293 300 
 
6.08 
 
161.6 165.7 
 
3.58 
 
2 435 368 371 304 167.3 
3 439 368 376 303 168.2 
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SP. INF Ave. Std 
Dev 
BC Ave Std 
Dev 
AC Ave Std 
Dev. 
DS Ave Std 
Dev 
US Ave. Std 
Dev 
C
O
D
 (
m
g
/L
) 1 843 825 
 
31.18 
 
304 289.33 
 
14.05 
 
244 260 
 
21.17 
 
176 222.67 
 
41.88 
 
237 212 
 
21.79 
 
2 789 288 252 257 197 
3 843 276 284 235 202 
R
es
is
t.
 
 
1 1129 1125 
 
6.08 
 
1328 1328 
 
0 
 
1415 1344 
 
62.22 
 
1658 1620.6
7 
 
32.35 
 
2970 2900 
 
60.83 
 
2 1128 1328 1318 1601 2870 
3 1118 1328 1299 1603 2860 
S
a
l 
(%
) 
 
1 0.44 0.44 
 
0 
 
0.37 0.37 
 
0 
 
0.35 0.37 
 
0.02 
 
0.29 0.30 
 
0.01 
 
0.16 0.177 
 
0.01 
 
2 0.44 0.37 0.37 0.3 0.17 
3 0.44 0.37 0.38 0.3 0.17 
B
O
D
o
  (
m
g
/L
) 1 200 173.33 
 
55.99 
 
176.25 178.25 
 
2 
 
156.25 162.83 5.77 
 
22.98 23.14 
 
0.23 
 
23.61 23.55 
 
0.16 
 
2 109 180.25 165.25 23.4 23.67 
3 211 178.25 167 23.04 23.37 
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Table 17: Physico-chemical parameters for WWTP2 (sampling period 2) 
 
SP. INF Ave. Std 
Dev 
BC Ave Std 
Dev 
AC Ave Std 
Dev. 
DS Ave Std 
Dev 
US Ave. Std 
Dev 
T
em
p
 (
℃
) 
 
1 18 18.67 
 
0.58 
 
18 18.33 
 
0.58 
 
19 19 
 
0 
 
19 18.67 
 
0.58 
 
19 18.33 0.58 
 
2 19 18 19 19 18 
3 19 19 19 18 18 
P
H
 
1 7.44 7.38 
 
0.07 
 
7.27 7.35 
 
0.07 
 
7.02 7.01 
 
0.02 
 
7.43 7.52 
 
0.08 
 
7.37 7.43 
 
0.06 
 
2 7.4 7.37 7.01 7.53 7.43 
3 7.3 7.4 6.99 7.59 7.48 
T
u
rb
. 
1 351 314.33 
 
32.15 
 
286 280.67 
 
27.39 
 
71 100.33 
 
32.33 
 
38 38.33 
 
5.51 
 
18 18.67 
 
2.08 
 
2 291 251 135 44 17 
3 301 305 95 33 21 
E
C
 µ
s/
cm
 
 
1 809 814.67 
 
5.51 
 
796 799 
 
3 
 
648 650.33 
 
2.52 
 
505 509 
 
3.61 
 
342 343 
 
1 
 
2 820 799 650 510 343 
3 815 802 653 512 344 
T
D
S
  
(m
g
/L
) 1 396 399 
 
3 
 
389 390.67 
 
1.53 
 
315 316.33 
 
1.53 
 
245 246.67 
 
1.53 
 
164.3 164.7 
 
0.36 
 
2 402 391 316 247 164.8 
3 399 392 318 248 165 
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SP. INF Ave. Std 
Dev 
BC Ave Std 
Dev 
AC Ave Std 
Dev. 
DS Ave Std 
Dev 
US Ave. Std 
Dev 
C
O
D
 (
m
g
/L
) 1 682.5 644.5 
 
53.36 
 
272 274.33 
 
4.04 
 
288 287.33 
 
2.08 
 
271 276.33 
 
6.81 
 
239 239 
 
1 
 
2 667.5 279 285 284 238 
3 583.5 272 289 274 240 
R
es
is
t.
 
 
1 1236 1227.6
7 
 
8.50 
 
1257 1252 
 
5 
 
1544 1538.6
7 
 
5.51 
 
1978 1964 
 
12.77 
 
2.94 2.92 
 
0.02 
 
2 1219 1252 1539 1961 2.91 
3 1228 1247 1533 1953 2.91 
S
a
l 
(%
) 
 
1 0.4 0.4 
 
0 
 
0.39 0.39 
 
0 
 
0.32 0.32 
 
0 
 
0.24 0.25 
 
0.01 
 
0.16 0.16 
 
0 
 
2 0.4 0.39 0.32 0.25 0.16 
3 0.4 0.39 0.32 0.25 0.16 
B
O
D
o
  (
m
g
/L
) 1 274 268.33 
 
7.37 
 
169.25 170.58 1.26 
 
132 126 
 
5.34 
 
24.03 23.42 
 
1.32 
 
21.78 21.1 
 
0.60 
 
2 271 171.75 121.75 21.9 20.64 
3 260 170.75 124.25 24.33 20.88 
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Table 18: Physico-chemical parameters for WWTP2 (sampling period 3) 
 SP. INF Ave. Std 
Dev 
BC Ave Std 
Dev 
AC Ave Std 
Dev. 
DS Ave Std 
Dev 
US Ave. Std 
Dev 
T
em
p
 (
℃
) 
 
1 22 22 
 
0 
 
22 22 
 
0 
 
22 19 
 
0 
 
21 21 
 
0 
 
21 21 
 
0 
 
2 22 22 22 21 21 
3 22 22 22 21 21 
P
H
 
1 7.38 7.40 
 
0.02 
 
7.27 7.25 
 
0.02 
 
7.33 7.32 
 
0.01 
 
7.88 7.88 
 
0.03 
 
7.65 7.66 
 
0.01 
 
2 7.4 7.23 7.31 7.85 7.66 
3 7.41 7.25 7.32 7.9 7.67 
T
u
rb
. 
1 338 339 
 
1 
 
79 76.67 
 
2.08 
 
116 117.33 
 
1.53 
 
45 44.33 
 
0.58 
 
23 26.67 
 
6.35 
 
2 339 75 117 44 34 
3 340 76 119 44 23 
E
C
 µ
s/
cm
 
 
1 759 750 
 
12.29 
 
525 532.33 
 
6.66 
 
521 528.67 
 
7.09 
 
372 379 
 
6.56 
 
316 317.67 
 
1.53 
 
2 736 538 530 380 318 
3 755 534 535 385 319 
T
D
S
  
(m
g
/L
) 1 371 366.67 
 
5.86 
 
255 258.33 
 
3.06 
 
252 256 
 
3.61 
 
178.8 182.37 
 
3.37 
 
151.3 152.2 
 
0.82 
2 360 261 257 182.8 152.4 
3 369 259 259 185.5 152.9 
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SP. INF Ave. Std 
Dev 
BC Ave Std 
Dev 
AC Ave Std 
Dev. 
DS Ave Std 
Dev 
US Ave. Std 
Dev 
C
O
D
 (
m
g
/L
) 1 745.5 764 
 
27.01 
 
240 256 
 
14 
 
296 296 
 
3 
 
296 263.33 
 
29.14 
 
238 269.67 
 
27.97 
 
2 751.5 262 299 240 291 
3 795 266 293 254 280 
R
es
is
t.
 
 
1 1317 1333.3
3 
 
21.73 
 
1903 1878.3
3 
 
22.81 
 
1920 1892 
 
25.24 
 
2690 2640 
 
45.83 
 
3170 3150 
 
17.32 
 
2 1358 1858 1885 2630 3140 
3 1325 1874 1871 2600 3140 
S
a
l 
(%
) 
 
1 0.37 0.37 
 
0.01 
 
0.25 0.26 
 
0.01 
 
0.25 0.26 
 
0.01 
 
0.18 0.18 
 
0 
 
0.15 0.15 
 
0 
 
2 0.36 0.26 0.26 0.18 0.15 
3 0.37 0.26 0.26 0.18 0.15 
B
O
D
o
  (
m
g
/L
) 1 147 139.67 
 
11.85 
 
60 58.5 
 
1.32 
 
201 199.33 
 
2.47 
 
24.87 24.93 
 
0.13 
 
24.9 24.9 
 
0.12 
 
2 126 58 196.5 24.84 24.78 
3 146 57.5 200.5 25.08 25.02 
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Table 19: Antibiotic resistant profiles 
 Antibiotic resistant phenotypes 
Is
o
la
te
 
C
IP
 
V
A
 
A
M
C
 
C
 
O
X
 
T
E
 
A
M
P
 
A
K
 
C
N
 
F
O
X
 
D
A
 
E
 
P
 
S
X
T
 
R
D
 
IP
M
 
K
Z
 
N
O
R
 
M
Y
 
A
Z
M
 
1 S S S S R S R S S R I S R S S S R R R R 
2 S S S S R S R S S R I S R S S S I R R R 
3 S S S S S S S S S S S S S S S S R I R R 
4 S S R S R S R S S R I S R I S S I S R S 
5 S S S S R S R S S R I S R S S S S S R S 
6 S S S S R S R S S R I S R S S S I S R S 
7 S S S I R S R S S R I S R S S S R S R S 
8 S S R S R S R S S R I S R S S S I S R S 
9 S R S S R S R S S R S S R S S S R S R S 
10 S S R S R S R S S R I I R R S S R R R R 
11 S S S S R S R S S S I R R R S S R S R S 
12 S S S S R S R S S R I S R S S S R R R R 
13 S S S S R S R S S R I S R S S S R R R R 
14 S S S S R S R S S R I S R S S S R S R I 
15 S S S S R S R S S R I R R I S S R S R S 
16 S S S S R S R S S R I S R S S S R R R R 
17 S S R S R S R S S R R I R R S S I S R S 
18 S S S S R S R S S R I S R R S S R S R S 
19 S S S S R S R S S R S I R S S I I S R S 
20 S S R S R S R S S R I S R R S S R S R S 
21 S S R S R S R S S R I I R S S S R S R S 
22 S S R S R S R S S R I S R S S S R S R S 
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Table 19: Continued… 
 Antibiotic resistant profile 
Is
o
la
te
 
C
IP
 
V
A
 
A
M
C
 
C
 
O
X
 
T
E
 
A
M
P
 
A
K
 
C
N
 
F
O
X
 
D
A
 
E
 
P
 
S
X
T
 
R
D
 
IP
M
 
K
Z
 
N
O
R
 
M
Y
 
A
Z
M
 
23 S S R S R S R S S R I S R I S S I S R S 
24 S S S R R S R S I R I S R S S I R S R R 
25 S S S I R R R S S R I S R S S I R S R R 
26 S S S S R S S S S R I I S I S S R S R R 
27 S S S S R S R S S R I S R I S S R S R R 
28 S S R S R S R S S R I S R S S S I S R S 
29 S S R S R S R S S R I S R S S S S S R R 
30 S S S S R S R S S R I S R I S S S S R I 
31 S S S S R S R S S R I I R S S S R S R R 
32 S S S R R S R S S R S S R I S S S I R R 
33 S S R S R S R S S R I S R R S S S S R R 
34 S S R S R S R S S R I I R I S S R S R R 
35 S S R S R S R S S R I S R S S S I I R R 
36 S S R S R S R S S R I S R S S S R S R R 
37 S S R S R R R S S R R R R S S S R S R R 
38 S S R R R S R S S R I S R S S S R S R R 
39 S S S S R S R S S R R S R R S S R S R R 
40 S S R S R S R S S R I S R S S S S S R S 
41 S S S S R S R S S R I S R I S S S I R R 
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Table 19: Continued… 
 Antibiotic resistant profile 
Is
o
la
te
 
C
IP
 
V
A
 
A
M
C
 
C
 
O
X
 
T
E
 
A
M
P
 
A
K
 
C
N
 
F
O
X
 
D
A
 
E
 
P
 
S
X
T
 
R
D
 
IP
M
 
K
Z
 
N
O
R
 
M
Y
 
A
Z
M
 
42 S S R S R S R S S R I S R S S S R I R R 
43 S S R S R S R S S R I S R I S S S I R R 
44 S S R S R S R S S R I S R S S S S S R S 
45 S S S S R S R S R R S R R S S S S I R R 
46 S S R S R S R R R R S R R S S S R S R R 
47 S R R S R S R S S R S S R S S S R S R R 
48 S R S S R S R S S R I I R S S S R S R I 
49 S S S S R S R S S R S R R S S S R S R R 
50 I S R S R S R S S R S R R S S S R I R R 
51 I S S S R S R S S R S R R S S S R I R R 
52 I R R S R S R S S R S R R S S S R I R R 
53 S R R I R I R I S R R R R I R S R S R R 
54 I R R S R S R S S R S R R R S S R I R R 
55 S R S S R I R S S R R R R I R R R S R R 
56 S R R S R S R S S R I R R S S S R S R R 
57 I R S I R S R S S R R I R S R S S S R R 
58 S R R S R I R S S R R R R S R R R S R R 
59 I R S I R S R I S R I I R S R S R I R R 
60 S R S S R S R S S R S R R I S S R S R R 
61 S R R R R I R S S R R R R R R R R S R R 
62 S R S I R R R S S R I R R S I S I S R R 
63 S R R S R R R S S R S R R S S S R S R R 
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Table 19: Continued… 
 Antibiotic resistant profile 
Is
o
la
te
 
C
IP
 
V
A
 
A
M
C
 
C
 
O
X
 
T
E
 
A
M
P
 
A
K
 
C
N
 
F
O
X
 
D
A
 
E
 
P
 
S
X
T
 
R
D
 
IP
M
 
K
Z
 
N
O
R
 
M
Y
 
A
Z
M
 
64 S R R I R I R S S R R R R S R S R S R R 
65 S S S I R S R S S R I R R S S S I S R R 
66 S S R I R R R S S R S R R R R R R S R R 
67 S R R I R I R S S R R R R I R S R S R R 
68 S R R S R R R S S R R R R I R S R S R R 
69 S R R S R R R S S R R R R S R S R S R R 
70 S R R S R I R S S R R R R I R S R S R R 
71 S R R S R I R S S R R R R S R S R S R R 
72 S S R I R R R R R R R I R S R S R R R I 
73 S R S S R S S S R R I I R S R S R R R I 
74 S R R S R R R S S R R R R S R I R S R R 
75 S S S S R S R S S R S R R R S S R S R R 
76 S R R S R I R S S R R R R I R S R S R I 
77 S R R S R S R S S R S R R R I S R S R R 
78 S R R S R S R S S R S S R S S S R S R S 
79 I R R S R S R S S R R R R R R S R S R S 
80 S S S S R S R S S R S R R R S S R S R S 
 
Key: AK- Amikacin; AMC- Amoxicillin/clavulanic acid; AMP- Ampicillin; AZM- Azithromycin; C- Chloramphenicol; CN- Gentamicin; DA- 
Clindamycin; E- Erythromycin; FOX- Cefoxitin; IPM- Imipenem; KZ- Cefozolin; MY- Lincomycin; NOR- Norfloxacin; OX- Oxacillin; P- 
Penicillin; RD- Rifampicin; SXT- Sulfamethoxazole/trimethoprim; TE- Tetracycline; VA- Vancomycin 
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Table 20: Virulence and antibiotic resistance genes detected in each isolate 
Isolate Virulence genes Antibiotic resistance genes 
hla hld lukS/F PV sea mecA aac-aph blaZ ermC msrA tetK 
1 (-) (+) (-) (+) (+) (-) (+) (-) (-) (+) 
2 (-) (+) (-) (+) (+) (+) (+) (+) (-) (-) 
3 (-) (+) (-) (+) (+) (+) (+) (-) (-) (+) 
4 (-) (+) (-) (+) (+) (-) (+) (-) (-) (+) 
5 (-) (+) (-) (+) (+) (+) (+) (+) (-) (+) 
6 (-) (+) (-) (+) (+) (+) (+) (+) (-) (+) 
7 (-) (+) (-) (+) (+) (+) (+) (+) (-) (+) 
8 (-) (+) (-) (+) (+) (+) (+) (+) (-) (+) 
9 (-) (+) (-) (+) (+) (+) (+) (+) (-) (+) 
10 (-) (+) (-) (+) (+) (+) (+) (-) (-) (+) 
11 (-) (+) (-) (+) (+) (+) (+) (-) (-) (+) 
12 (-) (+) (-) (+) (+) (+) (+) (+) (-) (+) 
13 (-) (+) (-) (+) (+) (+) (+) (+) (-) (+) 
14 (-) (+) (-) (+) (+) (+) (+) (+) (-) (+) 
15 (-) (+) (-) (+) (+) (+) (+) (+) (-) (+) 
16 (-) (+) (-) (+) (+) (+) (+) (+) (-) (+) 
17 (-) (+) (-) (+) (+) (+) (+) (+) (-) (+) 
18 (-) (+) (-) (+) (+) (+) (+) (+) (-) (+) 
19 (-) (+) (-) (+) (+) (+) (+) (+) (-) (+) 
20 (-) (+) (-) (+) (+) (+) (+) (+) (-) (+) 
21 (-) (+) (-) (+) (+) (+) (-) (+) (-) (+) 
22 (-) (+) (-) (+) (+) (+) (-) (+) (-) (+) 
23 (-) (+) (-) (+) (+) (+) (+) (+) (-) (+) 
24 (-) (+) (-) (+) (+) (+) (+) (+) (-) (+) 
25 (-) (+) (-) (+) (+) (+) (-) (+) (-) (+) 
26 (-) (+) (-) (+) (+) (+) (+) (+) (-) (+) 
27 (-) (+) (-) (+) (+) (+) (-) (+) (-) (+) 
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Table 20: continued… 
Isolate Virulence genes Antibiotic resistance genes 
hla hld lukS/F PV sea mecA aac-aph blaZ ermC msrA tetK 
28 (-) (+) (-) (+) (+) (-) (-) (+) (-) (+) 
29 (-) (+) (-) (+) (+) (-) (-) (-) (-) (-) 
30 (-) (+) (-) (+) (+) (-) (-) (+) (-) (+) 
31 (-) (+) (-) (+) (+) (+) (+) (+) (-) (+) 
32 (-) (+) (-) (+) (+) (+) (+) (+) (-) (+) 
33 (-) (+) (-) (+) (+) (+) (+) (+) (-) (+) 
34 (-) (+) (-) (+) (+) (+) (+) (+) (-) (+) 
35 (-) (+) (-) (+) (+) (+) (+) (+) (-) (+) 
36 (-) (+) (-) (+) (+) (+) (+) (+) (-) (+) 
37 (-) (+) (-) (+) (+) (+) (+) (+) (-) (+) 
38 (-) (+) (-) (+) (+) (+) (+) (+) (-) (+) 
39 (-) (+) (-) (+) (+) (-) (+) (+) (-) (+) 
40 (-) (+) (-) (+) (+) (-) (+) (+) (-) (+) 
41 (-) (+) (-) (+) (+) (-) (-) (+) (-) (+) 
42 (-) (+) (-) (+) (+) (+) (-) (-) (-) (+) 
43 (-) (+) (-) (+) (+) (+) (-) (-) (-) (+) 
44 (-) (+) (-) (+) (+) (+) (-) (+) (-) (+) 
45 (+) (+) (-) (+) (+) (+) (+) (+) (+) (+) 
46 (-) (+) (-) (+) (+) (+) (+) (+) (-) (+) 
47 (-) (-) (-) (-) (+) (-) (+) (+) (-) (-) 
48 (-) (-) (-) (-) (+) (-) (+) (+) (-) (+) 
49 (-) (-) (-) (-) (+) (-) (+) (+) (+) (+) 
50 (-) (-) (-) (-) (+) (-) (+) (+) (+) (-) 
51 (-) (-) (-) (-) (+) (-) (+) (+) (+) (+) 
52 (-) (-) (-) (-) (+) (-) (+) (+) (+) (-) 
53 (-) (-) (-) (-) (+) (-) (-) (-) (+) (-) 
54 (-) (-) (-) (-) (+) (-) (-) (+) (-) (-) 
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Table 20: Continued… 
Isolate Virulence genes Antibiotic resistance genes 
hla hld lukS/F PV sea mecA aac-aph blaZ ermC msrA tetK 
55 (-) (-) (-) (-) (+) (-) (+) (-) (+) (+) 
56 (-) (-) (-) (-) (+) (-) (-) (-) (+) (-) 
57 (-) (-) (-) (-) (+) (-) (-) (-) (+) (+) 
58 (-) (-) (-) (-) (+) (-) (-) (-) (-) (+) 
59 (-) (-) (-) (-) (+) (+) (+) (-) (+) (+) 
60 (-) (-) (-) (-) (+) (+) (+) (-) (+) (-) 
61 (-) (-) (-) (-) (+) (-) (-) (-) (-) (+) 
62 (-) (-) (-) (-) (+) (+) (-) (-) (+) (+) 
63 (-) (-) (-) (-) (+) (+) (-) (-) (+) (-) 
64 (-) (-) (-) (-) (+) (+) (-) (-) (+) (+) 
65 (-) (-) (-) (-) (+) (-) (+) (+) (-) (-) 
66 (-) (-) (-) (-) (+) (-) (+) (-) (-) (+) 
67 (-) (-) (-) (-) (+) (-) (+) (-) (-) (-) 
68 (-) (-) (-) (-) (+) (-) (+) (-) (-) (+) 
69 (-) (-) (-) (-) (+) (-) (+) (-) (+) (-) 
70 (-) (-) (-) (-) (+) (-) (+) (-) (-) (-) 
71 (-) (-) (-) (-) (+) (-) (-) (-) (-) (-) 
72 (-) (-) (-) (-) (+) (-) (-) (-) (-) (-) 
73 (-) (-) (-) (-) (+) (-) (-) (-) (-) (-) 
74 (-) (-) (-) (-) (+) (-) (-) (-) (-) (-) 
75 (-) (-) (-) (-) (+) (-) (+) (+) (+) (-) 
76 (-) (-) (-) (-) (+) (-) (+) (+) (-) (-) 
77 (-) (-) (-) (-) (+) (+) (+) (+) (-) (-) 
78 (-) (-) (-) (-) (+) (+) (+) (-) (+) (-) 
79 (-) (-) (-) (-) (+) (-) (+) (-) (+) (-) 
80 (-) (-) (-) (-) (+) (-) (+) (+) (-) (-) 
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